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ABSTRACT 
 
Bone is a dynamic living tissue and thus, upon trauma, it continuously 
undergoes absorption, reconstruction and remodelling. However, in the case of severe 
bone lesions, this repairing mechanism might fail, leading to a biomechanical failure of 
the tissue. In such clinical situations, tissue engineering offers the ultimate possibility of 
providing alternative successful therapies for the regeneration of injured bone tissue, 
through the creation of a functional tissue substitute in vitro. This is generally achieved 
through a specific interplay between cells and supportive materials – scaffolds, which 
can be further modulated by the culturing system used. A major challenge in the 
translation of such tissue engineered bone substitutes to viable clinical treatments 
consists in the need to grow large, fully viable grafts that are several centimetres in size 
that can be used for the regeneration of large critical size defects. The use of flow 
perfusion bioreactors has shown evident advantageous over static culturing, as these 
systems usually allow a more efficient transfer of nutrients and oxygen, enabling an 
uniform distribution of cell seeded on the 3D scaffold, thus stimulating the development 
of homogeneous tissue for subsequent implantation. Some of these systems have also 
demonstrated the ability to provide mechanical stimulus to cell – seeded scaffolds, 
leading to higher functionality of the resulting constructs. However, up to now, these 
studies have focused on culturing small constructs, which do not address the clinical 
need for developing grafts that can be used in the regeneration of bone critical sized 
defects 
The main objective of this thesis was to study the importance of scaffolds and cells 
in the regeneration of critical size defects and to develop a new flow perfusion 
bioreactor enabling to culture large sized defects with improved functionality for the 
treatment of large bone defects.Therefore, the main specific objectives proposed for 
this thesis were: 
 
- Studying the importance of the scaffold material and autologous stem cells 
obtained from the bone marrow in the regeneration of critical sized orthotopic 
defects. 
- Development of a new flow perfusion bioreactor system enabling the culture of 
3D-scaffold with large dimensions, up to 120 mm in length and 60 mm in 
diameter, allowing maintenance of cell viability/functionality in the interior of the 
scaffold, and also enabling mechanical stimulation through fluid flow induced 
shear stresses. 
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- Analysing the feasibility of the developed bioreactor, studying the behaviour of 
the three dimensional starch-based scaffolds seeded with bone marrow MSCs 
and cultured under static and flow perfusion culturing conditions. 
- Assessing the influence of three dimensional cell-scaffold constructs in vitro 
cultured in the newly developed bioreactor on the regeneration of bone critical 
sized defects performed in a large animal model 
- Studying the use of bone marrow stromal cells (from rat, goat and cat) as a 
reliable cell source for bone tissue engineering application, as they can be 
readily available and obtained by simple harvesting procedures from the same 
patient, avoiding the risk of disease transmission and/or immune rejection. 
These cells can be used in tissue engineering strategies but also in other 
regenerative medicine approaches, such as the direct implantation into a tissue 
defect to stimulate healing 
Under the scope of this thesis it was created, designed, built, developed and 
optimized a Bi-Directional Continuous Perfusion Bioreactor (patent pending) that 
enables culturing three dimensional cell-scaffold constructs of large dimensions, for the 
reconstruction of critical size defects for bone tissue engineering. The feasibility of the 
system was demonstrated by the functionality of the tissue engineering constructs 
obtained under in vitro culturing conditions provided by the bioreactor, that allows to 
mitigate diffusion limitations typical of static culturing and simultaneously provide 
physiological-like stimulus to the seeded cells.  
The 3D scaffolds studied in this thesis, namely fiber mesh based on a biodegradble 
polymeric blend of starch with polycaprolactone (SPCL) were able to promote 
adhesion, proliferation and differentiation of marrow stromal cells (of different animal 
species) towards the osteoblastic phenotype, particularly when cultured under flow 
perfusion conditions. Furthermore, the in vivo studies demonstrated that these 3D 
scaffolds, play an important role both in the formation of bone tissue and 
neovascularisation, conditions important for the development and sustainability of cell-
scaffolds of large dimensions, but also provided an excellent biomechanical 
environment for the regeneration of critical sized defects. In summary, the culture of an 
appropriate scaffold material with bone marrow cells, cultured in the new bioreactor 
herein developed may provide an important step forward in the development of bone 
tissue engineered grafts of large dimensions that are highly in demand in the 
orthopedical clinical field. 
 
  
 
XIV 
Leandro S. Gardel, PhD thesis, University of Porto, 2012 
 
RESUMO 
 
O osso é um tecido dinâmico que, quando traumatizado, sofre um processo 
contínuo de absorção, reconstrução e remodelação. Contudo, no caso de lesões 
ósseas severas, este mecanismo de regeneração pode falhar, levando à falência 
biomecânica do tecido. Nestas situações, a engenharia de tecidos oferece uma 
solução terapeutica alternativa, capaz de levar à regeneração do tecido ósseo 
danificado através da criação in vitro de um substituto de tecido funcional. Isto é 
conseguido através da interação entre células e um material de suporte tridimensional 
(“scaffold”), que podem ser posteriormente modulados através do sistema de cultura 
usado. Um dos maiores desafios para a translação clínica destes materiais hibridos 
(constituídos pelos scaffolds e células) produzidos por metodologias de engenharia de 
tecidos, é a necessidade da produção de materiais híbridos de grande dimensão 
(vários cm) totalmente viáveis para a regeneração de defeitos de tamanho crítico. A 
utilização de biorreatores de perfusão de fluxo permite uma maior eficácia na 
transferência de nutrientes e oxigénio e possibilita uma distribuição uniforme das 
células no biomaterial de suporte tridimensional levando assim, à estimulação do 
desenvolvimento de tecido homogéneo para subsequente implantação. A utilização 
deste tipo de bioreactores tem-se revelado vantajosa quando em comparação com 
sistemas de cultura estática sendo que, alguns destes sistemas demonstram serem 
também capazes de proporcionar estímulos mecânicos às células semeadas no 
biomaterial de suporte tridimensional, proporcionando uma maior funcionalidade dos 
materiais híbridos obtidos. Até ao momento, estes estudos têm-se focado na cultura 
de scaffolds de reduzida dimensão, que não permitem a sua utilização clínica na 
regeneração de defeitos ósseos de dimensão crítica.  
O principal objetivo desta tese consiste em estudar a importância dos scaffolds e das 
células na regeneração de defeitos de dimensão crítica e desenvolver um novo 
biorreator de perfusão de fluxo que possibilite a cultura de scaffolds de grandes 
dimensões conducentes ao tratamento de defeitos ósseos de dimensões críticas. 
Assim, os principais objetivos específicos desta tese foram: 
  
- Estudar a importância do material do biomaterial de suporte tridimensional e 
das células estaminais autológas obtidas por aspiração da medula óssea na 
regeneração de defeitos ósseos ortotópicos de tamanhos críticos. 
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- Desenvolver um novo bioreactor de perfusão de fluxo que possibilite a cultura 
de biomaterial de suporte tridimensional de grandes dimensões (até 120 mm 
de comprimento e 60 mm de diâmetro), que permita a manutenção da 
viabilidade/funcionalidade celular no interior do biomaterial de suporte 
tridimensional e possibilitar estímulos mecânicos, através das forças de tensão 
de corte induzidas pela perfusão do meio de cultura. 
 
- Analisar a funcionalidade do biorreator desenvolvido através do estudo do 
comportamento de scaffolds baseados numa mistura polimérica de amido de 
milho e policaprolactona (starch/polycaprolactone - SPCL), e semeados com 
células estaminais mesenquimatosas, originárias da medula óssea, após 
cultura no bioreactor de perfusão de fluxo ou cultura em condições estáticas. 
 
- Avaliar a influência dos materiais hibridos constituidos pelo scaffolds e células 
após cultura in vitro no novo biorreator, na regeneração em defeitos ósseos de 
tamanho crítico, através da implantação em modelos animais de grande porte 
(cabra). 
 
- Estudar a utilização da medula óssea (de rato, cabra e gato) enquanto fonte 
segura de células estaminais para aplicações em engenharia de tecido ósseo, 
uma vez que estão disponíveis em quantidades interessantes e podem ser 
obtidas através de procedimentos de recolha simples a partir do próprio 
paciente, evitando assim o risco de transmissão de patologias e/ou rejeição 
imune. Estas células podem ser usadas em estratégias de engenharia de 
tecidos mas também noutras técnicas de medicina regenerativa, como é o caso 
da implantação direta em defeitos tecidulares para estimulação da cicatrização 
óssea. 
No âmbito desta tese, foi criado, desenhado, construído, desenvolvido e otimizado 
um Biorreator de Perfusão Contínua Bi-direcional (patente pendente) que permite a 
cultura de scaffolds de grandes dimensões para a reconstrução de defeitos de 
tamanho crítico na área da engenharia de tecidos ósseos. A viabilidade do sistema foi 
demonstrada pela funcionalidade das estruturas de engenharia de tecidos obtidas em 
condições de cultura in vitro proporcionadas pelo biorreator que permite mitigar as 
limitações de difusão típicas de sistemas de cultura estática fornecendo, 
simultaneamente, um estímulo às células em cultura, semelhante ao existente em 
condições fisiológicas.  
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Os biomateriais de suporte tridimensional estudados nesta tese, nomeadamente a 
malha de fibra baseada numa mistura polimérica biodegradável de amido de milho 
com policaprolactona (SPCL), possibilitaram a adesão, proliferação e diferenciação de 
células medulares estromais (de diferentes espécies animais) em células de fenótipo 
osteoblástico, particularmente quando submetidas a condições de cultura em perfusão 
de fluxo. Paralelamente, o estudo in vivo demonstrou que estes biomateriais de 
suporte tridimensional têm um importante papel não só na formação de tecido ósseo e 
na neovascularização (condições importantes para o desenvolvimento e 
sustentabilidade de biomateriais de suporte tridimensional celulares de grandes 
dimensões) como também mostraram proporcionar um excelente ambiente 
biomecânico, fator importante no que diz respeito ao uso de biomateriais em defeitos 
de dimensão crítica. Em síntese, a cultura de biomateriais de suporte tridimensional 
apropriados, com células da medula óssea cultivadas neste novo biorreator pode 
providenciar um importante passo em frente no desenvolvimento de enxertos ósseos 
de grandes dimensões, desenvolvidos através de técnicas de engenharia de tecidos 
que constituem uma importante necessidade para o campo da ortopedia clínica.  
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Bone Biology 
 
1.1 Introduction 
The embryologic mechanisms of bone formation entail an orchestration of cellular 
humoral and mechanical factors resulting in the formation of skeletal bony tissues. Bone is 
a connective tissue with cells and fibres which are embedded in a hard substance that 
protects and supports it. In addition to these mechanical functions, bones serve an 
important chemical function, providing a reservoir for mineral hemeostasis (1, 2). Bone 
consists of several functionally distinct regions: At the articulating surfaces is the articular 
cartilage; Surrounding the entire bone is a membranous structure, the periosteum; Lining 
the area enclosing the cartilage (capsule) of the joints and also lining tendons sheaths are 
the synovial membranes, providing nutrition and lubrication to the articular cartilage while 
serving as a protective barrier; The woven lamellar, cancellous bone lies below the phyisis 
in a methaphysis, and the compact, cortical bone surrounds a marrow cavity in the 
disphyseal region(2). Bone is a dynamic tissue that, throughout life, is renewed and 
remodelled. It has a unique structure that provides a great tensile strength with the least 
amount of weight when compared to any other tissue, having the ability to adapt its 
internal structure to changes that might happen in the load environment (3). Structurally, 
bone is a dense material, or matrix, in which, as rule, spidery cells called osteocytes are 
embedded. The matrix is composed of collagen fibbers, crystals of a calcium-phosphate 
complex, and a ground substance, or cement, containing mucopolysaccharides, among 
many other components. The nucleated body of each osteocyte occupies a small cavity, 
or lacuna, in the matrix; and the long, branching, cytoplasmatic processes lie in fine 
tunnels, or canaliculi, which radiate from the lacuna.  
Canaliculi from neighbouring lacunae anastomose freely; thus, bone is 
characteristically permeated throughout by an extremely rich system of communicating 
cavities and canals (4).Bone is a unique tissue that gives mechanical support to the body. 
It is a major reservoir of calcium and bone marrow, which produces the blood cells. Cells 
present in bone are the supporting cell, termed osteoblasts and osteocytes, and 
remodelling cells called osteoclasts. Osteoblasts are the skeletal cells responsible for 
synthesis, deposition, and mineralization of bone. Osteocytes are derived from 
osteoblasts. After secreting osteoid and mineral salts, osteoblasts become isolated in a 
cavity of bone matrix and become an osteocyte. Osteoclasts are constantly eroding 
deposited bone, while osteoblasts are constantly replacing osteoid and minerals.  
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In this way, bone is a dynamic tissue that is being formed and broken down in a 
continuous cycle in response to physical and hormonal factors (5, 6).  
 
1.2 Normal Vascularization of Bone 
In 1691, Clopton Havers described in his book how a large nutrient artery pieces 
the shaft of long bones and ramified in bone marrow. He presumed that an oily medullary 
substance was expelled into a system of straight pores within the bone, these pores 
becoming known as Haversian canals. It is now well accepted that the nutrient artery 
penetrating the nutrient foramen, divides into ascending and descending branches of the 
medullary artery and these are the main source of centrifugal blood flow in the cortical 
bone of long bones. The medullary blood vessels arborize and anastomose with both the 
metaphyseal vessels as well as the periosteal vessels in regions of the strong soft tissue 
attachment. This allows increased compensatory blood flow from the anastomossing 
supply should one system, such as the medullary supply be knocked out(7).  
In Compact bones the vascularisation is performed between the afferent and 
efferent systems and function as the vascular lattice where critical exchange between the 
blood and surrounding living tissue occurs. 
Cortical canal of Havers and Volkmann and the minute canaliculi make this 
system, which convey blood supply to the osteocytes(7). 
 
1.3 Structure and composition of bone tissue 
All bones – long, flat, intramembranous, woven and compact- are specialized 
forms of connective tissues, and their form and function, like those of other connective 
tissues, depend on the arrangement and interactions of the elements of the extracellular 
bone matrix that distinguishes it from other connective tissue matrices and enables it to 
perform its unique functions(2). 
 
1.3.1 Macroscopic organization of bone tissue 
 Macroscopically, bone is considered to be a non-homogenous, porous (porosity 
varying from 5 to 95%) and anisotropic tissue (8).  
 Two main forms of bone may be seen in vertebrate organisms: woven bone 
(immature bone with randomly arranged collagen fibres in the osteoid, produced when 
osteoblasts rapidly produce osteoid) and lamellar bone (composed of regular parallel 
bands of collagen). The woven bone, which is rapidly formed, will eventually be 
remodelled and will form lamellar bone, a stronger type of bone (9, 10). 
Chapter I: General Introduction 
 5 
Leandro S. Gardel, PhD thesis, University of Porto, 2012 
 
In the mature skeleton two types of lamellar bone may be found: cortical bone and 
medullary bone.  
Compact or cortical bone (5-10% porosity) forms the walls of the diaphysis, it 
consists of parallel columns that individually are made of concentric lamellae disposed 
around Haversian channels (central channel with blood and lymphatic vessels and nerves, 
also called osteons) which, on their turn, connect with other Haversian channels and with 
periosteum and endosteum through Volkmann’s channels. The limits between osteons 
and surrounding bone are called cement lines. 
 Medullary bone or cancellous bone (50-95% porosity) occupies part of the central 
cavity of the bone and consists of trabeculae (a network of fine plates) which are 
separated by spaces that intercommunicate containing the medullary blood supply and 
filled mostly by fat tissue. An adult long bone, as for example the humerus or the femur, in 
a longitudinal cut consists of two enlarged ends called epiphyses which are connected by 
a hollow cylindrical shaft named diapysis. Between these, lies a very important cancellous 
type of bone named methapysis that contains important hematopoietic elements. 
Separating the epiphysis from metaphysis, we can distinguish a vital element for immature 
bone known as growth plate, wich is responsable for the longitudinal lengthening of long 
bones(9, 10). 
 
1.3.2 Microscopic organization of bone tissue 
Bone is composed of cells and an extracellular matrix predominantly collagenous 
called osteoid and it mineralizes after the deposition of calcium hydroxyapatite, which 
makes bone strong and rigid (10). 
 
1.4 Cells of bone tissue 
There are three principal cell types in all bones: osteoblasts, osteocytes, and 
osteoclasts. 
Osteoblasts synthesize and mediate the mineralization of osteoid and are found 
lined along the bone surface (where new bone is deposited), ranging from columnar to 
squamous shape, the nucleus is located in the basal region and the cytoplasm is 
basophilic  whit abundant endoplasmic reticulum. They are found on the surface of bone-
forming regions, know as haversian systems, which surround blood vessels within the 
matrix of woven bone (2). These cells are of mesenchymal origin and are of great 
importance in various functions:  
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Matrix synthesis – being responsible for producing all matrix components and 
matrix mineralization – it is believed that initiation of mineralization is under control of the 
osteoblast within matrix vesicles (whose function is to destroy inhibitors of mineralization 
and to concentrate precipitates and crystals of calcium and phosphorus) facing the bone-
forming surface (9, 10). 
Initiation of resorption – receptors that activate osteoclastic bone resorption are 
found on osteoblasts: hormones (PTH, for example) and citocines that estimulate this 
process bind to osteoblasts. In the particular case of parathyroid hormone these receptors 
located on the cell membrane of osteoblasts induce an increase in intracellular cAMP that 
will phosporylate intracellular proteins consequently activating a physiological response 
(PTH will cause osteoblasts to round up and separate from one another and will also 
activate the release of collagenases that will then destroy the thin and unmineralized layer 
of collagen allowing osteoclasts to gain access to bone surface through gaps formed by 
this osteoblastic separation and destruction of the collagen layer). Communication with 
osteocytes (osteoblast-osteocyte network) – osteoblasts are able to send cytoplasmic 
projections into the matrix during the synthesis of the latter. Some of these projections 
extend through canaliculi and then from lining cells to the osteocytes and from osteocyte 
to osteocyte, forming gap junctions that allow small molecules and also ions to travel 
between these cells. Osteocytes are inactive osteoblasts trapped inside formed bone and 
are able to assist in the nutrition of the bone. These are the principal cell type in mature 
bone and they reside in lacunae, microscopic holes in the bone. These cells are able to 
send cytoplasmatic projections that are able to penetrate through the bone in canaliculi 
and gap junctions are present where the cell contacts processes of an adjacent bone. The 
long cellular projections are able to shorten and lengthen and this activity possibly allows 
the movement of pulsatile fluid flow through lacunae and canaliculi in order to transfer 
metabolites (10, 11). Osteocytes and bone-lining cells are presently thought to be the 
primary mechanosensory cells responsible for interpreting mechanical forces in bone 
tissue and translating them to osteoblasts and osteoclasts for bone remodelling (12-14). 
 Multiple investigators report evidence supporting the key mechanosensory role of 
osteocytes in bone formation as detected by changes in matrix protein expression, and 
production of nitric oxide (NO) and prostaglandin E2 (PGE2), a potent stimulator for bone 
formation (14, 15). 
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The osteocytes trapped deeper in the bone are older than the more superficial 
ones. Osteocytes play a role in the homeostasis of calcium and that changes in their 
metabolic activity are able to solubilise small amounts of mineral in the lacunar walls. 
Osteocytes are the most abundant differentiated cells. Numerous of these cells are 
released from the lacunae when osteoclast resorption is occurring (10, 11). 
Osteoclasts are large phagocytic cells (20 to 100 µm in diameter) that have the 
capacity to erode the bone, and which are important in the process of bone turnover and 
refashioning. These cells are originated from the monocyte-macrophage system. 
Preosteoclasts are mononucleated cells that when activated will fuse with cells alike and 
when after accessing the bone surface, they differenciate further finally becoming 
multinucleated (15 to 30 nuclei per cell) osteoclasts. The activated ostoclasts have ruffled 
borders (is a resorbing organelle, and it is formed by fusion of intracellular acidic vesicles 
with the region of plasma membrane facing the bone (16) and secrete acid and lysosomal 
enzymes are directly responsible for removing the mineral and matrix bone (17, 18). After 
enzymatic and acid digestion (acid phosphatese, collagenase, cathepsins and neutral 
proteases) of the bone matrix the erosion lacune (Howship’s lacuna) is 
formed(2).Differences in mode of degradation have been observed as well. Calvarial (flat 
bone) osteoclasts use cysteine proteinases as well as matrix metalloproteinases (MMPs) 
to degrade the bone matrix, whereas resorption by long bone osteoclasts is accomplished 
mainly by cysteine proteinases (19, 20). This lacuna will remain even after the osteoclast 
is gone, which indicates prior areas of bone resorption.  
Osteoclasts are also found as part of cellular complexes involved in bone 
remodelation and these cells are responsible for the release and activation of TGF-beta, 
and of mineral and protein components of bone, participating in the maintenance of blood 
calcium homeostasis by responding to parathyroid (which stimulates osteoclastic 
resorption and the release of calcium ions from the bones) an calcitonin (acts as a 
mitogenic agent on pre-osteoblastic cell lineage) (10). 
Interleukine 1 (in vitro induces bone resorption and osteoclast-like cell formation in 
human and murine marrow cultures; in in vivo studies induced hypercalcemia and growth 
and differentiation of the earliest identifiable osteoclast precursor – CFU-GM), IL - 6 
(controversial role, potentiates the effect of PTH on calcium homeostasis and bone 
resorption in vivo) and IL-11 (effects on osteoclast differentiation), M-CSF (important role 
on osteoclast development), TGF-α (proliferative factor, stimulates the growth of early 
osteoclast precursors), TNF-α and β (stimulate the formation of osteoclast like 
multinucleated cells in human marrow cultures, increase bone resorption, enhance the 
effect of IL-1) are soluble factors that increase osteoclast activity. TGF-β (modulates  
Chapter I: General Introduction 
 8 
Leandro S. Gardel, PhD thesis, University of Porto, 2012 
 
osteoclastic bone resorption, migration and differentiation, inhibiting bone resorption) IFN-
γ (inhibitor of bone resorption in vitro, suppresses formation of and maturation of 
osteoclasts), IL-4 (high levels may inhibit bone formation and bone resorption), IL-18 
(inhibits osteoclastic formation in vitro), nitric oxide (produces rapid contraction and 
detachment of osteoclasts in cell surfaces, inhibits bone resorption), sex steroids 
(estrogen inhibits osteoclast formation), and osteoprotegerin (disrupts an F-actin ring 
inhibiting osteoclastogenesis and bone resorption) inhibit osteoclastic activity (21). Bone 
lining cells consist of inactive osteoblasts not buried in new bone. After bone formation 
stops, these cells will remain on bone surface and will only be re-activated after chemical, 
mechanical stimuli or both (9, 22). 
 
1.5 Biochemical composition of extracellular bone matrix 
The mature compact bone is made of approximately 65% inorganic salts and 35% 
organic matrix (1, 23). Of this organic component, about 90% is collagen (specially type I 
fibers), the protein which gives strength to the bone; in mature bone collagen fibers are 
organized in concentric layers in osteons (cortical bone) or parallel the rounding surfaces 
of trabecullae (cancellous bone). The remaining 10% is made of ground substance 
proteoglycans (essentially chondroitin sulphate and hyaluronic acid forming aggregates) 
which besides controlling the content in water of the bone, are also supposed to be 
involved in the regulation of the formation of collagen fibers for ulterior mineralization of 
the matrix  and non-collagen molecules which are supposed to be involved in the 
regulating the bone mineralization (osteocalcin – which is involved in binding calcium; 
osteonectin – which may have a bridging function between the mineral component and 
collagen; sialoproteins and other molecules) (8, 10). Differences in the organic matrix 
were observed in a study where cortical bone (midshaft of tibia) was compared with 
trabecular bone (lumbar spine), showing trabecular bone to have more osteonectin but 
less osteocalcin than cortical bone (24). 
The inorganic component consists of hydroxiapatite crystals which are deposited 
within the collagen fiber network. The principal salts in bone are: Ca, CO3, PO4, and OH. 
There are also substancial amounts of Na, Mg and Fe present in bone, which is also 
considered a “storehouse” for calcium and phosphorus (23). Although only one percent of 
the amount of calcium-phosphorus existing in the matrix can be rapidly deployed in ion 
(22)The inorganic component of bone controls the compression strength and stiffness, 
whereas the collagen is believed to contribute to the ultimate strength and toughness of 
bone (25-27). 
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1.6 Functions of bone tissue 
The most evident functions of bone tissue are obviously to support to the body 
organs and tissues, so that it maintains its basic structure, and to enable 
movement/locomotion. Moreover bones provide attachment points for the muscles, 
transmitting forces from one part of the body to another under controlled strain and to 
protect vital organs and structures (8). Within the bone it is found the bone marrow, an 
essential structure for hematopoiesis and immune function. In addition to this, bone also 
plays a function in mineral, specially calcium, homeostasis (this feature is however rather 
small when compared to other organs such as the kidney) (10). 
 
1.7 Remodelling of bone tissue 
The remodelling process consists in the activation of resorption -proteases that 
dissolve bone matrix and acid that will release bone mineral into the extracellular space 
beneath the ruffled border are secreted by osteoclasts (21) followed by formation of new 
bone. Theoretically, the total amount of new bone replaced is equal to the total amount of 
removed bone (so that the volume difference is equal to zero). This process allows that 
microfactures and other small damages suffered with time are removed and replaced with 
new tissue(9). 
Bone remodelling only happens in the internal surface of trabecular surfaces 
(cancellous bone) and of Haversian systems (cortical bone). The process is not performed 
individually by each different cell type, but actually by “basic multicellular units” (BMUs) 
which are groups of organized cells that operate replacing old bone by new bone in a 
discrete fashion, in a sequence that usually follows a similar pattern: activation – 
resorption – formation(28).  
 
1.8 Biology of bone fracture healing 
 Fracture healing represents a complex series of responses incluiding inflammation, 
wound repair, developmental responses and bone remodelling. Biologically, fracture 
healing has been classically divided into several stages, which include haematoma 
formation, inflammation, angiogenesis, cartilage formation, endochondral ossification and 
remodelling. The early stages are all non-specific to bone repair in that they are wound 
repair phenomena, common to soft tissue injury also. The specific bone repair 
phenomena include endochondral and intramembranous ossification and bone 
remodelling. 
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Basically, there are three stages in the process of post-fracture bone healing, 
which are similar to what occurs in other tissues.  
 
1.8.1 Inflammatory Phase 
After a trauma to the bone, which results in a fracture, the periosteum and the 
muscles around the bone are torn and many blood vessels are damaged. The hematoma 
(which will later organize itself and will serve as a fibrin scaffold for repair cells to perform 
their function) accumulates inside the medullary canal, between fracture ends and 
beneath elevated periosteum. This vascular damage will deprive osteocytes of nutrition 
which will cause their death. Thus, the edges of the fractures are dead. The presence of 
necrotic material in large quantities leads to an intense acute inflammatory response 
characterized by vasodilatation, plasma exudation and acute edema. Inflammatory cells, 
polymorphonuclear leukocytes and macrophages will then migrate to the region(22). 
 
1.8.2 Reparative Phase 
The cells directly involved in this process are pluripotent cells of mesenchymal 
origin. During this period the gap fracture is filled with bony like material and the 
revascularization of bone fragments occurs by a temporary formation of an extraosseous 
blood supply by connecting the surrounding soft tissues to the bone fragments and by 
establishment of a centripetal flow circulation.  
Under natural circumstances, the periosteal vessels will contribute to the majority 
of capillary buds early in bone healing, with the medullary artery being of greater 
importance later in the process. As soon as the intramedullary blood supply is re-
established the afferent vascular system returns to its normal pattern. All tissues require 
microvasculature to heal beyond scar, with the exception of cartilage, which makes 
microvasculature a good indicator of bone healing (29). 
It is know that the microenvironment around the fracture gap is acid, and this may 
stimulate the cell behaviour during this phase. Over time, as the reparative phase occurs, 
the pH will return to a slightly alkaline level. The hematoma, which provides some 
mechanic support on the site, tends to be invaded by granulation tissue composed mostly 
by fibrous tissue and cartilage known as fibrous callus. This process enhances the 
stability in the fracture ends leading to the next phase called mineralized callus. This 
occurs when there is a high quantity of collagen which leads to deposition of calcium 
hydroxyapatite crystals (30). 
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This deposition process tends to be highly organized and ends when the union of 
the fracture ends is safely achieved. During this phase it is very important that too 
stressful forces are absent of the fracture ends due to the need of an oxygen rich 
environment which otherwise can delay de union(22). 
 
1.8.3 Remodelling Phase 
The last phase in bone healing consists in the replacement of woven bone by 
longitudinal haversian systems in the fracture gap. This phase may occur for several 
years as evidenced by radioisotope studies that show that increased activity in a bone that 
has suffered a fracture may last for 6 to 9 years in human tibial fracture. The mechanism 
that controls this cell behaviour is believed to be electric: after stress, electro-positivity will 
occur on the convex bone surface (associated with osteoclastic activity) and electro-
negativity on the concave surface (associated with osteoblastic activity), producing current 
(piezoelectric effect). The resorption unit (which consists of osteoclasts that resorb bone 
and osteoblast that lay down new haversian systems) is the cellular module that controls 
remodelling).Two patterns are recognizable in bone healing: primary and secondary 
healing (9, 30). 
 
1.8.4 Primary bone healing 
Primary healing happens when strain across the gap is less than 2% and can 
occur in two different ways:  under small fracture gaps, by direct bridging of the fracture 
gap by haversian or, more commonly, in a process called “gap healing”, which consists in 
the woven bone being directly laid into the gap by osteoblasts followed by remodelation by 
haversian bone (30). 
This process involves attempts by bone cortex to re-establish new haversian 
systems by formation of “cutting cones” (remodelling units) in order to restore continuity of 
bone. During this process there is no formation of bone callus (31).  
 
1.8.5 Secondary bone healing 
Secondary healing occurs with the formation of a fracture callus by involving a 
combination of intramembranous (involving the formation of bone directly – without 
forming cartilage – from pluripotential mesenchymal and osteoprogenitor cells. The callus 
formed is a hard callus) and endonchondral ossification (involving the recruitment, 
proliferation and differentiation of mesenchymal cells into cartilage followed by  
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calcification and replacement by bone tissue. This process provides the formation of a soft 
callus, an early bridging callus that stabilizes the fragments formed after trauma (31, 32).  
The indirect bone healing occurs when there is an unstable environment that 
produces motion in the fracture ends or these are too distant to allow lamellar bone 
formation in a direct way. The degree of movement or strain defines the capability and 
conditions of bone healing and starts always with a soft callus that progress to 
mineralization. The gaps between the fractures ends are filled initially with hematoma 
(formed by the local ruptured vessels and turned tissues). The role of the hematoma is still 
controversial since some investigators believe that it should be removed to accelerate de 
bone healing and others support the fact that it contains important factors and cells that 
provide the development of the granulation tissue. These together produce some 
mechanical stability which is crucial for the next phases. With time these tissues tend to 
be replaced by fibrous connective tissue and fibrous cartilage forming the soft callus. This 
together with lamellar bone deposition increases the local stability and leads to the 
fibrocartilaginous mineralization. The mineralization occurs from the base of the fracture 
ends to the middle of the bridge forming trabecular and woven bone known as hard callus. 
At this stage the degree of instability at the site dictates the capability and the exuberance 
of this type of callus formed. The granulation tissue in fractures ends with too much 
motion tends to involve a larger area leading to a consequent bigger callus. At the same 
time the mineralization occurs, resorption mechanisms can be observed on the initial 
bone. These occur due to the high osteoclast activity leading to resorption cavities which 
penetrate trough fragment ends and newly formed bone gap. Then theses spaces tend to 
be filled with new mesenchymal cells with high osteoblast population forming aligned 
lamellar bone. This last stage can be active from months to several years until perfect 
oriented mineralization is achieved (2, 30, 33). 
 
1.8.6 Intramembranous bone formation 
In fractures with multiple bone fragments and sufficient local stability the initial 
phase consists in intramembranous bone formation. In these cases, bone is directly 
deposited on the fragments from the fracture site or in the bridging phase of much 
comminuted fractures. This type of bone formation is always combined with various steps 
of indirect bone healing process (30, 31). 
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1.9- Bone regeneration 
The processes of bone repair are sufficient for effective and timely restoration of 
skeletal integrity for most fractures, when an appropriate mechanical environment exists 
or is created whit internal fixation or coaptation. However, some situations require 
manipulation or augmentation of natural healing mechanisms to regenerate larger 
quantities of new bone than would naturally occur to achieve surgical goals. Specific 
situations that may require additional interventions include substantial loss of host bone 
from trauma or tumor resection, arthrodesis, or spinal fusion, non-or delayed unions, 
metabolic disease, arthroplasty, or insufficient healing potential of the host because of 
local or systemic disease or old age. Materials and strategies that are employed must 
duplicate and amplify the events of secondary bone union to achieve the desired results 
(34, 35). Bone can be regenerated through the following strategies: osteogenesis-- the 
transfer of cells; osteoinduction-the induction of cells to become bone; osteoconduction, 
providing a scaffold for bone forming cells or osteopromotion—the promotion of bone 
healing and regeneration by encouraging the biologic or mechanical environment of the 
healing or regeneration tissues (35). The most efficacious strategies use as many of the 
fundamental components of bone regeneration as possible, and each facet of bone 
regeneration relies upon mesenchymal stem cells (36, 37). 
 
1.10- Bone mesenchymal stem cells (MSC) 
Mesenchymal stem cells (MSCs) are an interesting candidate for cell-based 
therapeutics and regenerative medicine (38, 39). MSCs are a rare population of 
multiopotential cells capable of differentiating into osteoblasts, chondrocytes, adipocytes, 
tenocytes and myoblasts (Figure 1.1) (5, 40-46). Their origin is either the cambium layer 
of periosteum or bone marrow, although other sources such as muscles, fat, and 
synovium provide a limited source (32, 45, 47). 
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Figure1.1. Schematic representation of the principal source of adult stem cells. Adapted 
from: (57) 
 
Bone marrow and periosteum sources are richest in young age with numbers 
diminishing, but still present in old age. MSC number and biologic activity are greatest in 
methaphyseal bone and areas of thick and vascular periosteum, contributing to more 
robust healing at these locations (45, 46).  
The study of MSC has primarily utilized those retrievable from bone marrow 
aspirate (47). Isolation techniques are generally based on the adherent properties of the 
MSC. Density gradient centrifugation is sometimes employed to separate nucleated MSC. 
As the cells are cultured, MSC adhere to the flask surface (40, 47). The non-adherent 
cells are removed with the culture medium when it is changed, concentrating the MSC. 
The cells are repeatedly passaged, expanding the cell population, until a pure culture is 
produced. The isolated cells are confirmed to possess osteogenic potential by various 
techniques (32, 48, 49). 
In vitro experiments have demonstrated the formation of mineralized nodules, 
along with elevated production of alkaline phosphatase, osteopontin, bone sialoprotein, 
osteocalcin, types I and III collagen, and the generation of PTH and estrogen receptors, 
during the differentiation of MSC into osteoblasts (42, 50-52).  
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In view of this, various studies have already shown that culturing of 
osteoprogenitor cells from purified MSC in media supplemented with dexamethasone, 
ascorbic acid, and glycerophosphate initiates a development process that directs the cells 
into an osteoblastic differentiation pathway (42-44). The cells express bone matrix protein 
mRNAs and the deposition of a hydroxyapatite-mineralized extracellular matrix confirming 
that the cells isolated become bone forming cells (44, 47). 
 MSC can also maintain viability and multilineage potential after cryopreservation. 
Neither cryopreservation nor thawing negatively effects the growth or differentiation of 
MSCs (45). Therefore, MSC can be effectively isolated, culture expanded, preserved, and 
implanted. The osteogenic potential of marrow-derived MSCs has evoked widespread 
interest and been well defined, as evidenced by their ability to produce new bone after 
transplantation of MSCs in vivo  (41, 42) by the direct conversion of MSCs to osteoblasts, 
without progression through a cartilaginous intermediate (47). Because bone healing and 
growth involve migration, proliferation, and differentiation of osteocompetent cells, a major 
improvement in materials used for bone repair and regeneration is achieved through 
loading of the scaffold prior to implantation, with osteocompetent cells. Subsequent bone 
formation would therefore 
not depend on the local recruitment of osteocompetent cells. It is thought that by 
delivering stem cells directly to the site, both the need for chemotaxis of osteoblast 
progenitor cells to the defect and the level of proliferation required to repair the bone were 
decreased (48). 
 
1.11- Osteogenesis 
  Bone formation requires the cellular machinery to fabricate its structural 
components. As such, no strategy of bone regeneration can neglect introduction of cells, 
and the most efficacious strategies nurture an early cellular environment (35). Autogenous 
cancellous bone grafts are best example of an osteogenic graft and are the “gold 
standard” for bone regenerative materials (Figure 1.2). Cancellous autograft provides a 
mixture of cells from fully differentiated osteoblasts lining the cancellous bone to 
undifferentiated MSC in the marrow components (32). MSC can respond to the local 
biologic and mechanical environment and differentiate into any cellular component 
needed in secondary bone union, therefore offer robust bone healing potential for a 
variety of situations. 
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However, the cells do not work alone but are combined with matrix and signals 
provided by the cancellous particles, yielding a mixture that contains other facets of bone 
regenerating strategy. Autogenous cancellous bone grafts are easily obtained from the 
iliac crest, greater tubercle of the humerus, wing of the ilium and sternum in veterinary 
medicine, from iliac crest in human medicine and are the mainstay of osteogenic material 
in orthopaedic surgery.  
Harvesting bone graft requires a separate surgical site increasing surgical time and 
cost. Donor site morbidity is more common in humans (53, 54). The quantity of 
autogenous cancellous bone that can be harvested may be insufficient, especially in older 
or small patients, or when a very large amount of graft material is needed. Thus, although 
autogenous cancellous bone is principally ideal, substitutes are often needed. Another 
example of an osteogenic material is bone marrow (55, 56). Bone marrow aspirates 
contain MSC, cells already committed to osteogenic or chondrogenic lineage, and some 
biologically active proteins that stimulate bone regeneration in similar manner to naturally 
occurring fracture clot, many from platelet degranulation. However, use of bone marrow 
does not yield the magnitude of osteogenesis observed with cancellous bone for several 
reasons. Aspiration results in varying quality of bone marrow depending on technique and 
patient (55). 
 
Figure1.2. Schematic representation of the osteogenic lineage. Adapted from:(57) 
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1.12- Osteoinduction 
Materials that have the capacity to induce bone formation when placed into a site 
where no bone formation will occur are termed osteoinductive (Figure 1.3) (35, 58, 59). 
These materials do not work alone, but recruit MSC or their progeny to infiltrate the 
material (chemoattraction and migration) then induce the multipotential cells to multiply 
and become cells that comprise the regenerating bony callus (proliferation and 
differentiation). The best know example of osteoinductive materials is demineralised bone 
matrix (DBM). By decalcifying bone (usually allogeneic) in process that do not inactivate 
bone’s biologically active components, organic matrix exposed along with a plethora of 
bone stimulatory cytokines trapped within the organic matrix during bone formation. These 
are naturally occurring initiators and mediators of bone healing, which are released when 
bone fractures. Bone morphogenetic proteins (BMP), the most specific family of bone 
inducing cytokines, are members of the transforming growth factor (TGF-β) superfamily of 
growth factors that include cartilage-derived growth factors, and other growth and 
differentiation factors. Although often referred to as specific entity, the growth factors of 
DBM are a combination of biologically active cytokines, which may be chemotactic To 
MSC to follow certain osteoblastic or chondroblastic lineages, or stimulate replication of 
MSC or their progeny(58, 59). 
  
1.13- Osteoconduction 
A Material that provides a scaffold for MSC and theirs progeny to migrate into, and 
proliferate within, is termed osteoconductive(Figure 1.3) (35). These are materials with 
three-dimensional shape that offer an appropriate framework, surface characteristics for 
adherence of MSC, osteoblasts, osteocytes, chondroblasts and chondrocytes (60, 61), 
and interconnecting porosity for cellular proliferation and vascular ingrowth and thus may 
serve as temporary scaffolds for transplanted cells to attach, grow, and maintain 
differentiated functions (61-70). In any case, the role of the biomaterial is temporary, but 
rather crucial to the success of the strategy. Therefore, the selection of a scaffold material 
is both a critical and difficult choice (71). Specific examples of naturally occurring 
osteocondutive materials include autogenous cancellous bone, and some forms of DBM 
or deproteinized bone. Synthetic materials include metals, hydroxyapatite, collagen, tri-
calcium phosphate, apatitic calcium phosphate, calcium sulfates, porous coralline 
ceramics, bioactive glass, calcified triglycerides, or the polyhydroxy acid family of 
polymers(polylactide, polyglycolide), blends of corn starch(in amounts varying from 30 up 
to 50 %wt) with poly(ethylene vinyl alcohol) (SEVA-C), cellulose acetate(SCA), poly(ε-
caprolactone) (SPCL) and poly-lactic acid(SPLA) (60, 61, 72, 73).  
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Bioabsorption and osteoconduction are quite variable between materials and 
because of their relatively passive role in bone regeneration; these materials have limited 
utility alone. Although bone can infiltrate and often replace many of these materials, they 
lack essential osteogenic and osteoinductive properties and rely on natural cellular 
activities of MSC or their progeny to infiltrate and provide their own biologic signals for 
proliferation and differentiation (60), but the criteria of biodegradability and non-brittle 
nature (ideally with tissue matching mechanical properties) excludes the use of all metals 
and most ceramics as scaffolds materials (74) and gives preference to biodegradable 
polymers for most of the applications within the tissue engineering and regenerative 
medicine field (71). 
 
1.14- Osteopromotion 
A material or physical impetus that results in enhancement of regenerating bone is 
termed osteopromotive(Figure 1.3) (35). Osteopromotion can function at various stages 
during bone healing and provide different stimulatory signals to bone regenerating tissues. 
Osteopromotion differs from osteogenesis or osteoconduction as bone formation is 
enhanced without cells or a scaffold; however, osteopromotive stimuli alone cannot induce 
bone formation.  
Osteopromotion can be achieved by introduction of substances or materials that 
enhance bone regeneration, or by physical or mechanical strategies that induce 
proliferation and differentiation of MSC and their progeny. The good example of an 
osteopromotive substance is platelet-rich plasma (PRP), which is produced by 
centrifugation of the blood yielding a suspension of concentrated platelets. Platelets 
function not only in hemostasis, but are essential for initiation of the healing process, 
including bone healing. The a granules of platelets contain a rich source of growth factors 
including TGF-b, platelet-derived growth factor (PDGF), vascular endothelial growth factor 
(VEGF), and insulin-like growth factor (IGF). TGF-b is a potent chemotactic agent for MSC 
and supports differentiation of osteoblasts (73); PDGF and IGF I and II are potent 
mitogenic agents, and VEGF is a potent angiogenic agent (75). Platelets will release the 
contents of their granules on contact with fibrin or von Willebrands factor (73). Cellular and 
humoral factors are a essential mechanical factors cannot be neglected. MSC and their 
progeny respond aggressively to local mechanical forces and the local mechanical 
environment has a strong influence on cellular proliferation and differentiation Developing 
fracture callus or areas of regenerating bone are subjected to physical forces.  
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If these forces result in physical disruption of regenerative tissues then bone 
healing cannot occur and non-union results; however, forces of lesser magnitude may 
have a physical effect on regenerating tissues without cell death. Compression of MSCs 
resulting in increasing pressure within the cell will encourage chondroblastic 
differentiation; however, low-to-moderate magnitudes of tensile strain and hydrostatic 
tensile stress may stimulate new bone formation. This occurs because of deformation or 
elongation of the cells including MSC and early osteoblastic and chondroblastic cells. 
Cellular deformation results in intracellular signals, which in turn encourage regenerating 
cells to proliferate and follow an osteoblastic lineage, provided the biologic environment 
and oxygen levels are suitable (76). 
 
 
Figure1.3. Schematic representation of an ideal bone graft. Adapted from:(57) 
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Abstract 
Tissue engineering and regenerative medicine (TERM) strategies for generation of 
new bone tissue includes the combined use of autologous or heterologous mesenchymal 
stem cells (MSC) and three-dimensional (3D) scaffold materials serving as structural 
support for the cells, that develop into tissue-like substitutes under appropriate in vitro 
culture conditions. This approach is very important due to the limitations and risks 
associated with autologous as well as allogenic bone grafiting procedures currently used. 
However, the cultivation of osteoprogenitor cells in 3D scaffolds presents several 
challenges, such as the efficient transport of nutrient and oxygen and removal of waste 
products from the cells in the interior of the scaffold. In this context, perfusion bioreactor 
systems are key components for bone TERM, as many recent studies have shown that 
such systems can provide dynamic environments with enhanced diffusion of nutrients and 
therefore perfusion can be used to generate grafts of clinically relevant sizes and shapes. 
Nevertheless, in order to determine whether a developed tissue-like substitute conforms 
to the requirements of biocompatibility, mechanical stability and safety, it must undergo 
rigorous testing both in vitro and in vivo. Results from in vitro studies can be difficult to 
extrapolate to the in vivo situation, and for this reason, the use of animal models is often 
an essential step in the testing of orthopedic implants prior to clinical use in humans. This 
review provides an overview of the concepts, advantages and challenges associated with 
different types of perfusion bioreactor systems, particularly focusing on systems that may 
enable the generation of critical size tissue engineered constructs. Furthermore, this 
review discusses some of the most frequently used animal models, such as sheep and 
goats, to study the in vivo functionality of bone implant materials, in critical size defects. 
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2.1- Introduction 
The TERM field has expanded rapidly as new discoveries are made that render 
possible tissue replacement and regeneration. Considering the body’s tissues 
biochemical, biophysical and hydrodynamic requirements, functional tissue engineering 
requires the development of new tools for in vitro tissue culture, in order to create a 
biotissue that can develop in vivo and replace damaged tissue (1, 2). Moreover, the 
increasing patient demand for tissue-engineered products and therapies requires 
technologies for large scale production of tissue substitutes with precise control of 
shape/size and high quality (3-6). Bioreactors can be defined as devices in which 
biological or biochemical processes, or both, are re-enacted under controlled conditions 
(for example, pH, temperature, pressure, oxygen supply, nutrient supply, and waste 
removal). Originally most bioreactors were developed to test biomaterials but some of 
them were also invented with the objective of enabling extracorporal tissue growth (7). In 
fact, bioreactors might facilitate the aseptic growth of functional tissues and 
simultaneously offer several further advantages over culture in plates and flasks (8, 9). In 
addition, bioreactors can be custom designed for engineering tissues with complex three-
dimensional geometry containing multiple cell types (10). The fact that physical stimuli can 
modulate cell function and tissue development has further motivated the development of 
biomechanically active stimulation systems to culture functional cell-tissues constructs in 
vitro by exposing them to physiologically relevant mechanical and/or hydrodynamic 
stimulation. The overall goal is to have systems that reliably and reproducibly form, store, 
and deliver functional tissues substitutes that can sustain function in vivo. In essence, the 
bioreactor needs to provide the appropriate physical stimulation to cells, continuous 
supply of nutrients (e.g. glucose, amino acids), biochemical factors and oxygen, diffusion 
of chemical species to the construct interior, as well as continuous removal of by-products 
of cellular metabolism (e.g. lactic acid) (11). In the absence of a vascular blood supply in 
vitro, nutrient delivery to cells throughout three-dimensional (3D) tissue-engineered 
constructs grown in static culture must occur by diffusion. As a result, thin tissues and 
tissues that are naturally avascular (e.g., cartilage) have been more readily grown in vitro 
than thicker, vascular tissues such as bone (12-14). The ex vivo generation of larger 
three-dimensional tissue substitutes particularly requires the development of enlarged 
devices and systems that allow cells to distribute within a wide three-dimensional space, 
and at the same time satisfy the physicochemical demands of culturing such large cell 
masses into a scaffold (6, 15).  
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Several international research groups have demonstrated the advantages of using 
culture systems that combine both hydrodynamic and mechanical stimulation during 
tissue development (16-21). The vast majority of these studies report on the development 
and use of perfusion bioreactors, which are mostly composed of a perfusion pump with 
one or more output channels where the flow can be controlled and connected to single or 
multiple cell culture chambers through silicone tubes which allow the exchange of gases 
(O2, CO2) between the culture medium and the environment. Most of these groups work 
for the development of new combinations of stem cells and materials constructs to obtain 
functional tissue-engineered constructs for bone regeneration. Thus, they are also 
interested in developing and evaluating their concepts in highly reproducible large 
segmental defects in preclinical large animal models. These studies should allow the 
development of methods to produce reliable data (biocompatibility, mechanical stability 
and safety), creating a real set of information to allow, in the near future, the use of tissue 
engineered constructs of large dimensions, specifically translating into the orthopedics 
surgical field. This is an essential step in the process of assessing newly developed bone 
grafts prior to clinical use in humans. Animal models allow the evaluation of materials in 
loaded or unloaded situations over potentially long time durations and in different tissue 
qualities and ages. While some animal models may closely represent the mechanical and 
physiological human clinical situation, it must be remembered that it is only an 
approximation, with each animal model having unique advantages and disadvantages 
(22). This review examines the existent literature concerning the use of perfusion 
bioreactors systems and large animal models to evaluate tissue engineered constructs of 
large dimensions. 
 
2.2- Bioreactors for bone tissue engineering 
For tissue engineering purposes, dynamic culture bioreactors, such as spinner 
flasks (23, 24), rotating wall bioreactors (23, 25), and flow perfusion systems (19, 26), 
have shown promising results. In general, dynamic culture yields a much more 
homogeneous distribution of cells and matrix while systems enabling shear stresses 
applied by the medium flow may stimulate the cells to proliferate and differentiate. 
Furthermore, these systems enhance mass transport, ensuring continuous nutrition of 
cells and removal of waste products. The commonly used spinner flasks are low cost 
equipments, but the non-uniform media flow that is provided around scaffolds limits their 
use. The cells on the outer periphery of scaffolds are subjected to a turbulent flow, 
whereas the cells in the interior exhibit static molecular diffusion (27).  
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Similar drawbacks are seen in the rotating wall bioreactor. Some flow perfusion 
systems overcome the flow issues because medium is flushed directly through scaffolds 
(19, 26), thereby providing nutrient and stimuli throughout the entire volume of the scaffold 
(27). The design and performance of bioreactors is therefore of special relevance in 
recent and future tissue engineering strategies. Bioreactors that use a pump system to 
perfuse media directly through a scaffold are known as perfusion bioreactors (28). 
Perfusion bioreactors with defined mechanical stimulation functions are of special interest 
to optimize the ex vivo growth of the desired cell or scaffold constructs (7, 29). However, 
direct perfusion introduces a new level of complexity when scale-up is considered, and the 
engineering challenges may be significant (11).  
Nutrition, chemotransport enhancement and mechanical stimulation (dynamic 
tension, compression or hydrodynamic forces) of cells or cell/scaffold constructs, control 
over environmental conditions, culture duration, on-line evaluation of biological variables 
and automation of bioprocesses should be considered for the development and use of 
bioreactors (1, 29-35). Moreover, bioreactors should to be able to operate over long 
periods of time under aseptic conditions since maturation of a functional tissue substitute 
may take up to several weeks. Another important issue in the design of bioreactors is the 
monitoring of tissue growth. In fact, an advantage in the area would be the development 
and employment of techniques which could assess the integrity of the tissue non-
invasively (11). Oxygen and nutrient need and its consumption by the cells, metabolite 
removal and fluid flow within the site have a dramatic impact on the growth and survival of 
enlarged constructs for tissue substitution, and when controlled can be used as major 
positive modulators in elaborated bioreactors. This would allow for a higher efficiency in 
the tissue engineering process, as well as a high degree of certainty in harvesting tissues 
within the pre-determined manufacturing specifications.  
 
2.3- Perfusion bioreactors 
In addition to enhancing mass transport, perfusion bioreactor systems may be 
used to deliver controlled mechanical stimuli such as flow-mediated shear stresses and/or 
hydrodynamic forces to tissue constructs (36-38). Different perfusion bioreactor have 
been developed but most systems consist of a similar basic design consisting of a media 
reservoir, a pump, a tubing circuit, and perfusion chambers, columns or cartridges that 
hold the cell/scaffold constructs (39). Perfusion bioreactor systems have been developed 
to culture a variety of shapes and sizes of 3D bone tissue constructs (19, 25, 40-54).  
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In these systems, it is obvious that the flow-rate used for the medium perfusion is 
responsible to a great extent for the effects in the microenvironment of cells, i.e., for the 
magnitude of the shear stress sensed by the cells. Nevertheless, the local internal shear 
stress created by perfusion systems using hydrodynamic forces and experienced by the 
cells on three dimensional (3D) matrices is influenced not only by the medium flow rate 
but also by other parameters that have to be considered, for example, the porosity, the 
dimensions, the material and the geometry of the scaffold, the size, the anisotropy, and 
the degree of interconnectivity of pores, as well as the viscosity of the medium (55). 
Nowadays, multidisciplinary efforts are being made to improve the size and quality 
of the bone substitutes that can be obtained in vitro. These efforts focus on the cell types 
used, scaffold structure/composition, and also on the cultivation in perfusion bioreactor 
systems with various designs. However, most studies on perfusion bioreactors describe 
systems that only enable culturing small scaffolds, which do not meet clinically relevant 
constructs size in the field of orthopedics defects regeneration. In the following sections, 
the main differences between two basic types of perfusion bioreactors (with individual 
culture chambers and single culture chamber)which enable to culture scaffolds with 
different dimensions, are described and discussed in the light of the current clinical need 
for larger engineered bone substitutes.  
 
2.3.1- Perfusion bioreactors with individual culture chambers for 
culturing small dimension constructs 
In flow perfusion systems composed of individual chambers, usually the scaffolds 
are fitted in the culture chambers so that media cannot flow around it, thus perfusing 
media directly through the pores of the scaffold. The flow of medium through the scaffold 
porosity benefits cell differentiation by enhancing nutrient transport to the scaffold interior 
and by providing mechanical stimulation in the form of shear stresses (49, 56, 57). In fact, 
studies with perfusion systems have suggested that flow has many biological effects (27, 
58-61), such as prostaglandin E2 release (62), osteogenic differentiation enhancement 
(49) and mineralized matrix production increase on bone marrow stromal osteoblasts 
seeded in 3D scaffolds (63). Research works using either custom-made or commercially 
available perfusion bioreactor systems are specified in Table 1. 
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Table 1 Summarizes research studies describing the development and/or use of 
perfusion bioreactors of individual culture chamber in the field of bone tissue engineering  
Table1.Summary table on research studies describing the development/use of perfusion bioreactor of 
individual culture chambers in bone tissue engineering. 
 
References 
 
Perfusion 
Bioreactor 
(type) 
Scaffolds material 
(shape) 
Scaffolds 
volume 
 
Cell type and 
density in 
scaffolds 
Flow rate Principal effects 
25 
 
 
63 
 
 
61 
 
 
 
 
40 
 
 
 
64 
 
 
 
 
49 
 
 
 
 
 
 
65 
 
 
 
 
 
 
 
66 
 
 
 
 
 
 
 
67 
 
6 chambers 
for 
cell/scaffolds 
samples  
 
 
PLG 12.7X6mm  
Titanium mesh 10 
x0.8mm 
 
Titanium fiber 
mesh 10 X0.8mm 
 
SEVA-C and 
SPCL 8x2mm   
 
Titanium mesh 
8x0.8 mm 
 
 
 
CPC  8x8 mm 
 
 
 
 
 
Polystyrene 
8mmx3mm 
 
 
 
 
 
PGA 8mmx3mm 
 
 
 
 
 
 
Si-TCP 10x5mm 
0.7600 cm3 
 
0.1256 cm3 
 
 
 
 
0,1256  
cm3 
 
 
0.1005 cm3 
 
 
0.0402 cm3 
 
 
 
 
 
0.4021 cm3 
 
 
 
 
 
 
0.1507 cm3 
 
 
 
 
 
 
 
0.1507 cm3 
 
 
 
 
 
 
 
0.3962 cm3 
Ratosteoblasts
1.900,000  
Rat MSC/ 
500,000  
 
 
Rat 
osteoblasts/ 
500,000  
 
 
Rat MSC/  
500,000  
 
Rat MSC 
500,000 
 
 
 
 
Rat MSC 
1.500,000  
 
 
 
 
Murine 
osteoblasts 
(MC3T3-E1) 
Diffrents 
density 
 
 
 
 
Rat MSC 
500.000 
 
 
 
 
 
 
hTERT-MSC 
2.000,000  
0.030 ml/s 
 
Low 0.3 ml/min 
medium1ml/mi
n high 3 ml/min 
 
 
0.5 ml/min 
 
 
 
0.3 ml/min 
 
 
∼0.3 ml/min(1 
day) being 
increased to 1 
ml/min. 
 
∼0.3 ml/min(1 
day) being 
increased to 1 
ml/min 
 
 
0.15ml/mim 
oscillating 
flowd every 5 
mim/2 hs. After 
unidirectional 
flow 0.15/min 8 
hs.  
 
 
 
0.15ml/mim 
oscillating 
flowd every 5 
mim/2 hs. After 
unidirectional 
flow 0.15/min 8 
hs.  
 
0.1ml/min 
Proliferation =, ALP+, OC+ 
 
Proliferation+, ALP +, Ca2 + 
+, OP+ 
 
 
 
Proliferation +, ALP +, Ca2 + 
+ 
 
Proliferation +, gene 
expression of 
RUNX2 +, ALP=, OC= 
 
Proliferation +, ALP +, Ca2 + 
+, 
OP+ 
 
 
 
Proliferation +, ALP+,OP + 
 
 
 
 
perfusion seeding technique 
+,  improve seeding 
efficiency +, cell spatial 
distribution+,proliferation+  
 
 
 
 
 
 
ALP activity +,DNA + 
Ca+ +. 
 
 
 
 
 
 
Proliferation+, ALP +, gene, 
OP +, BSP2 +, BMP2 +, 
Col1 -, RUNX2-,OC- 
expression of ALP +,  
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56 8 chambers 
for 
cell/scaffolds 
samples  
 
 
HDCB  6.4 x3mm 0.0965 cm3 Murine 
osteoblasts 
(MC3T3-E1) 
2.000,000  
perfusion rates 
of 1.0, 0.2, 0.1, 
and 0.01 
ml/min 
Proliferation +, gene 
expression of 
RUNX2 +, ALP=, OC= 
59 Minucellss 
and 
Minutissue® 
b-TCP  5x5x5mm 0.125 cm3 Rat 
osteoblasts 
83,333  
 
0.033ml/min ALP + (in vitro/ in vivo), OC 
+,  
in vivo bone formation + 
26 
 
 
 
 
68 
 
 
 
U-shaped 
glass tube, 2 
scaffolds per 
tube 
 
ChronOS™ 
 
 
 
 
Porous 
hydroxyapatite 
ceramic 
8mmx4mm 
0.2010 cm3 
 
 
 
 
0.2010 cm3 
 
 
 
 
Human MSC 
6E + 07 
cells/cm3 
 
 
Human MSC 
4.8 ± 2.6x103 
 
 
 
 
1mm/s 
 
 
 
 
100µm/s 
MTT staining +, 
improvement 
in cell spatial uniformity 
 
 
SEM +, BSP +, COL1 +, OP 
+, NGFR -, 
STRO-I - 
27 Polycarbona
te  multiple 
perfusion 
cartridges 
(one scaffold 
per 
cartridge) 
 
Collagen  
11x1.5 mm, 
silk6x1.5mm 
Collagen; 
0.1425 cm3 
Silk: 0.0424 
cm3 
Human MSC 
Collagen: 
500,000cells 
Silk:500,000  
0.2 ml/min Ca2 + + 
53 
 
 
 
 
 
 
70 
 
 
 
 
 
42 
 
 
 
 
77 
 
 
Perfusion 
bioreactor  
multiple 
flow 
chambers(3 
scaffolds per 
chamber) 
 
PET16x1.2mm 
 
 
 
 
 
 
PET16x1.2mm 
 
 
 
 
 
PET16x1.2mm 
 
 
 
 
PET16x1.2mm 
 
2.4127 cm3 
 
 
 
 
 
 
2.4127cm3 
 
 
 
 
 
2.4127 cm3 
 
 
 
 
2.4127 cm3 
 
Human MSC 
1.000.000 
 
 
 
 
 
Human MSC 
800.000 
 
 
 
 
Human MSC 
1.000.000 
 
 
 
Human MSC 
1.540,000  
 
 
0.1 ml/min 
 
 
 
 
 
 
0.1ml/min 
 
 
 
 
 
0.1ml/min and 
1.5 ml/min 
 
 
 
0.2ml/min 
 
 
 
DNA+. SEM+,Van Kossa +, 
Lactate production +, 
Glucose consumption +, 
Osteogenic and adipocity 
differentiation+ 
 
Lactate production +, 
Glucose consumption +, 
~9.4%gas phase oxygen 
 
 
ALP (0.1ml +, 1.5ml ++), 
Ca+(0.1ml +, 1.5ml ++), 
CFU-f(0.1ml ++, 1.5ml +), 
FN(0.1ml/min ++, 1.5ml/min 
=), HSP47(0.1ml =, 1.5ml 
+). 
 
ALP   + Ca+ +,   
 BMP-2 +, ALP +, RUNX2 +, 
OC + 
 
62 4 chambers 
for 
cell/scaffolds 
samples  
 
CPC5x 3.5mm 0.0687 cm3 Murine 
osteoblasts 
(MC3T3) 
100,000 
0.025 ml/min. 
(4 h). After 
oscillating fluid 
flow( 40 
ml/min) 
PGE2 +, Proliferation = 
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73 6 flow 
wells 
chambers 
for 
cell/scaffolds 
samples 
 
b-TCP  10x8mm 0.6283 cm3 Murine 
osteoblasts 
(MC3T3) 
1.500,000  
oscillatory 
perfusion 
Proliferation +, ALP +, Ca2 + 
+, cell 
Vitality+ 
44 
 
 
 
 
 
 
48 
6  radial 
chambers 
for 
cell/scaffolds 
samples  
 
BCB 4x4mm  
 
 
 
 
 
 
BCB  
4 x4mm 
0.0502 cm3 
 
 
 
 
 
 
0.0502 cm3 
 
Human MSC, 
low density 
30.000,000, 
high density 
60.000,000  
 
Human 
adipose MSC 
1.500,000 
100 µm/s(low-
flow), 400µm/s 
(high flow)  
 
 
 
 
1.8ml/min 
cell distribution +, Col +, OP 
+, BSP2 + 
 
 
 
 
 Proliferation =,  cell 
Distribution +, Col +, OP +, 
BSP2 + 
75 Minucellss 
and 
Minutissue® 
BDBM  9x5mm 0.3180 cm3 Murine 
preosteoblast 
(MC3T3-E1), 
50,000  
18µl/min Proliferation +, Vitality + 
54 8 chambers 
for 
cell/scaffolds 
samples  
 
Polyurethane 
24x6mm 
2.7143 cm3 Murine 
osteoblasts 
(MC3T3-E1) 
10.857,200  
1.0ml/min Proliferation +, cellular 
Distribution+, vitality + 
47 6 chambers 
for 
cell/scaffolds 
samples  
 
PLGA 
10x3mm 
0.2356 cm3 hTERT-
hMSCs 
500000 
0.2ml/min Proliferation +,DNA +, ALP 
+, SEM +, Ca+ +, op + 
Mathematical signs indicate the effects induced by the systems listed as compared to static culture :(+), 
positive effect ;(=), no effect ;(-), negative effect. BCP, biphasic calcium phosphate; BMP2, bone 
morphogenetic protein 2; HA, hydroxyapatite; PCL, polycaprolactone; PDMA, polydimethylsiloxane; PGE2, 
prostaglandin E2; PMMA, polymethylmethacrylate; RUNX2, runt-related transcription factor 2; SPCL, starch/ 
polycaprolactone blend; SEVA-C, starch/ethylene vinyl alcohol blend; b-TCP, beta-tricalcium phosphate; OP, 
osteopontin, OC, osteocalcin; COL, Collagen; COL1, collagen1;BCB, bovine cancellous bone; BDBM, bovine; 
CFU, colony forming units; HSP-47, heat shock protein; PGA, Poly (glycolic acid); FN, fibronectin; hTERT-
hMSCs, humam bone marrow-derived mesenchymal stem cells tranduced with humam telomerase catalytic 
subunit; PLGA, porous polylatic glycolic acid; MTT, [3(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide; SEM,  Scanning electron microscopy; BSP, bone sialoprotein; NGFR nerve growth factor receptor; 
STRO-1,is a cell surface protein expressed by bone marrow stromal cells and erythroid precursors. 
 
In 2001 Goldstein et al (25), compared a perfusion flow bioreactor to other systems 
that promote media convection, namely a spinner flask and a rotary vessel. For this 
purpose they used Poly (DL-lactic-co-glycolic acid) (PLGA) foam discs  seeded with 
marrow stromal cells and cultured in the presence of dexamethasone and L-ascorbic acid, 
at a constant flow  rate.  
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Cell numbers per foam were found to be similar with all culturing systems 
indicating that cell growth could not be enhanced by convection, but histological analysis 
indicated that the rotary vessel and the flow system produced a more uniform  
distribution of cells throughout the foams. Alkaline phosphatase (ALP) activity per cell was 
higher with culture in the flow system and spinner flask after 7 days, while no difference in 
osteocalcin (OC) activity per cell was observed among culturing methods after 14 days. 
Based on these results, the flow system appears to be the superior culturing method (25). 
In 2002, Bancroft et al (63) reported the development of another flow perfusion 
bioreactor and investigated the effect of different flow rates, in rat bone marrow cells cells 
seeded into titanium fiber mesh scaffolds cultured in osteogenic media. Culturing seeded 
scaffolds at different flow rates for 16 days revealed a dose-dependent effect of flow 
perfusion rate on mineralized matrix production, matrix modeling, and cell matrix 
distribution. The latter was significantly higher in the flow perfusion cultures when 
compared with static culture (63). Van De Dolder et al, in 2003 (61), used the same 
bioreactor, biomaterial, culture medium and cells, to analyze the effect of flow perfusion 
(as compared to static conditions), at a constant flow rate, founding that this system can 
enhance the early proliferation, differentiation, and mineralized matrix production of rat 
bone marrow stromal cells(61). 
The same bioreactor developed by Bancroft et al, in 2002 (63), was used in other 
studies, using different types of scaffolds, such as porous biphasic calcium phosphate 
ceramic scaffolds(49), Poly(L-lactic acid) nonwoven fiber mesh scaffolds (43), and starch 
polycaprolactone (SPCL) biodegradable fiber mesh scaffolds (40, 41). Furthermore, 
Holtorf et al, in 2005 (64), showed that using this system, even in the absence of 
dexamethasone supplement, rat BMSCs can differentiate into osteoblastic (64). Gomes et 
al, in 2003 (40) have also showed that rat BMScs proliferation and differentiation are 
affected by the scaffold’s porosity and architecture (40) and reported increased production 
and localization of TGF-β1, VEGF, BMP-2, and FGF-2 in constructs cultured under 
increase fluid flow rate(41). Based on the same bioreactor design, Alvarez-Barreto et al, in 
2007 (65), developed and characterized an oscillatory flow-perfusion seeding technique, 
to improve seeding efficiency, cell spatial distribution and strength of cell adhesion. The 
technique consisted in the application of an oscillating flow for 2 h at 0.1 ml/min that is 
created by manually changing the direction of the pump every 5 min(65). This technique 
led to enhanced seeding efficiency and osteoblastic differentiation of rat BMSC cultured in 
poly (glycolic acid) (PGA) scaffolds (66). Bjerre and co-workers in 2008 (67), performed 
another modification of the same bioreactor. The modified system consists of 16 parallel 
flow chambers, each supplied by a common reservoir controlled by a peristaltic pump.  
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They analyzed the proliferation and differentiation of hMSC cultured on silicate-
substituted tricalcium phosphate scaffolds at a constant flow rate as compared to static 
culture. Data obtained from ALP activity and RT-PCR analysis of bone markers after 14 
days in flow culture demonstrated an increase in proliferation, differentiation and 
cell/matrix deposition (67).  
The perfusion bioreactor from Minucells and Minutissue®, are one of the few 
commercially available culture systems and has a different design: there is not a 
recirculation of the culture medium as in most systems described; the culture medium is 
perfused through 12 culture chambers in one direction, each one supporting a single, 
tightly fitting scaffold and the container is maintained at 37ºC by a thermo plat in room 
temperature, connected to another bottle (waste culture medium) where the flow ends. 
This system was used by Wang et al, in 2003 (59), to culture bone marrow-derived cell in 
porous ceramic scaffolds, using a constant flow rate. ALP and OC expression were 
increased in perfusion cultures when compared of static cultures (59). 
Wendt et al, in 2003 (26) developed a bioreactor for automated cell seeding of 3D 
scaffolds by continuous perfusion of a cell suspension through the scaffold pores in 
oscillating directions. In this system, scaffolds are placed in chambers (one scaffold per 
chamber) that are positioned at the bottoms of two glass columns and connected through 
a U-shaped glass tube at their base. Flow is induced with the use of a vacuum pump and 
the flow rate regulated with a flow meter. The direction of flow is reversed when the fluid 
level in one column reaches an optical sensor placed near the top of each glass column. 
The sensor detects the cell suspension, actuating a pair of solenoid valves, switching the 
vacuum to the opposite column, and therefore reversing the direction of fluid flow. To 
assess the efficiency and uniformity of perfusion seeding of Polyactive foams ChronOS® 
seeded with bone marrow stromal cells (BMSCs), as compared to static and spinner flask 
cultures, they used quantitative biochemical and image analysis techniques. The results 
showed that perfusion seeding of cells into Polyactive foams were more homogeneously 
distributed throughout the scaffold volume and formed more homogeneously sized cell 
clusters when compared to other systems (26). Braccini et al, in 2005(68), used the same 
system, to study the effect on seeding, expansion, and differentiation of BMSCs into a 3D 
hydroxyapatite scaffolds and subsequent in vivo outcomes. When implanted ectopically in 
nude mice, the engineered constructs generated bone tissue more reproducibly, 
uniformly, and extensively than scaffolds loaded with 2D expanded BMSCs (68). 
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Zhao and Ma, in 2005 (53),  modified a 3D perfusion bioreactor system developed 
previously by Ma et al, in 1999 (69),  which is composed of three circulating loops. The 
main circulating loop includes culture chambers and a section of the flow path for 
continuous circulation of medium. The inoculation loop includes culture chambers and a 
section of the flow path used for inoculating cells into scaffolds. The replenishing loop 
consists of the fresh media container and the section of the flow path used for supplying 
fresh media to the system. The two inlets and two outlets in each chamber are connected 
to independent inlets from the computerized peristaltic pump that has eight independent 
channels. This system enables the recirculation of media and has two sampling ports at 
the inlet and outlet of each chamber. Furthermore it can accommodate multiple flow 
chambers, depending on the operational requirements. To examine the dynamic seeding 
efficiency, the author used non-woven poly (ethylene terepthalate) (PET) fibrous scaffolds 
cultured with human mesenchymal stem cells (hMSC). They observed an inverse 
correlation between flow rates for seeding operation and seeding efficiencies and 
analyses showed that after a long period of culture, higher cell densities of hMSCs were 
found in the bioreactor system (53). With the same method and biomaterial Zhao et al, in 
2005 (70), studied the effects of the physiological oxygen environment on the intrinsic 
tissue development characteristics in the 3D scaffolds as compared to static conditions, 
using a mathematical modeling. Results show that the oxygen tension in the static culture 
is lower than that of the perfusion unit, where the cell density was 4 times higher (70). To 
demonstrate the effect of shear stress, Zhao et al, in 2007 (42), cultured porous 3D PET 
matrices with hMSC at different flow rates in the same bioreactor. The higher flow rate 
enhanced osteogenic differentiation potential at 14 days, and calcium deposition in the 
matrix after 20 days with osteogenic media (42). 
A perfusion bioreactor was developed by Timmins and co-workers in 2007 (71),  
the tissue culture under perfusion (T-CUP), based on the concept of controlled and 
confined alternating motion of scaffolds through a cell suspension or culture medium, as 
opposed to pumping the fluid through the scaffolds. Different cell types as well as scaffold 
designs and compositions were tested. When freshly isolated human bone marrow 
nucleated cells seeded into ENGipore® ceramic scaffolds cultured for 19 days in the T-
CUP resulted in stromal cell-populated constructs capable of inducing ectopic bone 
formation in nude mice (71). 
Grayson et al, in 2008 (44), described a bioreactor system that enables cultivation 
of up to six tissue constructs simultaneously in individual chambers, using a radial channel 
with direct perfusion and imaging capability.  
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Fully decellularized bovine trabecular bone was used as a scaffold, seeded with 
hMSCs using different cellular densities and different flow rates (low and high).The results 
of the study indicated that, at the seeding densities evaluated, greater initial cell numbers 
do not necessarily result in increased bone formation.  
The study also showed that flow rate of medium perfusion remains a significant 
parameter that allows a more uniform tissue development and supports higher cell 
densities within the constructs (44). Frohlich et al, in 2010 (48), using the same bioreactor 
showed that, human adipose-derived stem cells (hASCs), cultured in decellularized bone 
scaffolds, after 5 weeks of culture in osteogenic medium, presented significantly increases 
in the construct cellularity and in the amounts of bone matrix components (48). 
Costa et al, in 2008 (72), developed a perfusion bioreactor composed of 20 culture 
chambers, each one supporting a single, tightly fitting scaffold. A peristaltic pump controls 
the medium flow rate through the bioreactor, with silicon tubes directly connected to the 
system and to a medium reservoir (with recirculation flow). Using this system, a study was 
conducted using starch-polycaprolactone (SPCL) meshes statically seeded with goat 
bone marrow cells (gBMCs) and cultured in osteogenic medium for 7 and 14 days. The 
results showed enhanced cellular proliferation and differentiation by combination of fluid 
flow rate and flow inversion frequency during different culturing periods (72).  
Sailon et al, in 2009 (54), developed a flow perfusion chamber bioreactor with 8 
individual chambers to provide chemotransportation in thick scaffolds. Polyurethane 
scaffolds, seeded with murine preosteoblasts, were cultured. Flow-perfused scaffolds 
demonstrated increase in peripheral cell density and core density at day 8. This study  
established  that thick (>6mm) 3D constructs are sustainable using a flow-perfusion 
bioreactor(54)  
Yang and co-workers, in 2010 (47), developed a perfusion system that is 
composed of six culture cassettes, a multichannel cylinder pump and a medium reservoir. 
Each culture cassette contained a screw-top, a neoprene o-ring, and a screw-bottom with 
an internal cavity. The scaffold is press-fitted on a net in the internal cavity of the screw-
bottom. Media flows from top to bottom through the scaffold. Flow through each cassette 
is driven by the cylinder pump with each culture cassette on its own independent pumping 
circuit. In the complete perfusion culture circuit, media is drawn from the common media 
reservoir, pumped through each culture cassette, and returned to the common media 
reservoir. The entire flow circuit is connected with silicon tubing.  
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Using hMSCs transduced with human telomerase catalytic subunit hTERT 
(hTERT-hMSCs) cultured in porous PLGA scaffolds under perfusion for 12 days at a flow 
rate of 0.5 ml/min, they demonstrated that the flow enhances osteogenic proliferation and 
differentiation of hTERT–hMSCs, when compared to static conditions (47). 
An oscillatory perfusion bioreactor was fabricated by Du et al, in 2008 (73). The 
upper chamber consisted of six flow wells custom-machined in a block of Teflon. The 
base of each well was sealed with a silicon film. The scaffold is press-fitted to a silicon 
cassette that was then fixed into each well with an upper O-ring and steel cap with up-to-
down pressure to ensure that the media would perfuse only through the scaffold and not 
flow in between the scaffold and cassette or between the cassette and well wall. The 
lower chamber is filled with sterilized water using a 30-mL syringe with gas removed from 
the gas outlet. The movement of the syringe back and forth is controlled by a continuous 
cycle syringe pump, forcing the silicon membranes to move up and down, thus driving the 
media in the flow wells to perfuse up and down through the scaffolds in an oscillatory 
manner. Results obtained with a mouse immature osteoblast-like cell line, MC 3T3- E1 
seeded in porous beta-tricalcium phosphate (b-TCP) scaffolds suggested that the 
oscillatory flow condition not only allows a better seeding efficiency and homogeneity, but 
also facilitates uniform culture and early osteogenic differentiation (73). The same group 
designed a unidirectional perfusion system. A media bottle is set on each end of the 
perfusion chamber as both media reservoirs and gas bubble trappers. A gas-permeable 
bag is set in the circuit loop as a gas exchanger. The unidirectional media flow was driven 
by a pump. A couple of silicon tubes led from bottle 2 to the clean bench, so that the 
medium could be exchanged in a sterile environment without moving the whole 
complicated system. This system presents a recirculation flow, thus media is drawn from 
the media reservoir, pumped through the compartments, merged at the outlets of the 
chambers, and returned back to the media reservoir. The perfusion system with the 
scaffolds set inside is sterilized by ethylene oxide gas. To compare these two different 
types of perfusion systems developed, mouse osteoblast-like MC 3T3-E1 cells were 3D-
cultured with porous ceramic scaffolds for 6 days under static and hydrodynamic 
conditions with either a unidirectional or oscillatory flow. In perfusion culture with the 
unidirectional flow, the proliferation was significantly higher than in the other groups but 
was very inhomogeneous. Only the oscillatory flow allowed osteogenic cells to proliferate 
uniformly throughout the scaffolds, and also increased the activity of ALP(35).  
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2.3.2- Single Culture Chamber perfusion Bioreactors that enable 
culturing large sized constructs 
As seen in the previous section, many research groups have developed 
bioreactors that perfuse cell seeded constructs, and that have demonstrated the beneficial 
effects of perfusion on cell survival, proliferation, differentiation and ECM formation in the 
scaffold. However, these studies focus on the construction of  small-size tissue-
engineered bone  ranging from 0.04 to 2.7 cm3 (25, 27, 40, 44, 48, 56, 57, 61-63, 67, 73-
77). In this section we will describe some of the few available systems that may enable 
the culture of large dimension constructs. 
According to published works there has been an increasing focus on the 
development of such bioreactors which are usually designed with a single cellular culture 
chamber. Hosseinkhani et al, in 2005 (50), developed a perfusion bioreactor in which the 
cell-seeded scaffolds are set in a sample holder, while the medium is flowed by a 
peristaltic pump at a linear flow velocity to perfuse the medium through the scaffold using 
a medium recirculation method and only one medium reservoir. The perfusion system is 
operated in a CO2 incubator atmosphere. It was found that this system enabled 
improvement of MSCs proliferation and differentiation in collagen sponges reinforced with 
PGA fibers (50). Furthermore, in another study, it was shown that BMP- 2 expression of 
rat MSCs impregnated with plasmid DNA encoding for BMP-2 was enhanced with 
perfusion culture (78). In a subsequent in vivo study, the collagen–PGA scaffolds of 12 
mm diameter seeded with rat MSCs were implanted ectopically in Fischer male rats. 
Significant increase in ALP and OC expression at sites of implantation of constructs 
previously cultured in the perfusion system, was observed as compared to constructs 
obtained in static conditions (79).  
Xie et al, in 2006 (80), described a bioreactor system that is composed of 3 parts: 
the driving part, the reservoir, and the tubing part. The driving part consists of up to eight 
3-stop tubes which are fixed in an 8-channel pump head and driven by a peristaltic pump. 
The reservoir (only chamber) is a 75-cm2 flask containing the perfusion medium. In the 
tubing part, there are 2 silicone tubes with one end penetrating through the plug cap into 
the flask as the inlet and outlet. To study the effects of flow shear stress and mass 
transport, respectively, on the construction of a large-scale tissue-engineered bone 
substitute, Li et al (45), used a critical-sized b-TCP cylinder scaffold (14mm in diameter 
and 30mm in length with a tunnel of the 3,5 mm in diameter and 25 mm in length) seeded 
with hBMSCs.  
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The results suggested that shear stress accelerates osteoblastic differentiation of 
hBMSCs while mass transport shown to increase differentiation among lower ranges (45, 
80). 
A direct semi-automated perfusion bioreactor system (single chamber) was 
developed by Janssen and his researchers (81). Goat bone marrow stromal cells 
(GBMSCs) were dynamically seeded/cultured in this system in volumes (10 cm3) of small-
sized macroporous biphasic calcium phosphate (BCP) scaffolds. Cell load and distribution 
was shown using methylene blue block staining, and MTT staining was used to 
demonstrate the viability of the cells. Online oxygen measurements were correlated with 
proliferating GBMSCs. They conclude that this bioreactor enabled homogenous cell 
growth of GBMSCs (82). In posterior studies, the authors demonstrated that dynamically 
cultured GBMSCs grown on calcium phosphate ceramic produced bone when implanted 
into mice (51). Another study conducted in 2010 by the same group, concluded that this 
perfusion bioreactor system is capable of producing clinically relevant and viable amounts 
of human tissue-engineered bone that exhibit bone-forming potential after implantation in 
nude mice (81). 
Jaasma et al, in 2008 (83), developed a flow perfusion chamber bioreactor 
consisting of a syringe pump, a scaffold chamber, and a media reservoir which are 
connected via gas-permeable, silicone tubing and tubing connectors. The scaffold is held 
in place within a silicone O-ring and between two machined polycarbonate pieces. The 
scaffold is maintained under approximately 10% compression using aluminium spacers 
and an O-ring inner diameter is larger than the flow path diameter through the 
polycarbonate pieces of the scaffold chamber. The scaffold chamber is designed to 
accommodate compliant scaffolds, but stiff scaffolds can also be used by adjusting the 
spacer height. The syringe pump is programmable to allow for the application of steady, 
pulsatile and oscillatory flow profiles, and can accommodate up to six 50-ml syringes, 
which allows for the simultaneous culture of six cell-seeded constructs. The authors used 
Collagen-GAG (CG) scaffold with 12,7mm in diameter and 3,5 mm of thickness MC 3T3-
E1 cells and four scaffolds were cultured simultaneously, but each one in a different 
bioreactor. Flow analysis revealed that steady, pulsatile and oscillatory flow profiles were 
transferred from the pump to the scaffold. Comparing to static, bioreactor culture of 
osteoblast seeded CG scaffolds led to a decrease in cell number but stimulated an 
increase in the production of prostaglandin E2, an early-stage bone formation marker (83). 
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Other study examined the effect of short term flow perfusion bioreactor culture, 
prior to long-term static culture, in the same bioreactor developed by Jaasma et al, in 
2008 (83). Human fetal osteoblasts (hFOB 1.19) were seeded onto CG scaffolds. Results 
show that the bioreactor and static culture control groups displayed similar cell numbers 
and metabolic activity. However, histologically, peripheral cell-encapsulation was 
observed in the static controls, whereas, improved migration and homogenous cell 
distribution was seen in the bioreactor groups. Osteogenic markers investigated displayed 
greater levels of expression in the bioreactor groups compared to static controls. They 
demonstrated that this flow perfusion bioreactor improved construct homogeneity by 
preventing peripheral encapsulation whilst also providing an enhanced osteogenic 
phenotype over static controls (84).  
Barthold and other researches, in 2005 (85), constructed a perfusion chamber 
bioreactor (single chamber), to analyze and identify soluble factors such as the formation 
of l-lactate, lactate dehydrogenase, collagen I C-terminal propeptide, soluble ALP and OC 
during the culture of rabbit bone marrow mesenchymal stem cells to get detailed 
information about the differentiation of the osteogenic cells (85). This same bioreactor was 
used to test human trabecular bone cells seeded onto three different types of scaffolds 
(porous CaCO3, mineralized collagen, porous tricalcium phosphate), with 5mm in 
diameter and 3 mm thick, were used, stacking 9 samples that were simultaneously 
cultured in the bioreactor. The scaffolds were subsequently implanted in rat mandibules 
for 6 weeks. Scaffolds without cells and scaffolds cultured in static conditions were used 
as controls. Histomorphometric evaluation showed that neither seeding human trabecular 
bone cells nor the culturing technique increased the amount of early bone formation 
compared with the level provided by osteoconductive bone ingrowth from the defect 
edges(86). 
To engineer anatomically correct pieces, Grayson and his researcher’s (46) report 
that clinically sized, anatomically shaped, viable human bone grafts can be developed 
using hMSCs and a “biomimetic” scaffold-bioreactor system. They selected the 
temporomandibular joint (TMJ) condylar bone as their tissue model. Scaffolds were 
generated from fully decellularized trabecular bone by using digitized clinical images, 
seeded with hMSCs, and cultured with interstitial flow of culture medium. A bioreactor with 
a single chamber in the exact shape of a human TMJ was designed for controllable 
perfusion throughout the engineered construct. After 5 weeks of culture, tissue growth 
was evidenced by the formation of confluent layers of lamellar bone, a markedly increased 
volume of mineralized matrix, and the formation of osteoids (46). 
 
Chapter II: Review: Use of perfusion bioreactors and large animal models for long bone tissue engineering 
 45 
Leandro S. Gardel, PhD thesis, University of Porto, 2012 
 
 Yeatts et al (87), developed a bioreactor- the tubular perfusion system (TPS) - 
consisting of a tubular growth chamber and medium reservoir connected via a tubing 
circuit. The medium’s flow is driven by a Multichannel peristaltic pump at 3 ml/min for 
short-term studies and at either 3 or 10mL/min for the long-term studies. The circuit 
consists of silicone tubing that is connected using silver ion-lined microbial resistant tubing 
connector. The growth chamber consists of length silicone tubing. The growth chamber 
has 13cm in length and is packed with 30 cell seeded alginate beads. The tubing is placed 
in a cell culture CO2 incubator atmosphere. hMSCs were encapsulated in alginate beads 
(a total of 30 samples of 4mm diameter per bioreactor) and medium was perfused through 
the growth chamber and around the tightly packed scaffolds enhancing nutrient transfer 
while exposing the cells to shear stress. Results demonstrate that bioreactor culture 
supports early osteoblastic differentiation of hMSCs as shown by ALP gene expression 
and  increases in the gene expression levels of OC, OP, and bone morphogenetic 
protein(BMP)-2 (87). 
Bertrand et al, in 2011 (88), build a single chamber perfusion bioreactor based on 
fluidized bed bioreactor concepts for culture of clinical size scaffolds. It consists of a 
vertical cylindrical polycarbonate chamber connected to a reservoir containing the culture 
medium in a closed loop arrangement. The connections between the bioreactor chamber 
and the reservoir and between the bioreactor and a peristaltic roller pump are made of 
silicone tubing, Multiple perfusion bioreactors such as this were operated during 
experiments, using 140 units of coral scaffolds (each 3x3x3mm3) for each bioreactor, and 
seeded with GFP-C3H10T1/2 cells. To establish the flow influence, an in vitro study was 
conducted with various flow rates. To investigate the osteogenic potential of bone 
constructs, an in vivo study was carried out using sheep MSCs which were then 
subcutaneously implanted. The best flow rate determined for this bioreactor and this 
scaffold was the 10ml/min and 8 weeks as following the subcutaneous implantation in 
sheep, all retrieved samples had areas of mineralized bone and osteoid, with osteocytes 
located inside the matrix and a film of osteoblasts coating the newly deposited bone (88). 
Gardel et al, in 2011 (89), developed a single chamber Bidirectional Continuous 
Perfusion Bioreactor (BCPB ). The BCPB is composed by one vacuum and one peristaltic 
pump, connected through of a circular flow system which are connected via gas-
permeable, silicone tubing and tubing connectors, and also for rotational engines located 
in specific places, aiming at creating shears stresses, due to the medium flow perfusion 
using different gradients of pressure, to induce mechanical stimulations to the cells 
seeded onto the scaffolds.  
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The passage of the flow from the interior to the exterior of the three-dimensional 
support or from the exterior to the interior of the three-dimensional support is carried out 
through the use of a rigid tube (polycarbonate) with perforations in its central part and that 
has the same length of the three-dimensional support (that can have variable 
dimensions). This tube, containing the scaffold, is connected to a circular system and is 
located coaxially inside of the culture chamber. This culture chamber has four 
exits/entrances and is tightly closed, by that same circular system, which allows the 
control of the flow and the gradient of pressure inside of the chamber and inside of the 
perforated tube. Therefore this system enables to control the perfusion rate and gradient 
of flow, in the interior of the cell-scaffold constructs in culture, and it allow to culture 
constructs of significant dimensions, as it enable the access of nutrients to the interior of 
the material and the removal of the metabolic products from the interior of this, enabling 
the maintenance of the cells the viability. To prove the feasibility of this perfusion system, 
preliminary in vitro studies using Starch/Polycaprolactone (SPCL) fibbers mesh scaffolds 
(with 16mm in diameter and 3 mm thickness with a concentric hole of 6mm), were seeded 
with goat marrow stromal cells with and stacked, completing a 42 mm thick construct. The 
samples were cultured for a period of 14 and 21 days of culture in the bioreactor at a flow 
rate of 1 ml/min, using static cultured constructs as controls. The results showed higher 
ALP activity levels in dynamic cultures (14 days of culture) than those obtained under 
static conditions. SEM and histological images showed cells occupying the interior of the 
scaffolds cultured in the bioreactor, while cells were predominantly on the surface of the 
GBMC–SPCL constructs in the static cultures (90).  
In summary, the systems currently available for the culture of large sized 
constructs, described in this review, differ considerably with respect to ease of use, cost-
effectiveness, and degree of additional osteogenic stimuli provided, as well as monitoring 
and manipulation options. Further optimization of these systems may be achieved by 
adapting specific stimuli and by combining biophysical and biochemical stimuli within one 
system. However, a major challenge will be the translation of such bioreactor-based 
concepts into clinically applicable designs, because this requires adapting current designs 
or developing new bioreactors that enable culturing constructs of large dimension for 
clinical use, in accordance with Good Manufacturing Practices (GMP). 
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2.4- Large Animal models 
 
2.4.1- Selection of appropriate Animal Models 
Desirable attributes of an animal model include demonstration of similarities with 
humans, both in terms of physiological and pathological considerations as well as being 
able to observe numerous subjects over a relatively short time frame (91, 92). When 
deciding on the species of animal for a particular model there are several factors that 
should be considered, namely cost to acquire and care for animals, availability, 
acceptability to society, tolerance to captivity and ease of housing. The welfare and 
housing of animals is usually covered by a Federal Animal Protection Act and may vary 
slightly between countries. The Animal Protection acts outline the minimum requirements 
in terms of housing dimensions, lighting, flooring etc. and must be complied with when 
undertaking an animal study. Other factors include low maintenance care, ease of 
handling, resistance to infection and disease, inter-animal uniformity, tolerance to surgery, 
adequate facilities, support staff and an existing database of biological information for the 
species, ease of adaptability to experimental manipulation, ecological consequences and 
ethical implications (22, 93).  
More specifically, for studies investigating bone-implant interactions, an 
understanding of the species specific bone characteristics – such as bone microstructure 
and composition, as well as bone modelling and remodelling properties, are important 
when later extrapolating the results to the human situation. Finally the size of the animal 
must be considered to ensure that it is appropriate for the number and size of implants 
chosen (22). 
Within a field of study, no single animal model will be appropriate for all purposes, 
nor can a model be dismissed as inappropriate for all purposes. Furthermore, multiple 
model systems are likely required to establish a broad body of knowledge (94). 
International standards established regarding the species suitable for testing implantation 
of materials in bone, state that dog, sheep, goat, pig are suitable large animal models. At 
least two of each of the species mentioned above should be used for assessing each 
treatment at each implantation period. Long term implantation periods for these species 
are given as 12, 26, 52 and 78 weeks (22). 
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2.4.2-Animal models in bone repair research 
Animal models in bone repair research include representations of normal fracture 
healing, segmental bone defects, and fracture non-unions in which regular healing 
processes are compromised with the presence of a critical-sized defect site (95). In 
critical-sized segmental defect models bridging of the respective defect does not occur 
despite a sufficient biological microenvironment, due to the removal of critical amounts of 
bone substance. In contrast, in a true non-union deficient signaling mechanism, 
biomechanical stimuli or cellular responses may prevent defect healing rather than the 
defect size (96). Bone composition and biology of dog, sheep, goat, and pig are very 
similar to those of humans. Reviews of the literature comparing bone structure, 
composition, and biology in these animals identify modest differences in cancellous and 
cortical bone density at various sites, magnitude of sexual dimorphism, the age at which 
peak bone mass is achieved, and the rate and extent to which haversian remodeling 
replaces plexiform lamellar bone in the cortex of long bone (97). However, these points of 
variation do not provide evidence that any one of these animals provides a better match 
for human bone biology than the other (98). In a variety of study designs, pigs are 
considered the animal of choice and were described as a highly representative model of 
human bone regeneration processes in respect to anatomical and morphological features, 
healing capacity and remodeling, bone mineral density and concentration (99, 100). Pigs 
tend to be least used (101), likely due to difficult temperament, anatomically short and 
thick long bones, and large size.  
The short bones do not allow for large gap defects because adequate fixation is 
difficult to achieve (98), which leds to the the need for special implants, as one cannot use 
implants designed for human use (96). Non human Primates (NHPs) are sometimes held 
up as the model of choice for prediction of clinical performance for bone repair and 
regeneration methods. This supposition is based on arguments of evolutionary proximity 
and similar structural anatomic, endocrine, digestive, and dietary features and 
immunology. Of the three common NHP species, only the baboon approaches the skeletal 
size range that humans share with large canines, sheep, and goats. NHPs are very 
expensive and present husbandry challenges that preclude models involving intensive 
wound assessment, management, or immobilization. Although NHPs do not have 
companion animal status, arguments of perceived evolutionary affiliation raise social and 
ethic questions related to increasing their use in research (98).  
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Dogs are used most due to a rich background of prior experience, ease of 
husbandry, and accessibility. A large literature characterizing canine models supports 
continued preferential use of dogs in many settings, particularly in bone marrow biology 
and transplantation immunology (102-108). The use of dogs is being challenged, 
however, by social concerns regarding the dog as a companion animal (98). Although, the 
use of dogs as experimental models has significantly decreased mainly due to ethical 
issues, between 1998 and 2008 approximately 9% of articles published in leading 
orthopedic and musculoskeletal journals described dogs as animal models for fracture 
healing research (101). Mature sheep and goats possess a body weight comparable to 
adult humans and long bone dimensions enabling the use of human implants (109). 
Sheep are readily available and docile, but can be frail and less resilient, particularly when 
not in a group. Goats, similar in size and skeletal anatomy to sheep, have a thinner coat 
and less muscular bulk, and are more tolerant of stress and isolation (98). The mechanical 
loading environment occurring is well understood (110, 111). Since no major differences 
in mineral composition (112) are evident and both metabolic and bone remodelling rates 
are akin to humans (113), sheep and goats are considered a valuable model for human 
bone turnover and remodeling activity (96, 114), making them an increasingly viable 
alternative for bone research (98). 
 
2.4.3 Ovine models 
 Ovines are a convenient large animal model for biomedical research because of 
ease of handling and housing, animal cost and acceptance to society as a research 
animal (115). Sheep are long boned, and allow the use of many systems of internal 
fixation. Sheep are readily available and docile, but can be frail and less resilient, 
particularly when not in a group (98). 
 They are a less expensive animal model versus other species, and their size is 
conducive to the insertion of prosthetic implants comparable to those implanted in 
humans. The age of the animals, the timing of the study, and the duration of the 
experiment have to be considered in sheep versus other species. The use of a few widely 
accepted standardized sheep breeds would make interlaboratory comparisons easier, and 
disclosure of reproductive and dietary histories could further aid our understanding of the 
efficacy of this animal model (97). The number of sheep used in orthopedic research is 
increasing in the last decade involving fractures, osteoporosis, bone-lengthening and 
osteoarthritis, in comparison with companion animals (116).  
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This increase in usage may be related to the ethical issues and negative public 
perception of using companion animals for medical research (22). Adult sheep offer the 
advantage of having a more similar body weight to humans and having long bones of 
dimensions suitable for the implantation of human implants and prostheses (109). Sheep 
are described as having a predominantly primary bone structure in comparison with the 
largely secondary bone of humans. Age related changes in bone structure are also 
described; adult sheep have a plexiform bone structure comprising a combination of 
woven and lamellar bone within which vascular plexuses are sandwiched. Secondary, 
Haversian (osteonal) remodelling in sheep is more prevalent in old sheep. Aging results in 
secondary haversian remodeling that becomes more extensive at specific locations such 
as the posterior aspect of long bones and in ribs (97). Haversian canal distribution has 
been shown to be less dense in ovine bone than in human bone (117) and has been 
described as not uniformly distributed (22). Differences in bone density exist between the 
human and sheep, whereby sheep bone shows a significantly higher density and 
subsequently greater strength. Bone location must be considered when contemplating 
differences between human and sheep bones. In terms of mineral composition humans 
and animals do not show significant differences (22). 
 Despite the differences in bone structure being recognized, studies show that 
sheep are a valuable model for human bone turnover and remodelling activity (114). As 
found in other species, it is likely that bone location may also alter bone composition and 
turnover in the sheep (22). 
 
2.4.4 Caprine models 
As previously mentioned, goats are similar in size and skeletal anatomy to sheep 
but have a thinner coat and less muscular bulk, and are more tolerant to stress and 
isolation (98). Goats are generally classified as gentle, inquisitive, placid, and easy to 
handle, as well as clean and hardy in nature (97), making them an increasingly viable 
alternative for bone research (98).  
Like sheep, goats are considered food producing animals and thus also have the 
advantage of less critical public perception when used for research, than companion 
animals. When compared to other species, sheeps and goats are reported to be more 
tolerant to environmental conditions. (118). Histologically, the tibial cortical bone of goats 
does not have homogeneously distributed Haversian systems (concentrically oriented 
lamellar bone containing a centrally located blood vessel, also known as osteons).  
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Similar to the sheep, where the haversian systems are non-uniformly distributed 
throughout individual bones, in the goat, the Haversian systems are located primarily in 
the cranial, cranio-lateral and medial sectors of the tibial diaphysis, while the caudal sector 
is mainly comprised of lamellar bone (where the collagen fibres are arranged in sheets 
and do not contain a central blood vessel) (119). Liebschner, in 2004 (91) shown that 
while there are small differences in the apparent and ash density between the goat and 
humans, these differences are probably not as significant as the differences found 
between anatomic sites of the same species(91). The mineral composition of bone does 
not vary significantly across species and therefore one could conclude that this also holds 
true for the goat (22). Goat has a metabolic rate and bone remodeling rate similar to that 
of human’s presenting a suitable animal model for testing human implants and materials 
as they are considered (113, 120). However, the rate at which a bone graft is 
revascularised and converted into a vital trabecular structure is found to be faster in the 
goat, occurring at approximately 3 months in comparison to 8 months in humans. There is 
little information comparing the utility of goats versus sheep for implant-related studies. 
Therefore the choice of which small ruminant to use most likely depends on availability 
and other factors (22). 
 
2.5- Critical/cylindrical size defects 
Critical-sized defects are defined as ‘‘the smallest sized intraosseous wound in a 
particular bone and animal species that will not heal spontaneously during the lifetime of 
the animal’’ (96, 121, 122) or as a defect which shows less than 10 percent bony 
regeneration during the lifetime of the animal (96, 123). However, this has been re-defined 
as segmental bone deficiencies of a length exceeding 2–2.5 times the diameter of the 
affected bone (96, 124, 125). 
A critical defect in long bones, however, can hardly be defined by size only. The 
phenomenon of regeneration is also influenced by species, anatomic location, associated 
periosteum and soft tissue, and biomechanical conditions, as well as age, metabolic and 
systemic influences, and related injuries affecting defect healing (96, 121, 124). 
Congenital abnormalities, cancer resections, non unions or traumatic incidents are 
very common both in human and inveterinary traumatology, and as suggested above, 
these problems do not heal or regenerate spontaneously. In fact, the currently available 
therapies that are usually used in such clinical scenarios, mostly consisting on the use of 
auto or allografts, present several disadvantages. 
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Tissue engineering, using scaffolds and stem cells offer the potential to overcome 
such limitations. Therefore, it is important that studies on scaffolds development for such 
applications envision the need for obtaining constructs with a cylindrical shape, as long 
bones show anatomically a cylindrical shape, and thus facilitating the translation to clinical 
settings. The composition of the defect generally includes periosteum, cortical bone, and 
endosteum. After suture, the opening of the defect is bounded by overlying muscle or fat. 
The base of the defect may be cancellous bone and marrow, cortical bone, or muscle/fat, 
depending on defect length and orientation within the long bone. In general, defects in the 
metaphysis of young large animals will be comprised of highly vascular hematopoietic 
marrow. However, marrow in defects in the diaphysis will generally be fatty or yellow 
marrow, which is still vascular, but far less cellular. Advancing age in animals will also 
increase the ratio of fatty to hematopoietic marrow, changing the biological environment of 
the graft site. Soft tissue encroachment does not compromise bone formation in most 
cylindrical defects. Regardless, cylindrical critical defects can be very sensitive to 
detecting differences in efficacy between osteoconductive scaffold materials as well as the 
effects of bioactive factors and cell transplantation. The uniform radial geometry of 
cylindrical defects also provides the potential for control and modeling of biological 
gradients relevant to bone regeneration.  
Due to the pattern of diffusion and vascular ingrowth that must be oriented from 
the periphery to the center of the defect, cylindrical defects are particularly well suited for 
time-oriented studies of mass transport (e.g., the influence of diffusion, cellular metabolic 
demand, local oxygen delivery or generation, or gradients in the delivery of bioactive 
factors), degradation rate of implants, cell transplantation (survival and migration) and 
variables modulating the rate of bone or tissue ingrowth or vascular invasion into an 
implant (98). 
 
2.6- Creation of the cylindrical critical size defects in large animals 
Osteotomy approach techniques are used for the creation of cylindrical critical size 
defects and can be performed by using a CO2 Laser (126, 127), Oscillating saw (124, 
128-136), Gigli saw (137, 138), treaded saw (139) and a chisel/ osteotome (140-142). The 
edges of the defect are usually cut straight with less trauma but there are advantages and 
disadvantages in the choice of each technique.  
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The CO2 laser produces a cut with little trauma, it’s the most accurate to perform 
the osteotomy but quite expensive. Kuttenber et al (127), demonstrated that bone healing 
is similar and undelayed after both laser and oscillating saw. For practical applications, 
precise control of the depth of laser cutting and easier manipulation of the osteotome is 
required (127). The oscillating saw makes a straight cut without causing trauma to 
surrounding soft tissue and bone thermal necrosis caused by cutting blade unit can be 
avoided by a continuous irrigation of saline solution at the time of the cut; the technique of 
holding the cutting is easy and fast and cheaper when compared with the CO2, but more 
expensive when compared with the manual saws. Manual saws are much cheaper than 
all others, but require physical strength to make the cut and the start of this may not be 
accurate due to the difficulty of supporting the saw on the rounded and smooth bone 
surface, and care must be taken not to cause damage to surrounding soft tissues. The 
chisel (osteotomes) techniques require a hammer to be performed, and is not the best 
choice to perform an osteotomy in a long bone as it may cause jagged cuts in the bone 
surface. 
2.7- Fixation of the cylindrical critical size defects in large animals  
To simulate human in vivo conditions as closely as possible, a variety of large 
cylindrical critical size defect models, mainly in sheep and goat, have been developed in 
the last decade  to investigate the influence of different types of bone grafts on bone 
repair and regeneration. The method of fixation is an important variable to be studied in 
large cylindrical critical size defect models. Fixation should not only reflect what occurs in 
the clinic but also provide sufficient rigidity to support bone healing (143). The method of 
fixation is more important for defects within weight-bearing bones than the nonweight-
bearing bones (144). At present, most long bone defect models use bone plates, 
interlocking intramedullary nails and external fixator to fix the defect, thus reflecting the 
situation within the clinic (143). Sufficient reduction and stability can be achieved by bone 
plates even in complicated fractures (145). Bone plate osteosynthesis is performed using 
standard instrumentation, differing according to the size of the implant and the type of 
plate fixation. 
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 Most studies on bone tissue engineering using caprine and ovine models are 
performed in the diaphyseal bone (tibia, femur) requiring the use of cortical screws that 
are a very efficient devices for fixing a splinting device such as a plate.  
The goal is to achieve as much contact area as possible in a sufficiently stable 
implant of minimal size; it is recommended that the screw diameter should not exceed 
40% of the diameter of the bone. There are a number of different sizes of cortex screws 
available to enable fixation of bones of different diameters. Newly developed screws for 
use in humans, such as self-tapping screws, monocortical screws and those used in 
locking systems, are likely to find an increasing application in animal models. Various 
types of bone plates are available in the market for use as bone fixation methods, such as 
dynamic compression plates (DCP), limited contact dynamic compression plates (LC-
DCP), locking compression plates (LCP), non dynamic compression plates and 
reconstruction plates. For sheep and goat weighing between 15 and 45 kg, plates with 
screws of 3.5 and 4.5 mm are used, but for weights superior of these values the use of 
screws 5.5 mm should be considered. However, conventional bone plates can result in 
histologically and radiologically verifiable bone loss, which has been attributed to stress 
protection (Wolff’s law). An increase in cortical bone porosity proximate to the plate soon 
after bone plate osteosynthesis has been observed. This porosity is explained by impaired 
vascular perfusion underneath the plate due to high compression forces between plate, 
periosteum, and bone (96, 146). New plate systems were developed where load and 
torque transmission act through the screws (interlocking screws), the stabilization system 
acts like an external skeletal fixator (ESF) making a total plate–bone contact unnecessary 
to achieve stable fixation (96). The plates can be placed in three different functions: 
compression mode (the plate creates an axial compression), neutralization mode (the 
plate protects the interfragmentary compression), biological mode (the plate acts as a 
splint to maintain the correct length of the bone and the normal spatial alignment of the 
joints proximal and distal to the fracture).  
For example, to study the effects of different bioceramics during bone repair of a 
tibial defect model in sheep of 16 mm length, Gao et al (147), implanted biocoral and 
tricalcium phosphate cylinders (TCP). The defects were stabilized medially using two 
overlapping contoured autocompression plates of 4 mm thickness (8 and 6 holes) and 
cortical screws (147). However, this method of fixation is not commonly used in the clinical 
practice.  
Chapter II: Review: Use of perfusion bioreactors and large animal models for long bone tissue engineering 
 55 
Leandro S. Gardel, PhD thesis, University of Porto, 2012 
 
A DCP stainless steel plate was used by Kirk-Head et al (148), for the stabilization 
of a 25 mm long mid-diaphyseal critical size defect in long bone of the sheep, in order to 
observe the use of recombinant human BMP-2 and a poly [D, L-(lactide-co-glycolide)] in 
1year of the long-term healing (148).  
Several studies selected this as a method of fixation bone plate for osteosynthesis. 
Wefer et al (149), used as a method of fixing an anterolateral plate to implant a porous 
hydroxyapatite scaffold in a 20 mm critical size defect in the sheep long bone, to develop 
and test a scoring system based on real-time ultrasonography (149). Meinel et al (149), 
performed a non-critical 10 mm segmental tibia defect using for stabilization a 3,5 mm of 
11 hole DCP plate, to study the treatment of bone defects by releasing of the  insulin-like 
growth factor(IGF-1) from biodegradable poly(lactide-co-glycolide) microspheres (150). To 
evaluate a synthetic calcium phosphate multiphase biomaterial, Mastrogiacomo et al 
(151), created a 48 mm tibial defect model in sheep and stabilized with a 4.5 mm 
neutralizing plate (151). However, Reichert et al (96), in their review article reported that 
they observed bent plates and axial deviations in presented X-ray and CT images, and 
concluded that the chosen fixation, performed by Mastrogiano et al, seemed insufficient in 
this study (96). Teixeira et al (152), created a tibial critical size defects of 35 mm size, 
being the bone defects in the diaphysis of the sheep stabilized with a titanium bone plate 
(103 mm in length, 2 mm thickness, and 10 mm width), but as reported by the authors, 
plate bending occurred in 42% of the animals most likely caused by insufficient thickness 
of the fixation device (152). To demonstrate that the compartmentalization of tissues may 
have an important role in bone regeneration in long-bone defects, Klaue et al (153), 
created a foreign-body membrane with a temporary poly-methylmethacrylate spacer with 
the same critical size of the defect created (30 mm) on mid-diaphyseal of the sheep 
femurs and stabilized with an 8-hole, 4.5 mm low covering dynamic-compression plate 
(LC-DCP). The obtained results suggested that regeneration of bone can be enhanced by 
compartmentalisation of the bone defect (153). To study the different immunological 
characteristics between Human and ovine MSCs, Niemeyer et al (134) , applied a 
xenogenic transplant (human MSCs) and an autologous transplant (ovine MSCs) to a 
sheep animal model. For this purpose, they performed a critical size defect of 30 mm on 
the tibial diaphysis and stabilized it with a seven-hole locking compression plate and self- 
taping screw.  
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The results demonstrated that the xenogenic transplantation of human MSCs led 
to poorer bone regeneration than the autologous transplantation of ovine MSCs. 
Nevertheless, no local or systemic rejection reactions could be observed after xenogenic 
transplantation of human MSCs (134). To investigate whether MSCs and osteogenic 
protein-1 (OP-1) can improve allograft integration, Bella et al (154), performed a 30 mm 
full-size bone defect in the mid-diaphysis of the metatarsal bone of a sheep and stabilized 
with a seven-hole titanium dynamic compression plate (3.5 mm wide, 10,5 mm long). The 
results demonstrated that the association of MSCs and OP-1 improve bone allograft 
integration promoting an almost complete bone restoring when compared to other groups: 
allograft alone (control group), MSC group, OP-1 group (154). 
A locked intramedullary nail is a stainless steel our titanium nail that is placed 
within the medullary cavity and is locked to the bone by screws or bolts that cross the 
bone and pass through holes in the nail. They are available in several diameters and can 
be locked with screws or bolts of 4.5 or 3.5 mm diameter and are the most suitable for use 
in ovine and caprine models. Locked intramedullary nails resist bending, axial, and 
rotational forces because they are locked with either bone screws or locking bolts. These 
are most effectively used to stabilize mid-diaphyseal fractures of the femur and tibia in 
animal models used in tissue engineering approaches and in the last decade several 
researchers have used this method for orthopedic fixation in their studies. To establish a 
new critical bone defect model of 30 mm, den Boer et al (114), used an interlocking 
intramedullary nail (AO® unreamed humeral nail); the defect (30mm length) was inflicted 
on sheep tibiae and bone healing was quantified through X-ray absorptiometry (114). A 
study conducted by Bloemers et al (155), indicated that new calcium phosphate based 
materials might be a potential alternative for autologous bone grafts. To conduct this 
study, they used a segmental tibial defect (30 mm) in sheep fixed by an AO® unreamed 
interlocking titanium tibial nail (155). To see the effect of platelet rich plasma (PRP) on 
new bone formation in a 25 mm diaphyseal tibial defect in sheep, Sarkar et al (156), 
stabilized the defect with intramedullary nail with locking screws on the proximal and distal 
surface and added stainless steel plate applied medially (156).  
The effect of chondroitine sulphate on bone remodelling and regeneration was 
investigated by Schneiders et al (157), for which they performed a 30 mm tibial mid-
diaphyseal defect site and reconstructed it using hydroxyapatite/collagen cement 
cylinders. The stabilization was achieved by insertion of a universal tibial nail (UTN, 
Synthes®, Bochum) (157).  
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To investigate the feasibility of BMSCs on coral scaffold infected with adenoviral 
vector containing the BMP-7 gene (AdBMP7), Zhu et al (136), performed a segmental 
bone defect of the 25 mm in length at the mid-portion of the femoral diaphysis of the goat, 
and stabilized this defect with an internal fixation rod and interlocking nails (136).  
The interlocking intramedullary nail can be applied in two different ways, either 
static or dynamic compression. depending on the number of screws to use and their 
positioning(distal or proximal), the outcome of animal experiments and clinical retrievals 
strongly suggested that, particularly the mechanical load, has a positive effect on bone 
graft incorporation (158-160).  
To prove this, Bullens et al (135), studied if a static or dynamic mode of nail 
fixation influenced the healing of segmental defect reconstructions in long bones. In this 
study, 35 mm critical size defects in goat femurs, were reconstructed using a cage filled 
with firmly impacted morsellised allograft mixed with a hydroxyapatite paste (Ostim®). All 
reconstructions were stabilized with an interlocking intramedullary stainless steel 
unreamed femur nail and AO® locking screws. Authors found that healing of these defects 
was not significantly influenced by the mode of fixation of the nail in this animal model 
(135). To analyze the efficacy of allogeneic mesenchymal precursor cells in the repair of 
sheep tibial segmental defects, Field et al (161) created 30 mm defects and stabilized 
them with a locking intramedullary nail and allowed to heal over a nine-month-period. The 
group treated with allogeneic cells and scaffolds displayed a significantly greater level of 
callus formation and rate of bone apposition in the defect, compared to the scaffolds 
without cells (161). 
External skeletal fixation (ESF) and circular external fixation (Ilizarov model) are 
two types of the bone fixation which have been more widely used in large animals studies, 
offering versatility and smooth application. In fact, They offers major advantages over 
“conventional methods” in the management of fractures caused by the creation of critical-
size defects, as the fact that they are relatively easy to apply, maintaining limb use and 
joint mobility, are well tolerated by patients, have a low cost when compared to plate 
systems, and involve a relatively low risk procedure. 
 
 
 
 
Chapter II: Review: Use of perfusion bioreactors and large animal models for long bone tissue engineering 
 58 
Leandro S. Gardel, PhD thesis, University of Porto, 2012 
 
 In addition, external fixators are associated to minimal intra-operative trauma and 
the surrounding soft tissues are only marginally affected. The linear external fixators are 
composed of bars and clamps that can vary in amount depending on the type to be 
applied (type I frame, type II frame  and type III frame), being the type III frame the most 
strong of all. The distal and proximal bone fragments should be secured with at least two 
pins at each end, and the conformation of these pins can be, smooth pin, negative and 
positive threaded pins. One of the most common complications with linear external 
fixators is the pin loosening often resulting in pin track infections, but this complication can 
be eliminated with the use of positive threaded pins. The linear external fixation has been 
selected by some research groups as a method of bone fixation to be implemented. For 
example, to study the effect of bioresorbable polylactide membranes, applied alone and/or 
in combination with autologous bone graft, in bone healing, Gugala et al (162) performed 
a critical defect of 40 mm in sheep tibia and stabilized with an AO® external fixator type II 
frame. Only in groups where the defect was filled with autogenous cancellous bone graft 
and covered with a membrane, defect healing was observed (162).  
Maissen et al (163) studied the influence of rhTGFbeta-3 loaded on a poly (L/DL-
lactide) carrier, as compared to the carrier only, autologous cancellous bone graft, and to 
untreated defects, on mechanical and radiological parameters of a healing bone defect in 
the sheep tibia. An 18 mm long defect was fixed with a unilateral (type I frame) external 
fixator and the results showed significant differences between the groups, indicating the 
autologous cancellous bone graft bone graft treatment performed better than the others 
group (163). 
Based on its design and configuration, circular fixators are indicated for the 
treatment for lengthening or shortening bone, limb deformities, arthrodesis, non-union and 
fractures by presenting greater rigidity and versatility, but few researchers choose this 
method for bone fixation in their studies in large animals models. Recently, Liu et al (164), 
reported on the use of highly porous b-TCP scaffolds to repair 26 mm long goat tibial 
defects, stabilized using a circular external fixator. Study groups included defects treated 
with b-TCP ceramic cylinder loaded with osteogenically induced autologous bone marrow 
stromal cells, beta-TCP ceramic cylinder without cells and defects left untreated. X-ray, 
micro-computed tomography and histological analysis performed at 32 weeks post-
implantation showed that the porous beta-TCP ceramic cylinder loaded with cells led to 
was significantly better results than all the other groups (164). 
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2.8- Conclusions 
Bone Tissue Engineering and Regenerative Medicine (TERM) has the potential to 
become a real alternative to autologous bone grafts, but before this can happen it is 
necessary to solve the problem of homogenously supplying oxygen and nutrient to cells 
within a large scaffold. Several bioreactors have been developed that hold potential to 
improve mass transfer in large cellular scaffold constructs and to apply favorable 
mechanical stimuli, thus facilitating the cellular viability, proliferation and differentiation. 
One of the major breakthroughs was the development of the perfusion bioreactor system 
that increase the mass transfer of cellular scaffolds not only at the periphery but also 
within its the interior of scaffolds, increasing cellular proliferation and osteogenic 
differentiation. A significant volume of work was reported in this review, related to the use 
of perfusion bioreactor systems for bone tissue engineering. However, most perfusion 
bioreactors described herein do not enable the culture of large constructs. Thus, 
additional efforts are required to develop improved design for the successful culture of 
large scaffolds to be used in clinical settings. 
 Given the amount of research conducted on many bioreactor systems, the next 
obvious step should t be the evaluation of constructs developed in perfusion bioreactors, 
using large animal models and critical size defects, to enable easier translation of 
outcomes to the clinical scenario. However, little work has been reported using perfusion 
bioreactor cultured bone tissue engineering constructs implanted in critical size defects 
animal models. Therefore, the selection of an experimental model, to access the feasibility 
of a determined tissue engineering concept, is critical to the success of the preclinical 
studies and must be considered in the light of the proposed ideas to be tested. The rapid 
progression of this research area and the great number of novel developments must be 
supported by systematic assessment based on clinical practicability and experience, the 
knowledge of basic biological principles, medical needs and commercial practicality. 
Preferentially, an animal model should match the clinical setting that it is to reflect, both in 
terms of creation of the defect and the cells or scaffolds that will be used for repairing it. It 
is clear that each of the species discussed here demonstrate unique advantages and 
disadvantages in terms of their appropriateness as a model for demonstrating the 
response of bone tissue to an implant material. Considerations should include the species 
and the type of defect (location, size, method of creation and repair, and fixation) as well 
as the post operation care and monitoring.  
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Although there is no ideal animal model, a deep understanding of the differences 
of bone (macroscopic, microscopic and remodeling attributes) are likely to improve the 
choice of model and interpretation of these in vivo studies. Probably, a combination of 
different animal models for different strategies may be more realistic. However, to allow 
comparison between different studies is fundamental that animal models, methods of 
orthopedic fixation, surgical procedures and devices for measuring qualitatively, 
quantitatively and objectively the samples are standardized to achieve a reliable data pool 
as a base for future lines of research in TERM. New horizons are opened in TERM, 
whether clinicians, surgeons, scientists, and entrepreneurs begin to work in 
multidisciplinary teams. These progresses will aid in ensuring that TERM fulfills the 
expectations for revolutionizing medical care.  
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Materials and Methods 
The main aim of this chapter is to provide a general overview of the 
methodologies, materials, cells and animal models used in the experiments performed. 
Although, these are described in each of the chapters that follow in this thesis herein are 
provided further details. The layout of the present section is expected to provide a more 
comprehensive overview of the work performed.  
 
3.1 Development of a new flow perfusion culture system 
 Under the scope of this PhD thesis a new flow perfusion culture system, Bi-
Directional Continuous Perfusion Bioreactor (BCPB), was designed, developed and 
optimized. This gave origin to an International patent application (1). 
 
3.1.1 Design philosophy 
 The main objective was to develop a perfusion system that was capable of 
supporting the culturing of constructs of large dimensions promoting cell viability in the 
interior of scaffolds and simultaneously direct cellular activity through application of 
mechanical stimuli. For the development of this device several parameters were 
considered, such as: (I) easy handling/assembling in a flow chamber and easy fitting in a 
standard incubator), (II) easy sterilization of parts and maintenance of sterile condition 
throughout the culture period, (III) constituent parts washable and non toxic, (IV) 
transparent culturing chamber to allow easy visualization of the culture inside the 
incubator, (V) design preventing possible losses of pressure gradient, which would result 
in the flow reduction in the contact area of scaffolds with constituents parts inside the 
bioreactor, (VI) a flow rate that can be tightly controlled by a peristaltic pump, (VII) the flow 
system that allow the gases exchange without allowing the passage of possible 
contaminants to the interior of the system. 
 
3.1.2 Materials used in constituents parts 
 The main parts of the BCPB are fabricated either from Plexiglass (Acrylic) or 
Polytetrafluoroethylene (PTFE). Plexiglass is the material used in the fabrication of the 
culture chamber of the BCPB. This material can be sterilized with ethylene oxide gas, 
formaldehyde or plasma and offers the advantage of being relatively transparent, allowing 
the visualization of the scaffold and the culture environment inside the bioreactor culture 
chamber. 
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 In addition to this, it is readily machined to allow the fabrication of the unit and 
widely available in the market. The constituent parts that close the culture chamber as 
well as the parts that support the polycarbonate or the stainless steel 316L tube inside of 
bioreactor are made of PTFE which possess an excellent dimensional stability, even at 
high temperatures (up to 260°C or 300°C for short periods) making it suitable for 
sterilization by autoclaving, ethylene oxide gas, formaldehyde or plasma. PTFE 
possesses good mechanical properties and shows an excellent UV  . Both Plexiglass and 
PTFE are biologically inert. For all these reasons, Plexiglass and PTFE are suitable 
materials for the production of cell culture devices. 
Polycarbonate or Stainless steel 316L was used for the fabrication of the 
perforated coaxial tube that supports the scaffold. This material possesses high 
mechanical properties, is biologically inert, easily sterilized by autoclaving, ethylene oxide 
gas or formaldehyde, available in the market and easily machined. 
 
3.1.3 Design description 
 The main difference between the BCPB and the bioreactors currently 
commercialized is the fact that the BCPB offers the possibility to control the flow rate and 
the pressure gradient inside and outside the large dimension scaffolds. This main 
advantage is directly related to the possibility of controlling the medium flow passage in 
the perforated tube to the inside of the scaffold and from there to the culture chamber 
and/or the passage of the medium circulating in the culture chamber to the inside of the 
scaffold, and from there to the perforated tube. 
This innovative system (Figure 3.1) is composed by a cell culture chamber (Figure 
3.2-1) with a cylindrical shape, made from acrylic (transparent) with four exits/entrance 
channels (Figure 3.2-1A) (Figure 3.2-1B) (Figure 3.2-1C) (Figure 3.2-1D) that can be used 
to connect three way valves, that will be connected to the silicone tubes. The tubing used 
to connect each component in the circuit is platinum-cured silicone tubing (Masterflex® 
tubing; Cole Parmer®). The platinum curing minimizes the amount of leachable 
chemicals, and has a relatively low-protein binding. These silicone tubing have a highly 
gas permeability to both carbon dioxide and oxygen, this way allowing proper gas 
exchange for oxygen delivery and maintenance of proper culture medium pH. These four 
exits/entrance channels may be used for: i) acoplation of sensors for measurement of O2, 
CO2, Ph, temperature, etc.; ii) acoplation of manometers to measure the pressure 
gradients; iii) harvesting of samples or inoculation of cells, or other substances, such as 
antibiotics growth factors etc. 
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Figure 3.1: Design of the cellular culture chamber with the scaffold and culture medium. 
 
In each of the two free extremities of the cell culture chamber, two lids (Figure 3.2-
2) made of PTFE will be encased, being one of the lids composed of four distinct parts 
and the other one composed of five distinct parts. The part of the lid that is in direct 
contact with the cell culture chamber (Figure 3.2-2A) is responsible for preventing 
drainage of the culture medium, through the use of two O-rings; The second part (Figure 
3.2-2B) works as a backstop of the part (Figure 3.2-2A) and presents an hexagonal form 
that is levelled with the part of the other lid, allowing the horizontal positioning of the 
bioreactor, when placed in a plain surface; The part that contains the rolling systems and 
the retainers (Figure 3.2-2C) has a cylindrical shape. In one of the lids, this part contains a 
gear-wheel (Figure 3.2-2D). Both lids contain in its interior a compartment comprising the 
rolling system (stainless steel) (Figure 3.2-3) and the silica retainer (Figure 3.2-4) that 
prevents medium drainage, allowing the coaxial perforated tube a rotational movement of 
360 degrees (Figure 3.2-5). The part of the support system of the cell culture chamber 
(Figure .2-2E) has a cylindrical shape, and is connected by the support arm (Figure 3.2-
13) that connects the cell culture chamber (through part Figure 3.2-2E) to the support 
base (Figure 3.2-14), that will keep the system suspended when its functioning, also 
having the function of allowing the 180-180 movement degrees, to which the cell culture 
chamber will be submitted. To allow the connection and fixation of the coaxial perforated 
tube to the main tubes (that provide the connection to the exterior tubes of the system) 
two parts (tubes) (Figure 3.2-6) (Figure 3.2-7) made of polycarbonate or stainless steel, 
are used. These tubes run through all the length of the system, including the support cell 
culture chamber, until reaching its exterior limit (Figure 3.2-11). 
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Figure 3.2: Overview of the design of the BCPB. 
 
 
 
 
Figure 3.3: Two parts of extremities of the cellular chamber culture. 
 
However, each lid has a different mechanism of connection to the perforated 
coaxial tube, being one of the connections carried through by screws (Figure 3.2-9 and 
Figure 3.3), and the other using a sliding fitting mechanism (Figure 3.2 -8 and Figure 3.3). 
Therefore, one of the ends of the coaxial perforated tube (Figure 3.2-5) has a screw, while 
the other has a mechanism of connection by sliding. The length and the number of orifices 
of the perforated tube is variable and  will be determined by the size of the three-
dimensional support (Figure 3.2-10; Figure 3.4 and Figure 3.5) that is intended to be used. 
This also determines the length to be slid for the coaxial tube in the interior of the part of 
connection to the system of bearing to establish a perfect tight-shut. 
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Figure 3.4: Coaxial perforated tube in polycarbonate or stainless steel and scaffold. 
 
Figure 3.5: Scaffold size of the same size of the perforations in the tube. 
 
The polycarbonate or stainless steel tubes that connect the perforated tube to the 
exterior (Figure 3.2-11), is linked to the continuous circular medium flow system through a 
three-way valve (Figure 3.2-12) in both sides of the cell culture chamber. However, the 
rotational movements of these tubes must be neutralized through the use of another 
rolling system (Figure 3.2-3) (Figure 3.2-4), in order to prevent the rolling up of all the 
tubes connected to them. Two engines are connected to the BCPB: the first one, engine 1 
(Figure 3.2-17) is responsible for the rotational movement of 360 degrees, operating at a 
maximum speed of 52 rpm (coaxial perforated tube). This motor force is transmitted to the 
perforated tube through a pulley system (Figure 3.2-16). The second engine, engine 2 
(Figure 3.2-17) is responsible for the rotational movement of 180-180 and 360 degrees, 
operating at a maximum of 52rpm (cell culture chamber); the force of this motor is 
transmitted to the Cell culture chamber through a gear-wheel system (Figure 3.2-18). For 
the functioning of the BCPB, a circular flow system was specifically designed. It is 
composed of a peristaltic pump (Figure 3.6-20), responsible for the positive flow gradient 
in the cellular culture chamber and the perforated coaxial tube, the pump driving the flow 
is a six-channel peristaltic pump (Cole Parmer®).  
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This pump gives accurate and consistent flow rates ranging from 0.1 to 10 mL/min 
with the tubing size used in our system (Cole Parmer® L/S 16), so it is possible with a 
single pump capable of pumping six different and independent bioreactors, with same flow 
per minute; b) a vacuum pump (Figure 3.6-21), that is responsible for the negative flow 
gradient in the cellular culture chamber and the perforated coaxial tube, a medium 
reservoir bottle of the peristaltic pump (Figure 3.6-22), a medium reservoir bottle of the 
vacuum pump (Figure 3.6-23), and a culture medium bottle collector (Figure 3.6-24). A 
three way valve will be located between the bottle collector and the reservoir bottle of the 
peristaltic pump, which will have to direct the flow of the bottle collector directly to the 
peristaltic pump, thus allowing the exchange of a new medium of culture for old medium of 
culture in the bottle reservoir of the peristaltic pump. Without this it would be necessary to 
stop all the flow system. 
 
Figure 3.6: Overview of the BCPB circular flow system. 
 
3.2 Scaffolds 
 
3.2.1Starch-poly (ε-caprolactone)(SPCL) fiber-meshs scaffolds 
 
SPCL fiber-mesh scaffolds were produced from a polymeric blend (30/70 wt %) of 
corn starch with the synthetic polymer PCL. Starch is one of the most abundant naturally 
occurring polymers that present excellent characteristics for application in the biomaterials 
field, such as low toxicity, biodegradability and biocompatibility (Martins et al, 2008). PCL, 
is a versatile, biocompatible and on another hand is a approved biodegradable polyester 
that has been used in the production of devices approved by the Food and Drug 
Administration (FDA)(2).  
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The combination of these two polymers in a blend confers increased biodegrability 
to PCL and improves the processability and mechanical properties of starch (3). 
 SPCL is a biodegradable polymer susceptible to be degraded by hydrolysis mainly 
catalysed by the enzymes lipase and α-amylase (4, 5). Degradation studies of SPCL fibre-
mesh scaffolds have been performed in solutions containing these hydrolytic enzymes in 
physiological concentrations (6). The results have shown that after 12 weeks of immersion 
the scaffolds were completely degraded. Furthermore, the products resultants from 
degradation are non toxic and are either metabolized via the tricarboxylic acid cycle or 
eliminated by direct renal secretion (4, 7) . 
 SPCL fibers are processed by melt spinning. An extruder equipped with a 12mm 
diameter screw is used with a 0.5 mm monofilament die. Die temperature are the 150°C 
and the screw speed 1 rpm. Extrusion is performed in the ambient environment. Hot fiber 
are driven into a cooling bath (water 13°C) and cold-drawn after the bath, using a 
caterpillar with a speed of 21 m/min and a winding unit with a speed of 28 m/min. Fibers 
are produced in the range 120–500 µm diameter(6). 
 SPCL fiber meshes were prepared by a fiber bonding process consisting of cutting 
and sintering the fibers previously obtained by the above-described melt spinning method. 
Briefly, a selected amount of fibers will be placed in a glass mould and heated in an oven 
at 150°C/ 5 min. Immediately after removing the moulds from the oven, the fibers will be 
slightly compressed by a teflon cylinder (which runs within the mould) and then cooled at 
−20°C/ 5min.  
 The advantage of fibre-mesh design is the large surface area for cell attachment 
which also enables rapid diffusion of nutrients enhancing cell survival and growth (6). 
Another great advantage of SPCL fibre-mesh scaffold architecture and specially pore 
interconnectivity is its application in tissue-engineering strategies that involve the use of 
bioreactor cultures. Studies performed by Gomes et al, with a flow perfusion bioreactor, 
showed that SPCL fibre-mesh scaffold provided an appropriate matrix for the proliferation 
and osteogenic differentiation of rat bone marrow cells(8, 9). Furthermore, the fibre- mesh 
structure allowed a homogenous distribution of the cells and throughout deposition of 
mineralized matrix (9) when cultured under flow perfusion conditions. 
 A complementary study demonstrated the influence of porosity of these scaffolds 
in a flow perfusion bioreactor and concluded that the best outcome was obtained with 
SPCL fibre-mesh scaffolds with a porosity of 75%, rather than 50 % (8). 
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SPCL fiber mesh scaffolds, aiming at bone TE applications, have demonstrated 
great potential in this field (10-14). 
 
3.3 Harvesting, isolation and culture of bone marrow mesenchymal stromal 
cells 
Mesenchymal stem cells (MSC) are an interesting candidate for cell-based 
therapeutics and regenerative medicine (15, 16). While several tissues remain an 
important source of therapeutic relevant differentiated cells, stem cells have emerged as a 
strong alternative due to their potential of expansion- self-renewal potential-and the fact 
that they can be obtained from autologous sources. Additionally, MSCs can be 
differentiated into a variety of connective tissues, including bone, cartilage, fat, muscle 
and tendon, when cultured with appropriated supplemented culture media and specific 
environments (17, 18). 
In the studies described in this thesis we have used MSCs from rat and goat bone 
marrow. The experimental protocols to obtain the bone marrow aspirate were performed 
according to the guidelines and after approval by the National Ethical Committee for 
Laboratory Animals from the Direcção Geral da Agricultura. 
 
3.3.1 Harvesting, isolation and culture of rat bone marrow stromal 
cells (RBMSC’s)  
Rat bone marrow stromal cells (RBMSC’s) were used in the works described in 
chapter IV, which describes the behaviour of SPCL fiber mesh scaffolds seeded with 
these cells in the regeneration of critical sized defects in a rat model. 
RBMSC’s cells were obtained from femora of male Fisher rats weighing between 
150-200g. Femora were washed 3 times in culture medium α-MEM (Minimal Essential 
Medium) with added 50 µg/ml gentamycin, 100 µg/ml ampicillin and 0.3 µg/ml fungizone. 
Epiphyses were cut off and diaphyses flushed out with 15 ml complete culture medium α-
MEM, supplemented with 10 % FCS (foetal calf serum, Gibco), 50 µg/ml ascorbic acid 
(Sigma, Chemical Co., St.Louis, MO, USA), 50 µg/ml gentamin, 100 µg/ml ampicillin, 0.3 
µg/ml fungizone, 10 mM Na β-glycerophosphate and 10–8 M dexamethasone (all Sigma). 
Cells were incubated in a humidified atmosphere of 95 % air, 5 % CO2 at 37°C. The 
medium was changed three times a week. 
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After 7 days of primary culture, cells were detached using trypsin/ EDTA (0.25% 
w/v trypsin / 0.02% EDTA). The cells were concentrated by centrifugation at 1500 rpm for 
5 minutes and resuspended in a known amount of media. Cells are counted and 
resuspended in complete medium.  
 
3.3.2 Harvesting, isolation and culture of goat bone marrow stromal 
cells (GBMSC’s) 
Goat bone marrow stromal cells were used in the works described in chapters V 
and VI, concerning the in vitro studies for assessing the feasibility of the developed 
bioreactor and the in vivo study that focused on assessing the behaviour of SPCL fiber 
mesh scaffolds seeded with these cell in the regeneration of critical sized defects in a goat 
model.  
The iliac regions of the 6 adult goats were shaved and disinfected and animals 
were placed under general anaesthesia. Using a bone marrow aspiration needle (T-lok™ 
Angiotech Pharmaceuticals, Inc., USA) and a 10mL syringe, already containing 1mL 
heparin (5.000U.I, Heparin sodium, B. Braun Medical, Inc., USA), 10mL of bone marrow 
aspirate was harvested from the iliac crest of adult goats and transferred into a sterile tube 
and mixed with 30 ml basic culture medium – DMEM (Dulbecco’s Modified Eagle’s 
Medium) (Sigma-Aldrich, USA) supplemented with 10%  fetal calf serum and 1% A/B 
(Invitrogen, Spain). GBMCs were centrifuged for 10 minutes at 1200 rpm and a dense 
cellular pellet was collected and cultured in a basic culture medium – DMEM (Dulbecco’s 
Modified Eagle’s Medium) (Sigma-Aldrich, USA) supplemented with 10% autologous 
serum isolated from goat peripheral blood and 1% A/B (Invitrogen, Spain)(13, 19). Four 
days after the harvesting procedure, cells were rinsed in a sterile phosphate buffered 
saline (PBS, Sigma, USA) solution and medium was changed. Then, cells were 
cryopreserved at 1P, expanded until 90% confluence and sub-cultured at 1P and 2P 
before seeding  
 
3.3.2.1 Cryopreservation of cells  
GBMSC’s were cryoprezerved upon expansion until 90 % of confluence. At 
confluency, cells cultured in 75cm2 flasks were enzymatically lifted with 3 ml of the 0.05 % 
trypsin-EDTA (Invitrogen, Spain), for 5 minutes in the incubator. After this the trypsin was 
neutralized by adding the same amount of basal culture medium (DMEM), and taking 10 
µl of the cell suspension to count the number of cells with the Neubauer chamber; 
afterwards, the cell suspension was centrifuged at 1200 rpm at 4ºC, the supernatant was  
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removed and the pellet was resuspended in the required volume of Foetal Bovine Serum 
(FBS) to obtain a final concentration of 1x106 cells/ml. To each cryotube, 100µl of 10 % 
glycerol or dimethyl sulfoxide (DMSO) and 900µl of cell suspension were added. The 
cryotubes were placed at – 80 ºC for 4 hours. After this the cryotubes were transferred 
into the liquid nitrogen container. 
 
3.3.2.2 Replating cells after cryopreservation 
GBMSC’s stored in a liquid nitrogen chamber (-196ºC), at early passages and at 
high concentration maintain their characteristics and can be thawed and used when 
necessary. For this purpose, the cryotubes containing the cells are removed from the 
liquid nitrogen chamber, the culture medium is cooled in a glass container with ice, and 
the cryotubes are placed as quickly as possible in a thermostatic water bath at 37 ºC, until 
it is partially thawed; after this the cryotubes are placed directly on ice, the cells are placed 
in a 15 ml tube and approximately 9 ml of cold culture medium is added, this cell 
suspension are centrifuged for 10 minutes at 12000 rpm at 4ºC, the supernatant is 
removed, and the pellet is resuspended in approximately 2 ml of culture medium. Finally, 
the cell suspension is transferred into 75 cm2culture flasks, and 15 ml culture medium 
(osteogenic or basal) was added.  
 
3.3.3 Harvesting, isolation and culture of cat bone marrow stromal 
cells (CBMSC’s) 
 CBMSC’s were used in the work reported in chapter VII which describes a 
case study where it was performed the application of an autologous stem cell therapy in 
the treatment of a tibial fracture gap in a cat. 
 Under general anaesthesia (ketamine HCl at 5 mg/kg IM and medetomidine 
at 80µ/kg IM), maintained on isoflurane (2%) in oxygen(1500ml/min), 2ml of bone marrow 
(BM) was harvested from the femoral medullar cavity through the use of a biopsy needle 
(T-Lok TM). The cat bone marrow aspirate was mixed with 10ml of osteogenic media 
consisting of alfa-DMEM supplemented with osteogenic supplements namely, 108 M 
dexamethasone, 1% Antibiotics; 10%(FBS), 50µgml-1 ascorbic acid and 10mM β-
glycerophosphate, and heparin (1/1000units) and the mixture was centrifuged (1200rpm/5 
min). The pellet was removed and the cells were resuspended in the same media and 
seeded in two 75 cm2 culture flasks and then placed inside an incubator.  
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Cells developed a fibroblastic- like morphology in visible symmetric colonies at 
about 4 days after initial plating. Non-adherent cells were removed with medium changes 
performed every 2-3 days. The osteoblastic differentiation was induced by culturing cells 
for 2 weeks in osteogenic medium. 
 
3.4 Osteogenic differentiation 
The differentiation of MSCs towards the osteogenic lineage is a highly 
programmed process that is well described in vitro. Usually it requires the 
supplementation of culture media with dexamethasone, β-glycerophosphate and ascorbic 
acid (16, 20). Dexamethasone (DEX) is routinely added to osteoprogenitor cells, having 
both inhibitory and stimulatory effects over skeletal cells.. It has also been suggested that 
even a transient exposure of stem cells to DEX may be effective in inducing and 
maintaining the osteoblastic phenotype (20). Glycerophosphate is the organic phosphate 
source, playing an important role in the mineralization process and modulation of 
osteoblast activities, namely on the alkaline phosphatase (ALP) activity and osteocalcin 
production. Ascorbic acid (AA) increases cell viability and is a cofactor in the hydroxylation 
of proline and lysine residues and is therefore necessary for the production of collagen  
(21). AA has also been demonstrated to increase ALP activity. Together with β-
glycerophosphate, AA was found to be a prerequisite for the formation and mineralization 
of the extracellular matrix. The osteogenic culture medium that was used in several works 
of thesis (chapter IV;V,VI;VII) was composed of Alpha Modified Eagle Medium α MEM 
(Sigma Aldrich, Germany), supplemented with 50 µg/ml AA(Sigma Aldrich, Germany), 108 
M Dexamethasone(Sigma Aldrich, Germany), 10 mM β-Glicerol Phosphate(Sigma Aldrich, 
Germany), 10 % FBS (Gibco,UK) and 1 % Antibiotic/Antimycotic (Gibco, UK), (designated 
in further sections as Osteogenic Medium). 
 
3.5 “In-Vitro” biological testing 
 
3.5.1 Culture of Goat bone marrow stromal cells in SPCL constructs 
 
3.5.1.1 Seeding GBMSC’s onto SPCL constructs 
For the in-vitro and in-vivo goat studies (chapters V and VI) the polymer scaffolds 
were cut into disk of diameters of 16 mm and of thicknesses (3-4mm) with a inner 
cylindrical hole of 6mm (Figure 3.7). 
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All samples were sterilized by a standard procedure with ethylene oxide. The 
sterile samples were placed in 12–well cell culture plate (Costar® Corning; NY). Each 
sample was seeded with 300µl of a cell suspension containing 1x106 GMBCs, prepared in 
osteogenic medium. 
 
Figure3.7. Schematic representation of the SPCL fiber-meshs scaffolds. 
 
3.5.1.2 Static culture 
For static culturing (controls), the SPCL scaffolds were placed in four 12 well non-
adherents plates. A total of 14 samples were seeded with cell suspension for static culture 
for 14 days and 14 samples were seeded with cell suspension for static culture for 21 
days. The well plates were transferred to the incubator and incubated overnight. The four 
12 well plates of static culturing were taken out of the incubator and 10ml of osteogenic 
culture medium was added to each sample (static control). The scaffolds-cell was cultured 
for 14 days and 21 days. All GBMSC’s–SPCL constructs were maintained in a 37 ºC 
environment with 5% CO2.The culture medium was changed each 7 days. 
 
3.5.1.3 Bioreactor culture  
The plates containing cell-scaffolds constructs to be cultured in the bioreactor were 
carefully transferred to two BCPB’s, in a flow laminar cabinet, as follows: each sample 
(3mm length and 16 mm diameter, with a inner hole of 6mm) was carefully inserted into 
the polycarbonate perforated tube and stacked until completing a total of 14 samples, 
corresponding to 42 mm length construct. The perforated tube with the construct was then 
connected to the two end parts of the bioreactor that aims to promote the hermetic and 
aseptic closure of the culture chamber; afterwards the main chamber of the bioreactor 
was connected to the flow system and slowly filled with the culture medium at a rate of 
1ml/mim, with the flow directed from inside the chamber to the perforated tube, enabling 
the medium to flow from outside to inside the cells-scaffold construct.  
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Finally, the whole system was transferred to the incubator (at 37ºC environments 
with 5% CO2) where it was operated for 14 and 21 days. The culture chamber has a 
capacity for 216 ml of culture medium while the bottle reservoir has a capacity of 450 ml of 
medium; every week 400 ml of old medium were exchanged with 400 ml of fresh medium, 
without stopping medium flow in the bioreactor system. Each sample of the static group 
was cultured in the presence of 10 ml of culture medium which was changed every week.  
 
3.6 “In-Vitro” characterization of the cultured cell-scaffolds constructs 
 
3.6.1 Cell morphology – Scanning Electron Microscopy (SEM) 
The morphological analysis of cells growth, attachment, and distribution on the 
surface of the scaffolds was conducted by using SEM. To achieve these goals it is 
required the use of methods of fixation or stabilization of the cells on the scaffolds to 
obtain biological samples in their natural state. Due to the non-electric conductivity of 
those samples it is also needed to coat the samples with a conductive material such as 
gold or carbon. To overcome the limitation in the level of vacuum required for biological 
samples and/or the charging of non-conducting samples, a so-called environment SEM 
(E-SEM), was developed (Ziegler C, 2005).The constructs (scaffolds-cells) were fixed with 
2.5 % Glutaraldehyde ( Sigma,USA) in PBS solution during 1 hour  at 4°C. Then, they 
were dehydrated through graded series of ethanol (70, 80, 90, 100 %) and let to dry 
overnight at room temperature. Finally, they were gold or carbon sputter coated (Fisons 
Instruments, model SC502; England) during 2 minutes at 15 mA, and analyzed by SEM 
(Leica Cambridge, model S360; England) equipped with an energy dispersive 
spectrometer (EDS;link-el-II). 
 
3.6.2 Cell viability assay 
The cellular viability on the scaffolds was assessed by a colorimetric assay named 
CellTiter 96® AQueos One Solution Cell Proliferation Assay (Promega, USA). The principle 
of this assay is based on the bioreduction of a tetrazolium compound [(3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymetyhoxyphenyl)-2(4-sulphophenyl)-2H-tetrazolium, 
inner salt(MTS)] into a brown formazan product that is soluble in culture medium(Cory et 
al.,1991). This conversion is accomplished by the production of nicotinamide adenosine 
dinuccleotide phosphate (NADPH) or nicotinamide adenine dinucleotide (NADP) by the 
dehydrogenase enzymes existing in the metabolically active cells.  
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The quantity of formazan product measured by the amount of 490nm absorbance 
in a microplate reader (Bio-Tek, model Synergie HT; USA), after 3 hours of incubation at 
37 ºC. Three specimens per condition and per time point were characterized. 
 
3.6.3 Cell proliferation assay 
Determinations of Deoxyribonucleic acid (DNA) synthesis over time are frequently 
taken to be representative of the amount of cell proliferation (22). The most commonly 
used technique for measuring nucleic acid concentration is the determination of 
absorbance at 260nm (A260). The major disadvantages of the absorbance method are the 
large relative contribution of RNA and single-stranded DNA to the signal, the interference 
caused by contaminants commonly found in nucleic acid preparations, the inability to 
distinguish between DNA and Ribonucleic acid (RNA) and the relative insensitivity of the 
assay (an A260 of 0.1 corresponds to a 5 µg/ml double-stranded DNA solution). 
Alternatively, DNA content may be assayed by several fluorescence emissions, including 
reaction with DAPI, PicoGreen or Hoechst 33258. 
In this work, cell proliferation was quantified by the total amount of double-stranded 
DNA (dsDNA) using an ultrasensitive fluorescent nucleic acid stain (23) during the 
culturing periods. For this, Quant-iTTM Picogreen® dsDNA and RNA with minimal reagent 
was selected since it enables to quantify as little as 25 pg/ml of dsDNA with a standard 
spectrofluorometer and fluorescein excitation and emission wavelengths. The Quant-iTTM 
Picogreen® dsDNA Assay Kit (InvitrogenTM, Molecular ProbesTM, Oregon USA) was used 
according to the manufactures’s instructions. Briefly, cells in the construct were lysed by 
osmotic and thermal shock and the supernatant used for the DNA quantification assay. A 
fluorescent dye, PicoGreen, was used because of its high sensitivity a specificity to 
double-stranded DNA. The fluorescence of the dye was measured at an excitation 
wavelength of 485/20 nm and at an emission wavelength 528/20 nm, in a microplate 
reader (Synergie HT, Bio-Tek; USA). Triplicates were made for each sample and per 
culturing time. The DNA concentration for each sample was calculated using time. The 
DNA concentration for each sample was calculated using a standard curve (DNA 
concentration raging from 0.0 to 4.5µg/ml) relating quantity of DNA and fluorescence 
intensity. 
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3.6.4 Determination of alkaline phosphatase activity in cells – scaffold 
constructs  
The progression of differentiation can be assessed by biochemical assays. Routine 
assays involve the quantification of activity of alkaline phosphatase (ALP), a cell surface 
protein bound to the plasma membrane though phosphatidylinositol phospholipid 
complexes (21).  
High ALP activity is associated with the active formation of mineralized matrix, and 
highest levels are found in the mineralization front of the bone healing process. 
The ALP activity was determined for all time culture periods, using the same 
samples used for DNA quantification. Briefly, the activity of ALP was assessed using the 
p-nitrophenol assay. Nitrophenol phosphate disodium salt (pnPP;Fluka BioChemika, 
Austria), which is colourless, is hydrolysed by the alkaline phosphatase produced by the 
cells at ph 10.5 and temperature of 37 ºC, to form free p-nitrophenol, which is yellow. The 
reaction was stopped by the addition of 2M NaOh (Panreac Quimica, Spain) and the 
absorbance read at 405 nm in a microplate reader (Bio-Tek, Synergie HT; USA). 
Standards were prepared with 10 µmol/ml p-nitrophenol (pNP;Sigma, USA) solution, to 
obtain a standard curve ranging from 0 to 0.4 nmol/ml/hr. Triplicates of each sample and 
standard were made, and the ALP concentrations read off directly from the standard 
curve. 
 
3.6.5 Histological analysis 
The samples retrieved for the in vitro were rinsed in PBS, fixed in 4% formalin, 
dehydrated in a graded series of ethanol and embedded in methylmethacrylate 
(Technovit® 7100 NEW, Kulzer, DE). The procedure was based on the protocol provided 
by the manufacturer; following polymerization, sagittal microtome sections of 10 µm in 
thickness were prepared per implant. In order to observe cells and matrix formed, sections 
were stained with hematoxylin & eosin.  
 
3.6.6 Light microscopy 
 Stained constructs were observed under an optical microscope (BX61 Olympus 
Corporation, Germany) and images captured by a digital camera (DP70 Olympus 
Corporation, Germany). 
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3.6.7 Statistical analysis 
The PASW Statistics18 software package (IBM, Somers, NY) was used for the 
statistical analysis. Descriptive values are presented as mean ± SD unless stated 
otherwise. Kolmogorov-Smirnov test with Lillefors significance correction was used to test 
the normality of the data. The one way ANOVA was used to determine if exist differences 
among the groups and Tukey test was used to assess the pairwise comparisons between 
groups. The statistical significance level considered was P <0.05. 
 
3.7 “In-Vivo” tudies 
Care and management of animals were conducted as per the guidelines of the 
Animal Ethics Committee and Supervision of Experiments on Animals. 
 
3.7.1 Rat animal model 
 
3.7.1.1 Seeding rat bone marrow stromal cells in SPCL 
constructs 
For the in vivo rat study (chapter IV) the polymer scaffolds were cut into disk of 
diameters of 8 mm diameter and 2 mm of thicknesses. All samples were sterilized using 
ethylene oxide, as described above. The sterile samples were placed in 12–well cell 
culture plate (Costar® Corning; NY) and each sample was seeded with 200µl of a cell 
suspension containing 250.000 RBMSC’s in osteogenic medium. 
 
3.7.1.2 Characterization of DNA in cell-seeded meshes 
DNA assays (Invitrogen, Madrid, Spain) (n=6) were performed on day 0 and 1, 
after seeding of the RBMSCs onto SPCL scaffolds.. Culture medium was removed and 
meshes were washed twice with PBS. 1 ml of MilliQ was added to each sample. Cells 
were harvested by placing the scaffoldss with inoculated cells in a 1.5 ml tube. 1 ml of 
MilliQ was added to each sample. Cell suspension was frozen to -80°C, heated to 37°C, 
frozen to -80°C again and stored at -80°C until usage. 
DNA standard curve was made with Salmon testes DNA. 100 µl of sample or 
standard were added to 100 µl Picogreen working solution. The samples were incubated 
for 5 minutes at room temperature in the dark.  
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After incubation, DNA was measured using a fluorescence microplate reader (Bio-
Tek instruments, Winooski, VT, USA) with excitation filter 365 nm and emission filter 450 
nm. The quantity of DNA was correlated to the number of cells, using the standard curve 
of cell number versus the measured emission. 
 
3.7.1.3 Animal surgical procedures 
Thirty inbred male Fisher rats (250g; Charles River, Barcelona, Spain) were used, 
in which each rat received one implant in a circular critical size cranial defect of 8 mm. 
The implantation periods were 4 and 8 weeks and the rats were divided into three groups: 
SPCL meshes loaded with osteoblast-like cells, SPCL meshes and empty defects (only 8 
weeks). 
 The care and use of laboratory animals were performed according to the national 
guidelines after approval by the national ethical committee for laboratory animals and 
conducted in accordance with European standards on animal welfare. During the entire 
study, adequate measures were taken to minimize any pain and discomfort. One animal 
was housed in each cage and the proper intake of fluids and food were monitored on a 
daily basis. Also, the animals were observed for signs of pain, infection and proper 
activity. Surgery was performed under general inhalation anesthesia, induced by 4% 
isoflurane and maintained with 2.5% isoflurane by a non-rebreather mask. The rats were 
monitored with an oxy-pulse meter during surgery. To minimize postoperative pain, 
buprenorfine (Temgesic) (0.05 mg/kg s.c.) was administered postoperatively.  
After anesthesia the rats were immobilized on their abdomen and the skull was 
washed and disinfected with iodine. A longitudinal incision was made down to the 
periosteum from the nasal bone to the occipital protuberance, and soft tissues were 
sharp-dissected to visualize the cranial periosteum. Subsequently, a midline incision was 
made in the periosteum and the periosteum was undermined and lifted off the parietal 
skull. To create a central full thickness bone defect in the parietal cranium, a hollow 
trephine bur (ACE dental implant systems, Paço D'Arcos, Portugal) with an outer diameter 
of 8.0 mm in a dental hand piece was used. The bone defect was carefully drilled under 
continuous cooling with physiologic saline and without damaging of the underlying dura. 
Then, the created bone segment was carefully removed, without damaging the underlying 
sagittal sinus.  
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Following insertion of the implants the periosteum was closed using resorbable 
MonoPlus® 4-0 suture materials (BBraum, Portugal). Subsequently, the skin was closed 
using the same resorbable sutures. Eventually, the rats were euthanized 4 or 8 weeks 
after surgery by an overdose of thiopentone (Tiopental, BBraum, Portugal). 
 
3.7.2 Characterization of the samples retrieved from in vivo study performed 
in a rat model 
 
3.7.2.1 Micro-CT analysis 
Before implantation and after retrieving the cranium including the implanted 
samples, specimens were scanned and analyzed using microcomputed tomography 
(µCT) (SkyScan 1072 high-resolution micro-CT, SkyScan, Kontich, Belgium). The data 
from the initial scanning were used to quantify the total porosity of the implants.  
 
 
After retrieving the implants, the quantitative evaluation of newly formed bone was 
calculated by determining a region of interest (ROI), which was set between the pre-
existing bone and the implants. Within this ROI, new bone formation was distinguished 
from pre-existing bone and composite through structure and color differences. New bone 
formation was expressed in mm3, using standardization of the 3-dimensional region of 
interest. 
 
3.7.2.2. Histology  
After scanning the implants with the microCT, implants were prepared for 
histological evaluation. The samples were dehydrated in a graded series of ethanol, 
decalcified and embedded in paraffin. After hardening, sagittal microtome sections of 5 
µm in thickness were prepared per implant. The sections were stained with hematoxylin 
and eosin or Masson’s trichrome solution, which is frequently used as bone-specific 
staining. Subsequently, sections were investigated with a light microscope. 
 
3.7.2.3. Statistical analyses 
Statistical analyses were performed with GraphPad Instat 3.05 software 
(GraphPad Software Inc., San Diego, CA, USA) using an one-way analyses of variance 
(ANOVA) with a Tukey multiple comparison post test.  
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3.7.3 Goat animal model 
Six goats, 2-year-old females (n=2 in each group), with an average weight of 25 kg 
(ranged, 23–27.5 kg) were used. Animals were kept in separate cages with free access to 
food and water. Cylindrical critical size defects were performed in the tibial shafts, with the 
main purpose of comparing the new bone formation in defect implanted with GBMSC’s-
SPCL constructs cultured either in the flow perfusion bioreactor or under static conditions. 
Therefore three study groups were considered: Bioreactor group (6 and 12 weeks); Static 
(6 and 12 weeks) and empty defect (6 and 12 weeks). Autologous approach culture was 
used in this study, ie, animals were implanted with constructs containing the cells that 
were previously harvested from each animal. 
 
3.7.3.1 Cell seeding onto SPCL scaffolds 
As described in previous section 3.5.1.1. A total of 56 samples were 
seeded. 
 
3.7.3.2 Static Culture Groups 
The SPCL scaffolds were placed in four 12 well non-adherents plates. A total of 14 
samples were seeded with 300 µl of a cell suspension containing 1x106 cells in basal 
medium composed of α-MEM (Minimal Essential Medium) with 10 % FCS (foetal calf 
serum, Gibco), 50 µg/ml gentamycin, 100 µg/ml ampicillin and 0.3 µg/ml fungizone (all 
from Sigma) for static culture 6 weeks group and 14 samples for static culture 12 weeks 
group. The well plates were transferred to the incubator and incubated overnight. The four 
well plates were then transferred to the incubator and three hours after seeding it was 
added 1.6 ml of basal medium to each well and incubated overnight. After this the 12 well 
plates of static culturing were taken out of the incubator the basal medium was removed 
and 10ml of osteogenic culture medium was added to each sample (static control). The 
scaffolds-cell was cultured for 14 days. All GBMC–SPCL constructs were maintained in a 
37 ºC environment with 5% CO2.The culture medium was changed each 7 days. 
 
3.7.3.3 Bioreactor culture groups 
 The SPCL scaffolds were placed in four 12 well non-adherents plates (Costar; 
Becton-Dickinson). A total of 14 samples were seeded with 300 µl of a cell suspension 
containing 1x106 cells in basal medium for bioreactor culture for 14 days (6 weeks 
implantation group) and additional 14 samples for bioreactor culture for 14 days (12 weeks 
implantation group).  
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 The four well plates were then transferred to the incubator and three hours after 
seeding it was added 1.6 ml of basal medium to each well and incubated overnight. The 
four 12 well plates of bioreactor culturing were taken out of the incubator and were then 
carefully transferred to two bioreactors to which were added 216 ml of osteogenic culture 
medium in each bioreactor. The scaffolds-cell was cultured for 14 days. All GBMSC’s–
SPCL constructs were maintained in a 37 ºC environment with 5% CO2. The culture 
medium was changed each 7 days. 
 
3.7.3.4 Animal surgical procedures 
The animals were premedicated with intramuscular injection medetomidine 
hydrochloride (Domitor®, Pfizer, Portugal) at 0.11mg/kg body weight, and ketamine 
hydrochloride (Imalgene®, Merial, Portugal) at 10mg/kg body weight.  
Thiopentone (Tiopental®, BBraum, Portugal) sodium at 5mg/kg body weight 
intravenously was given for induction of anesthesia. Antibiotic therapy with Cephazolin 
(Cefazolin® 500mg, Sagent, Portugal), 10 mg/kg was administered subcutaneously as 
prophylactic antibiotics. The animals were intubated immediately with size nº 9 Magill 
endotracheal tube. Anesthesia was maintained with increments of medetomidine 
hydrochloride and ketamine hydrochloride dose-effect every 20–30 min. The animals were 
fixed in the right lateral position on an operating table. Asepsis of the skin after shaving 
was done with chlorhexidine (LifoScrub®, BBraum, Portugal) solution and wrapped using 
sterile technique, a skin incision of 15 cm length along the right tibia was made and the 
tibia was exposed using a standard medial approach. The periosteum was elevated and a 
40 mm bone segment was excised from the mid diaphyseal region using an oscillating 
saw under abundant irrigation. A stainless steel biological healing plate of 7 holes (Servive 
Portugal, Valencia) and cortical screws of 3.5 mm and 16 mm in length more wire banding 
(Cerclagem) techniques were used for immobilization of the bone. The GBMSC’s–SPCL 
constructs by bioreactor perfusion culture were placed into the right tibia defects 
(bioreactor group, 6 and 12 weeks). The GBMSC’s–SPCL constructs for culture in static 
state (static group, 6 and 12 weeks) and control group (empty defect, 6 and 12 weeks) 
were implanted into the right tibia by the same procedure. The surround soft tissue and 
skin (intradermal suture) incision was closed with uninterrupted sutures with absorbable 
synthetic monofilament suture (MonoPlus®, BBraum, ortugal). 
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 Limb immobilization was performed with the use of a modified Robert Jones 
bandage for a week. During the first week after surgery, cephazolin (10 mg/kg) was 
routinely administered intramuscularly once a day and the physical exams of all the 
animals were conducted daily. The animals were sacrificed at 6 and 12 weeks with an 
injection of high doses of thiopentone (Tiopental, BBraum, Portugal). 
 
3.7.4 Characterization of the samples retrieved from in vivo study 
performed in a goat model 
 
3.7.4.1 Digital radiography 
In vivo, digital radiography of all the goats were taken in the immediate 
postoperative, 6, and 12 weeks post operation. Standard mediolateral and craniocaudal 
radiographic views of the right tibia were obtained using a radiography machine (Philips®, 
Corp.), all exposure were taken at 50 kVp for 2.5 mAs, and each image was immediately 
reviewed using a diagnostic imaging software (CrystalView®).  
To ensure diagnostic quality of exposure and positioning. The changes of 
radiopacity in and around the GBMC–SPCL constructs at the defect and bone union at the 
cut-ends of the original tibias were analyzed. Radiographs of the tibia removed from the 
goats were taken by routine procedures. 
 
3.7.4.2 Micro-CT 
The formation of mineralized tissue in the GBMSC’s–SPCL constructs explants 
was evaluated using a high-resolution µ-CT Skyscan 1072 scanner (Skyscan, Konitich, 
Belgium). Each sample was scanned in high-resolution mode with a pixel size of 17.58µm 
and exposure time of 1.6ms. The x-ray source was set at 52 keV of energy and 163µA of 
intensity. Approximately 400 projections were acquired over a rotation of 180º with a 
rotation step of 0.45º. Each one of these projections were segmented into binary images 
with dynamic threshold of 220-255 (grey values) to assess new bone formation. These 
data sets were used for morphometric analysis (CT analyser, v1.51.5 SkyScan) and to 
build the 3D models (ANT 3D creator, v2.4 SkyScan). The distribution and quantification 
of the new bone formation in the scaffolds was assessed by 3 D virtual models that were 
created, visualized and registered using both image processing software´s (CT analyser 
and ANT 3D creator). 
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3.7.4.3 SEM 
Cell adhesion and morphology at the surface of the GBMSC’s–SPCL constructs 
explants were also analysed by SEM. Scaffolds were washed in 0.15M phosphate 
buffered saline and fixed in 2,5 % glutaraldehyde in phosphate buffered saline for 1 hours 
at 4ºC. After rinsing 3 times in phosphatese buffered saline, the scaffolds were 
dehydrated using a series of graded ethanol (70, 80, 90, and 100%) and let to dry 
overnight at room temperature. 
 Finally, they were gold or carbon sputter coated (Fisons Instruments, model 
SC502; England) during 2 minutes at 15 mA, and analyzed by SEM (Leica Cambridge, 
model S360; England) equipped with an energy dispersive spectrometer (EDS;link-el-II).   
 
3.7.4.4 Histological analysis 
The samples retrieved were rinsed in PBS, fixed in 4% formalin, dehydrated in a 
graded series of ethanol and embedded in paraffin, sagittal microtome sections of 5 µm in 
thickness were prepared per implant. In order to observe cells and matrix formed, sections 
were stained with hematoxylin & eosin and Masson trichrome, which are frequently used 
as bone-specific staining. Samples were then visualized under a light microscope and 
images taken with an attached camera. 
 
3.7.4.5 Light microscopy 
 Stained constructs were observed under an optical microscope (BX61 Olympus 
Corporation, Germany) and images captured by a digital camera (DP70 Olympus 
Corporation, Germany). 
 
3.7.4.6 Statistical analysis 
The PASW Statistics18 software package (IBM, Somers, NY) was used for the 
statistical analysis. Descriptive values are presented as mean ± SD unless stated 
otherwise. Kolmogorov-Smirnov test with Lillefors significance correction was used to test 
the normality of the data. The one way ANOVA was used to determine if exist differences 
among the groups and Tukey test was used to assess the pairwise comparisons between 
groups. The statistical significance level considered was P <0.05. 
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3.7.5 Cat animal model  
 
 3.7.5.1 Cells harvesting, culturing and implantation 
  CBMSC’s cells, harvested/isolated and cultured as previously described in 
section 3.3.3, were enzymatically lifted with 3 ml of trypsin after reaching 80%- 90% of 
confluence at passage 3 (p3), centrifuged (1200rpm/5min) and the pellet was removed. A 
cells suspension containing 9x106 cells in 0, 6 ml of phosphate-buffered saline (PBS) 
solution was prepared and injected in the gap site using a 1mL sterile syringe. 
 
  3.7.5.2 Osteogenic differentiation - Determination of the alkaline 
phosphatase activity  
  To characterize the osteogenic differentiation in vitro, cells were cultured in 
6 well plates at a density of 3x105 cells/well. Plates with osteogenic medium for days 0, 
7(first week) and 21(third week), changing the medium every 2-3 days. ALP activity of the 
CBMSC was measured to evaluate osteoblastic-like differentiation; for this purpose, the 
samples were collected on days 0, 7(first week) and 21(third week), washed twice with a 
sterile PBS solution and transferred into 1.5 ml microtubes containing 1ml of ultra pure 
water; the tubes containing the cells samples were then incubated for 1h at 37 0C in a 
water –bath and then stored in a -80 0C freezer until testing. For the ALP assay, 20µl of 
each sample plus 60µl of substrate solution (0.2% (w/v) p-nytrophenyl (pNP) phosphate in 
a substrate buffer: 1 M diethanolamine HCL, at pH 9.8) was placed in each well of a 96-
well plate were added 20µl of sample plus 60µl of substrate solution: 0.2% (w/v) p-
nytrophenyl (pNP) phosphate in a substrate buffer: 1 M diethanolamine HCL, at pH 9.8. 
The plate was then incubated in the dark for 45 min at 37 0C. After the incubation period, 
80 µl of a stop solution (2M NaOH containing 0.2 mM ethylenediaminetetraacetic acid 
(EDTA), was added to each well. Standards were prepared with 10µmol ml-1 pNP and the 
stop solutions in order to achieve final concentrations ranging between 0 and 0.3µmol-1. 
Triplicates were made for each sample and standard. Absorbance was read at 405 nm 
Microplate ELISA Reader and sample concentrations were read off from standard graph. 
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3.7.5.3 Osteogenic differentiation- Alizarin red staining 
 To asses mineralization, 3x105 cells/well cultured in 6-well plates with 
osteogenic medium for different time points 7(first week) and 21(third week) were stained 
with Alizarin Red (Fluca, Germany). 
 
 3.7.6 Characterization performed upon cells implantation  
 
  3.7.6.1 Radiography 
To visualize the development of the mineralization in the gap site, X-rays (X-rays: 
Cosmos BS, Philips Medical Systems, Carlsbad, CA) were carried out and all exposure 
were taken at 48 kVp for 2.5 mAs were performed at days 0, 7(first week) and 21(third 
week) upon cells implantation. 
 
  3.7.6.2 Determination of alkaline phosphatase activity in cat 
blood serum 
 Assessment of ALP In vivo was carried out by harvest of 2 ml of peripheral blood 
serum for assay in IDEXX VetTest® chemistry analyzer  in days 0 (day of the application 
of the cells), 7(first week) and 21(third week).  
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Chapter IV 
Osteogenic properties of starch poly(ε-caprolactone) (SPCL) fiber meshes 
loaded with rat bone marrow stromal stem cells (RBMSCs) in a rat critical-
sized cranial defect 
 
 
 
 
This chapter is based on the following publication: Link* DP, Gardel* LS, Correlo VM, 
Gomes ME, Reis RL. Osteogenic properties of starch poly(ε-caprolactone) (SPCL) fiber 
meshes loaded with rat bone marrow stromal stem cells (RBMSCs) in a rat critical-sized 
cranial defect. 2012 submitted.  
*These authors contributed equally to this work 
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Abstract 
Bone marrow stromal cells (BMSCs) are able to differentiate into the osteogenic 
lineage and together with a suitable scaffold, these cell-scaffold constructs can aid the 
bone regeneration process. A suitable scaffold could be starch poly(å-caprolactone) 
(SPCL) fiber meshes, which have shown a high potential to support bone formation in 
previous in vitro and in vivo studies. However, previous in vivo studies were limited to 
subcutaneous and non-critical sized orthotopic defect models. Therefore, the aim of this 
study was to assess the effect of these scaffolds alone or combined with rat bone marrow 
stromal cells (RBMSCs) in the regeneration of a critical size cranial defect in a rat model. 
Therefore, SPCL fiber meshes were pre-loaded with RBMSCs and subsequently 
implanted in a critical-sized cranial defect in male Fisher rats. Empty defects and defects 
filled with cell-free scaffolds were used as controls groups. After four and eight weeks of 
implantation, samples were analyzed to assess new bone formation by means of MicroCT 
and histological analysis. 
In general, histological analyses revealed that all study groups showed new bone 
formation from the defect edges towards the interior of the defects. Also, bone was formed 
in the center of the scaffolds, especially in the groups containing pre-loaded RBMSCs. 
MicroCT reconstructions showed that bone formation increased over time and was 
enhanced with the inclusion of pre-loaded RBMSCs compared to SPCL scaffolds alone. 
According to these results, the pre-loaded RBMSCs contributed to the bone regeneration 
process in a critical-sized bone defect. Furthermore, SPCL fiber meshes proved to be a 
very suitable material to use for bone regeneration purposes. 
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4.1 Introduction 
Autologous and allogenous bone grafts are still the method of choice for the 
treatment of bone defects caused by trauma, disease or tumor resection. However, both 
of these methods are associated with significant clinical problems, like donor site 
morbidity and the possible transfer of diseases, respectively. In view of this, innovative 
tissue engineering techniques have been introduced, which include the use of stem cells 
in combination with a suitable scaffold to create tissue substitutes in vitro.(1, 2) These 
stem cells are commonly derived from bone marrow stroma, which provides a cellular 
reservoir for the regeneration of bone tissue. Unfortunately, a limitation in the use of bone 
marrow cells for bone tissue engineering is the relatively low number of osteoprogenitor 
cells in the marrow stroma. Culturing bone marrow stromal cells in osteogenic media has 
shown to provide good expansion rates of osteoprogenitor cells and can eventually lead to 
a pre-differentiated state of these cells, which have shown to have a positive influence in 
the bone regeneration process in vivo.(3, 4) The majority of these bone tissue engineered 
constructs include stem cells in combination with natural and synthetic scaffolds.(5, 6) 
These scaffolds provide mechanical support and serve as a substrate to which cells 
attach, and subsequently proliferate and undergo differentiation. Specifically in bone 
tissue engineering strategies, these scaffolds support bone formation by serving as a 
guide for new bone growth along the scaffold surface and hence bridge the gap between 
bone ends.(7) Whereas in non-critical sized defects, implantation of scaffolds or cells 
alone could be sufficient to support new bone formation, in critical-sized defects the bone 
regeneration process requires a combination of cells of the osteoblastic lineage with a 
porous scaffold to stimulate bone formation from within the construct.(8-10) For the 
present study, it was selected a scaffold based on a polymeric blend of starch poly (ε-
caprolactone) (SPCL), which proved to be biocompatible and biodegradable.(11) SPCL 
can be processed by melt-spinning to create fibers which can be combined, under the 
influence of temperature and pressure, into physical bonded fiber meshes. These fiber 
meshes exhibit a high surface area combined with high pore interconnectivity, that 
enables adequate diffusion of nutrients and waste while maintaining sufficient mechanical 
properties and thus allows cell attachment and proliferation.(12) Previous studies showed 
that SPCL fiber meshes supported bone-like tissue formation in vitro (13, 14) and 
enhanced the regeneration of a non-critical sized orthotopic defect(15), while only 
showing a moderate inflammatory response in a subcutaneous and intramuscular study in 
rats.(16)  
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Critical-sized cranial defects in rats constitute a well-known and established animal 
model to assess the potential of tissue engineered constructs to induce new bone 
formation/regeneration.(17-19) Thus, in this study, SPCL fiber meshes were pre-loaded 
with RBMSCs and subsequently implanted in a rat critical-sized cranial defect. Empty 
defects and defects filled with cell-free scaffolds were used as control groups. After four 
and eight weeks of implantation, samples were analyzed to assess new bone formation by 
means of MicroCT and histological analysis. The pre-loaded RBMSCs are expected to 
contribute to the bone regeneration process in a critical-sized bone defect, while SPCL 
fiber meshes are envisioned to provide an adequate support for cells 
adhesion/proliferation and also for new tissue ingrowth, upon implantation.  
 
4.2 Materials and Methods 
 
 4.2.1 Scaffolds preparation 
Polymeric fibers based on SPCL (a 30:70 w/w% blend of starch with poly(ε-
caprolactone) were obtained by melt spinning. An extruder equipped with a 12mm 
diameter screw was used with a 0.5 mm monofilament die. Die temperature was 150°C 
and the screw speed 1 rpm. Extrusion was performed in an ambient environment. Hot 
fiber was driven into a cooling bath (water 13°C) and cold-drawn after the bath, using a 
caterpillar with a speed of 21 m/min and a winding unit with a speed of 28 m/min. Fibers 
were produced with diameter in the range of 120–500 µm. 
SPCL fiber meshes were prepared by a fiber bonding process consisting of cutting 
and sintering the fibers previously obtained by the above-described melt spinning 
method.(12) Briefly, a selected amount of fibers were placed in a glass mould and heated 
in an oven at 150°C; immediately after removing the moulds from the oven, the fibers 
were slightly compressed by a teflon cylinder (which runs within the mould) and then 
cooled at −20°C. All samples were cut into cylindrical mesh samples of 8 mm diameter 
and 2 mm height and sterilized using ethylene oxide.  
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4.2.2 Cell isolation and seeding into scaffolds 
Rat bone marrow stromal cells (RBMSCs) were obtained from femora of male 
Fisher rats weighing between 150-200g. Femora were washed 3 times in culture medium 
α-MEM (Minimal Essential Medium) with added 50 µg/ml gentamycin, 100 µg/ml ampicillin 
and 0.3 µg/ml fungizone. Epiphyses were cut off and diaphyses flushed out with 15 ml of 
osteogenic culture medium composed of α-MEM supplemented with 10 % FCS (foetal calf 
serum, Gibco), 50 µg/ml ascorbic acid (Sigma, St.Louis, MO, USA), 50 µg/ml gentamin, 
100 µg/ml ampicillin, 0.3 µg/ml fungizone, 10 mM Na β-glycerophosphate and 10–8 M 
dexamethasone (all Sigma). Cells were incubated in a humidified atmosphere of 95 % air, 
5 % CO2 at 37°C and the culture medium was changed three times a week. 
After 7 days of primary culture, cells were detached using trypsin/ EDTA (0.25% 
w/v trypsin / 0.02% EDTA). The cells were concentrated by centrifugation at 1500 rpm for 
5 minutes and resuspended in a known amount of osteogenic medium. The cell 
suspension was seeded onto the SPCL fiber meshes at a density of 250.000 cells per 
sample. Cell-seeded samples were characterized in terms of DNA content and ALP 
activity in same day of seeding and 1 day after seeding, i.e., at the time they were 
implanted. 
 
4.2.3 Characterization of cell-seeded meshes  
 
4.2.3.1DNA quantification 
DNA quantification assays (Invitrogen, Madrid, Spain) (n=6) were performed on 
day 0 and 1, after seeding of the RBMSCs onto SPCL scaffolds. Culture medium was 
removed, the cell seeded meshes were washed twice with PBS and 1 ml of MilliQ was 
added to each sample. Cell-seeded meshes were frozen to -80°C, heated to 37°C, frozen 
to -80°C again and stored at -80°C until usage. 
DNA standard curve was made with Salmon testes DNA. 100 µl of sample or 
standard were added to 100 µl Picogreen working solution. The samples were incubated 
for 5 minutes at room temperature in the dark. After incubation, DNA was measured using 
a fluorescence microplate reader (Bio-Tek instruments, Winooski, VT, USA) with 
excitation filter 365 nm and emission filter 450 nm. The quantity of DNA was correlated to 
the number of cells, using the standard curve of cell number versus the measured 
emission. 
 
 
Chapter IV: Osteogenic properties of starch poly(ε-caprolactone) (SPCL) fiber meshes loaded with rat bone 
marrow stromal stem cells (RBMSCs) in a rat critical-sized cranial defect 
 
 109 
Leandro S. Gardel, PhD thesis, University of Porto, 2012 
4.2.4 Surgery 
Thirty inbred male Fisher rats (250g; Charles River, Barcelona, Spain) were used 
for the study. A single circular critical size cranial defect of 8 mm was performed in each 
rat, which were divided into three study groups, implanted for 4 and 8 weeks: i) group 
implanted with SPCL meshes loaded with RBMSCs, ii) group implanted with SPCL 
meshes alone (without cells) and iii) group with defects left empty The care and use of 
laboratory animals were performed according to the national guidelines after approval by 
the national ethical committee for laboratory animals and conducted in accordance with 
National and European standards on animal welfare. During the entire study, adequate 
measures were taken to minimize any pain and discomfort. One animal was housed in 
each cage and the proper intake of fluids and food were monitored on a daily basis. Also, 
the animals were observed for signs of pain, infection and proper activity. Surgery was 
performed under general inhalation anesthesia, induced by 4% isoflurane and maintained 
with 2.5% isoflurane by a non-rebreather mask. The rats were monitored with an oxy-
pulse meter during surgery. To minimize pain, buprenorfine (Temgesic) (0.05 mg/kg 
s.c.) was administered postoperatively.  
 After anesthesia the rats were immobilized on their abdomen and the skull was 
washed and disinfected with iodine. A longitudinal incision was made down to the 
periosteum from the nasal bone to the occipital protuberance, and soft tissues were 
sharp-dissected to visualize the cranial periosteum. Subsequently, a midline incision was 
made in the periosteum and the periosteum was undermined and lifted off the parietal 
skull. To create a central full thickness bone defect in the parietal cranium, a hollow 
trephine bur (ACE dental implant systems, Paço D'Arcos, Portugal) with an outer diameter 
of 8.0 mm in a dental handpiece was used. The bone defect was carefully drilled under 
continuous cooling with physiologic saline and without damaging of the underlying dura. 
Then, the created bone segment was carefully removed, without damaging the underlying 
sagittal sinus. Following insertion of the implants the periosteum was closed using 
resorbable MonoPlus® 4-0 suture materials (BBraum, Portugal)(Figure 1 A, B and C). 
Subsequently, the skin was closed using the same resorbable sutures. The rats were 
euthanized 4 or 8 weeks after surgery by an overdose of pentobarbital. 
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Figure4.1. Surgical approach and implantation of the scaffold. 
 
4.2.5 Characterization of the explants 
 
4.2.5.1 MicroCT 
After retrieving the cranium including the implanted samples, specimens were 
fixated in 4% formalin solution (pH=7.4) and scanned using microcomputed tomography 
(µCT) (SkyScan 1072 high-resolution micro-CT, SkyScan, Kontich, Belgium). The data 
from the initial scanning (non-implanted SPCL samples) was used to quantify the total 
porosity of the implants. After retrieving the implants, the quantitative evaluation of newly 
formed bone was calculated by determining a region of interest (ROI), which was set 
between the pre-existing bone and the implants. Within this ROI, new bone formation was 
distinguished from pre-existing bone and composite through structure and color 
differences. New bone formation was expressed in mm3, using standardization of the 3-
dimensional region of interest. 
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4.2.5.2 Histology 
After scanning the explants with the microCT, samples were prepared for 
histological evaluation. The samples were dehydrated in a graded series of ethanol, 
decalcified and embedded in paraffin. After hardening, sagittal microtome sections of 5 
µm in thickness were prepared per implant. The sections were stained with hematoxylin 
and eosin or Masson’s trichrome solution, which is frequently used as bone-specific 
staining. Subsequently, sections were analyzed under a light microscope. 
 
4.2.6 Statistical analyses 
Statistical analyses were performed with GraphPad Instat 3.05 software 
(GraphPad Software Inc., San Diego, CA, USA) using an one-way analyses of variance 
(ANOVA) with a Tukey multiple comparison post test.  
 
4.3 Results 
SEM examination showed that RBMSCs adhered and were well-spread on the 
surface of the SPCL fibers, one day after seeding. DNA analyses showed that the cell 
seeding suspension contained 231 ± 3 ng/ml DNA, whereas the DNA quantity after 1 day 
of culturing on the SPCL fiber meshes was 159 ± 24 ng/ml DNA. Therefore, the calculated 
seeding efficiency was 69%, resulting that approximately 172.500 RBMSCs (of the 
250.000 that were seeded) were efficiently seeded onto the SPCL fiber meshes. (Figure 
4.2) 
 
 
 Figure4.2. Implant characterization and SEM picture before implantation after 1 day of 
culturing. 
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4.3.1 In vivo experiment 
 
4.3.1.1 General observations 
During surgery and when the implants were inserted into the cranial defect, some 
infiltration of blood in the SPCL fiber meshes occurred. Also, some implants were 
completely press-fitted into the critical-sized cranial defect, where others were less press-
fitted. From the thirty-two male Fisher rats, two rats died during surgery, due to heavy 
blood loss after cutting the main cerebral sinus. All other rats remained in good health and 
did not show any wound complications. At retrieval, the cranial implants were all covered 
by periosteum and implants remained intact. No inflammatory signs or adverse tissue 
reactions were macroscopically observed. 
 
4.3.1.2 MicroCT 
Before implantation, MicroCT reconstructions showed that SPCL fiber meshes 
exhibited an average overall porosity of 62.5% with a mean pore diameter of 275 µm. 
After retrieving the implants with their surrounding tissue, samples were scanned with the 
MicroCT. Reconstructions of the obtained scans showed that after 4 weeks of 
implantation, new bone formation in the implants loaded with SPCL seeded with RBMSCs 
was 5.99 ± 4.09 mm3, while SPCL without cells showed 3.83 ± 1.70 mm3 of new bone 
formation. After 8 weeks of implantation new bone formation was 7.35 ± 3.15 mm3 in the 
implants containing RBMSCs, while SPCL without cells showed 4.91 ± 2.51 mm3 new 
bone (Figure 4.3 and 4.4). 
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Figure4.3. MicroCT reconstructions of the various implant formulations. 
 
 
 
Figure4.4. MicroCT quantification of the new bone formation of the various implant 
formulations. 
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4.3.1.3 Histology 
Light microscopic analysis of the obtained histological sections showed that after 
four weeks of implantation, minimal bone ingrowth from the cranial bone into the SPCL 
fiber meshes (without cells) had occurred. The SPCL meshes loaded with RBMSCs 
showed limited bone ingrowth from the cranial bone after four weeks of implantation, but 
some bone formation was found in the center of the implants.  
The SPCL fiber meshes showed some new bone formation from the cranial bone 
after eight weeks of implantation and also some bone formation at the cerebral side of the 
implants occurred. However, no bridging of the entire defect was observed. The SPCL 
implants loaded with RBMSCs showed some new bone formation from the cranial bone 
into the implants and also bone was formed in the center of the implants, after 8 weeks of 
implantation. Although some bone formation at the cerebral side of the implants occurred, 
no bone bridging of the defect was noted. Empty defects showed minimal bone formation 
and no bone bridging were observed, confirming that the created defects were critical-
sized. At all implantation periods, fibrous tissue between implants and cranial bone was 
observed, especially when there was no close contact between implant and bone. (Figure 
4.5) 
 
 
Figure4.5. Histological sections stained with hematoxylin and eosin (first two rows) and 
Masson’s trichrome (bottom row) of SPCL fiber meshes loaded with MSCs after four (A) 
and eight (B) weeks of implantion. Four (C) and eight (D) weeks of implantation of SPCL 
fiber meshes and empty controls (E) after eight weeks were stained as well. C = cranial 
bone; F = fibrous tissue; N = newly formed bone; S = SPCL fibers 
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4.4 Discussion 
Current drawbacks of cell-based bone tissue engineering approaches are the low 
yield of autologous cells with bone inducing capacities and the lack of standardized 
methods for expansion as well as for differentiation of bone progenitor cells. As a 
consequence, the reproducibility and predictability in human patients is low. Several 
solutions have already been suggested to solve this problem, like the use of cell selection 
(20, 21) or dynamic cell culturing (flow perfusion system).(22, 23) Furthermore, an 
autologous approach avoids immune responses that might jeopardize the recipient and 
also avoids adverse effects on the bone regeneration process. Still, the final cell 
population has to be incorporated in a scaffold material that possesses osteoconductive 
properties. For bone regeneration purposes, the ideal scaffold material is considered to be 
bioactive, slowly biodegradable, moldable and easy to apply. Also, the success of a 
scaffold material relies on an adequate porosity, and pores must be interconnective to 
allow bone and vascular ingrowth, diffusion of nutrients and waste removal. In our study, 
the used SPCL fiber meshes exhibit an interconnective porous network that seems to 
benefit cell ingrowth enabling access to nutrients, as well as the removal of metabolic 
wastes. However, the seeding efficiency of the SPCL fiber meshes was nearly 70%. This 
means a loss of about 30% on the cell seeding on the SPCL fiber meshes, suggesting 
that a downside of the interconnective porous network is that some cells go easily through 
the fiber meshes during seeding, without attaching to the SPCL. Especially when there is 
only a limited amount of cells available, a preferred solution could be to confine the 
scaffolds to a device that prevents cell suspension leakage. Also in a lesser extent, 
increasing the fiber content, increasing the fiber diameter, or mixing the SPCL fiber 
meshes with nano-sized fibers, could improve the cell seeding efficiency.(24, 25) 
Nonetheless, the results still showed that the relatively small number of cells implanted 
(1700 cells/cm3) do benefit the bone regeneration process, whereas previous studies used 
a significant higher amount of seeded cells (>10.000 cells/cm3) to get comparable results 
in a rat critical-sized cranial defect.(25, 26) 
During surgery, when the implants were placed into the cranial defect, some 
infiltration of blood in the SPCL fiber meshes occurred. This could potentially influence the 
bone regeneration inside the implants. However, the effect of blood on bone repair 
remains controversial. To mimic the blood clot formation, platelet rich plasma (PRP) is a 
commonly used experimental approach, although results are not conclusive. Some 
studies claim that the effect of platelet rich plasma is impairing bone regeneration (27, 28), 
whereas other studies report a stimulated early bone repair (29, 30). 
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 Also, some studies indicate that diluted amounts of PRP present in a bone graft 
stimulate bone formation, once it is dosed in a optimal concentration (30-32). Therefore, a 
moderate infiltration of blood could be beneficial for bone regeneration. In our study, new 
bone formation was present especially after 8 weeks of implantation. However no 
significant differences were observed between groups containing SPCL scaffolds loaded 
with RBMSCs compared to SPCL scaffolds without loaded cells. The lack of significant 
differences between the experimental groups might be explained by the infiltration of 
blood, as the growth factors present in the blood clot could contribute to the recruitment of 
osteogenic precursor cells, diminishing the effect of the loaded RBMSCs in the implants. 
Another reason for the lack of significant differences is that pre-seeded cells loaded on 
implants are essential in the early stages of bone regeneration, but eventually the hosts’ 
own cells are responsible for the new bone formation, rather than the pre-seeded 
RBMSCs. In fact, it has been reported that pre-seeded RBMSCs indirectly contribute to 
the new bone formation by means of releasing growth factors, which in turn, recruit other 
cell types and therefore do not directly participate in new bone formation.(31, 33, 34)  
Furthermore, some implants were more efficiently press-fitted into the critical-sized 
cranial defect than others, thus, not all implanted constructs were tightly in contact with 
the surrounding bone. More bone formation was observed when close contact between 
implant and bone was detected, compared to implants with less contact between the 
implant and the cranial bone. Previous studies showed that implant fixation is an important 
factor in the bone regeneration process.(17, 35) Lacking an optimal contact between bone 
and an implant causes fibrous tissue formation and therefore delays the bone forming 
process. This explains the relatively large standard deviation between implants from the 
same implantation group and further explains why the difference between the 
experimental groups is not significant. 
However, MicroCT reconstructions showed that there is a clear trend, although not 
statistically significant, for increased bone formation in the defects filled with SPCL 
scaffolds seeded with RBMSCs, as compared to defects filled with SPCL scaffolds alone, 
at both 4 and 8 weeks of implantation. In fact, all experimental groups observed bone 
regeneration from the defect edges towards the interior of the implants but only in the 
groups with the pre-loaded RBMSCs, bone formation was also observed in the center of 
the implants. However, the additional amount of bone formed in the center of the implants 
was not sufficient to led to statistical significant differences between both groups 
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4.5 Conclusions 
In general, histological analyses revealed that all study groups showed new bone 
formation from the defect edges towards the interior of the defects. Also, new bone was 
formed in the center of the scaffolds, especially in the groups containing pre-loaded 
RBMSCs. MicroCT reconstructions showed that bone formation increased over time and 
was enhanced with the inclusion of pre-loaded RBMSCs compared to SPCL scaffolds 
alone. According to these results, the pre-loaded RBMSCs contributed to the bone 
regeneration process in a critical-sized bone defect. Furthermore, SPCL fiber meshes 
proved to be a very suitable material to use for bone regeneration purposes. 
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Abstract 
This works reports the development and preliminary assessment of a new 
bioreactor for the culturing of large sized 3D scaffolds–cells constructs aimed at 
applications in bone tissue engineering. The Bidirectional Continuous Perfusion Bioreactor 
(BCPB) was designed to promote the mechanical stimulation of cells through the creation 
of shear forces induced by flow perfusion, using different pressure gradients, controlled by 
a peristaltic pump. Additionally, it provides the possibility of varying both perfusion flow 
rate and direction. However, the main innovation of the system herein presented consists 
in the possibility of culturing scaffolds of large dimensions that can be suitable for the 
regeneration of critical sizes defects, as the control of flow perfusion and pressure 
gradient in the inside/outside of the scaffold, enables a culture environment that favours 
the access to nutrients and removal of metabolic wastes of the cells located in the inner 
regions. The functionality of the developed system was preliminarily evaluated by culturing 
starch/polycaprolactone (SPCL) fibbers mesh scaffolds with previously seeded goat bone 
marrow stromal cells (GBMSC’s) for 14 and 21 days. For this purpose, cylindrical blocks 
(16mm of diameter) of cell-seeded scaffolds were stacked into a 42 mm thick construct. 
Static cultured constructs were used as controls. The samples resulting from these s 
experiments were characterized concerning DNA content, ALP activity and cell 
morphology/distribution using scanning electron microscopy and histological analysis. The 
results showed higher ALP activity levels in the bioreactor cultures than those obtained 
under static conditions. However, the number of cells (obtained from DNA amounts) in 
constructs cultured in the bioreactor showed lower values compared to static cultures, 
suggesting that static conditions tend to privilege the metabolic path way  for cellular 
proliferation while dynamic conditions tend to privilege the metabolic path for osteogenic 
differentiation.. Histologically, it was observed that the migration was improved and 
homogenous cell distribution was observed in the bioreactor groups. In conclusion, these 
results demonstrate the feasibility and the benefit of culturing cell/SPCL constructs in this 
BCPB system. 
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5.1 Introduction 
 A major challenge in the translation of tissue engineered bone grafts to viable 
clinical treatments of osseous defects has been the need to grow large, fully viable grafts 
that are several centimetres in size. The current size limitations are primarily due to the 
limited transport of metabolites to cells within the core regions of the graft that prevents 
cell survival and proliferation. Traditionally, in two-dimensional (2D) cell culture techniques 
(e.g., Petri dishes and culture flasks), a monolayer of cells is in continuous contact with 
the culture medium, and simple diffusion is sufficient to maintain cell viability (1), but these 
conditions are clearly  inadequate for culturing cells seeded onto three-dimensional (3D) 
tissue engineering scaffolds. Given the clinical need to use 3D tissue constructs of large 
dimensions, the use of  perfusion bioreactors has shown evident advantageous over static 
culturing, as these systems usually allow a more efficient  transfer of nutrients and 
oxygen, stimulating the development of homogeneous tissue cultured in vitro for 
subsequent implantation. Whereas the primary role of perfusion has been to increase the 
transport rates of nutrients, metabolites, and oxygen to and from the cells, interstitial flow 
of medium has the additional benefit of providing hydrodynamic shear stress induced 
stimulation, a known regulatory factor of bone development and function (2). In fact, 
several previous studies, have demonstrated that the use of bioreactors with a flow 
medium favours bone-like tissue formation within 3D tissue constructs (3-6). However, 
these works have focused on culturing small constructs, not addressing the clinical need 
for developing grafts that can be used in the regeneration of critical sized defects. Based 
in this approach, we aimed to develop and optimize in vitro conditions to create functional 
bone tissue in 3D tissue constructs of large dimensions. For this purpose we designed 
and developed a new perfusion bioreactor named Bidirectional Continuous Perfusion 
Bioreactor (BCPB), presenting an innovative and advanced design. The BCPB creates 
mechanical cellular stimulus through the generation of shear forces due to medium flow 
perfusion using different pressure gradients, controlled by peristaltic pumps. Additionally, 
it provides the possibility of varying both perfusion flow rate/flow direction through 
rotational forces generated by mechanical engines specifically designed for the BCPB. 
Furthermore, the flow-perfusion bioreactor is a scalable technology that should support 
porous scaffolds of any thickness.  
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This is, in fact the main innovation of the BCPB, as it enables the possibility of 
culturing scaffolds of large dimensions, since the systems allows the control of flow 
perfusion and pressure gradient inside and outside of the scaffold, providing the adequate 
access to nutrients and removal of metabolic wastes of the cells located in the inner 
regions of thick 3D constructs, thereby maintaining cell viability and activity. The feasibility 
of this new flow-perfusion bioreactor in sustaining “thick” 3D tissue constructs that 
approaches sizes of surgical importance was also addressed in the present work. For this 
purpose, constructs composed of SPCL (a blend of starch and polycaprolactone) fiber 
meshes of 16 mm diameter (with a 6mm interior hole) and 3 mm thick, were seeded with 
1x106 goat marrow stromal cells (GBMCSs) and stacked, completing a 42 mm thick 3D 
tissue construct. After 14 and 21 days of culture in the bioreactor at a flow rate of 1 
ml/min, the samples were collected for MTS, DNA and ALP assays, histological analysis 
and scanning electron microscopy (SEM). Static cultured constructs were used as 
controls. The results obtained demonstrated that this new flow-perfusion bioreactor 
provides adequate conditions to enable cells distribution into the core of a thick scaffold 
and stimulates osteogenic differentiation of GBMSC’s. It is envisioned that this bioreactor 
may lead to significant advances in bone tissue engineering, enabling the culture of 3D 
constructs of large dimensions with different scaffolds compositions and with stem cells of 
different sources  
 
5.2. Materials and Methods 
 
5.2.1 Flow-perfusion bioreactor design philosophy 
 The main aim of this work was to develop a new flow perfusion system for 
culturing 3D-scaffolds of large dimensions for bone tissue engineering, thus a system that 
would enable cellular distribution into a thick construct, enabling maintenance of cell 
viability/functionality in the interior of the scaffold. In order to develop such system, several 
other basic requirements were considered: this should be easily sterilized and maintained 
in sterile conditions throughout the culture period, the system should be reasonable easy 
to operate and deliver the flow through the scaffolds enabling a controllable, repeatable, 
and reliant rate of flow to meet the envisioned requirements.  
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The designed and developed perfusion bioreactor was named BiDirectional 
Continuous Perfusion Bioreactor (BCPB) and is mainly composed of the following 
elements: (1) One single culture chamber that enables culturing cell-seeded 3D constructs 
of large dimensions, up to 120 mm in length and 60 mm in diameter (2) a perfusion flow 
system that allows controlling the medium flow passage from the inside of the scaffold to 
the culture chamber and/or the passage of the medium circulating in the culture chamber 
to the inside of the scaffold, enabling the access to nutrients by the cells in the scaffold 
interior as well as the removal of their metabolic products.  
 
For this purpose, the systems uses a perforated tube (Fig 5.1 A and B) into which 
the scaffold is inserted; Then by manipulating the flow directions, using the peristaltic and 
vacuum pumps, it is possible to direct the perfusion of medium into the interior of the 
construct and/or from there to the culture chamber. This is the system feature that is 
expected to assure a uniform cellular distribution in the construct, enabling an adequate 
access to nutrients and removal of metabolic wastes.  
 
 
Figure5.1. A) Coaxial perforated tube in polycarbonate and scaffold. B) Scaffold 
positioned in the tube.  
 
 5.2.2. Construction and functioning of the BCPB 
The BCPB is constituted by a cell culture chamber (Figure 5.2A) made of acrylic, 
transparent, with four output/inputs connected to three-way valves that are connected to 
silicone tubes (to allow the passage of the culture medium); these three-way valves 
enable the possibility of connecting syringes for antibiotics and growth factors inoculation 
and/or connecting sensors for pressure, O2 CO2, Ph and glucose. In each end of the cell 
culture chamber, a part made of teflon is connected to promote a hermetic and waterproof 
sealing.  
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These parts present an hexagonal form that, when levelled with the other part, 
allows the linear positioning of the bioreactor when placed on a flat surface; these parts 
also have a round and smooth shape section, that allows the support of the entire system 
in arms that connect to the support base, keeping the whole system sustained when 
operating inside of the incubator (Figure 5.2B). To hold the constructs/samples in the 
culture chamber, it is used a perforated coaxial tube made of polycarbonate that can have 
variable length and number of holes, depending on the size of the three-dimensional 
construct to be used (Figure 5.1 A and B).  
 
 
Figure5.2. A) Representation of the cell culture chamber with the scaffolds inserted in the 
perforated tube and filled with medium culture. B) Picture of the complete BiDirectional 
Continuous Perfusion Bioreactor (BCPB) system under operation in a CO2 incubator. 
 
The perforated coaxial tube, coming from within the bioreactor is connected to the 
continuous circular flow system through a three-way valve. The circular flow system 
(Figure 5.3) is composed of a peristaltic pump responsible for the positive flow gradient, a 
vacuum pump responsible for the negative flow gradient and a collector bottle for the 
culture medium; additionally, a reservoir bottle is associated to the peristaltic pump, and 
another reservoir bottle to the vacuum pump. The balance between positive and negative 
gradient within the bioreactor is monitored by connecting a pressure gauge to the cell 
culture chamber and the vacuum pump can be adjusted to maintain the pressure gauge 
within the bioreactor at zero. The exchange of the flow direction is performed by changing 
the positioning of the tubes (connected to the peristaltic and vacuum pump) in the two 
inputs in the bioreactor.  
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A three-way valve is positioned between the collector bottle and the reservoir 
bottle of the peristaltic pump, which will function, when desired, directing the flow from the 
bottle directly to the peristaltic pump, allowing to exchange the culture medium, without 
being necessary to stop the entire flow system. 
 
 
Figure5.3. Schematic representation of the flow system “circuit” that is associated 
with the continuous bi-directional flow bioreactor 
 
5.2.3 Preliminary evaluation of the bioreactor functionality 
 
  5.2.3.1Scaffolds design and preparation  
The polymer scaffolds used in this study are based on a biodegradable polymer 
blend of starch and polycaprolactone (SPCL) that has been intensively investigated for 
tissue engineering applications (7-11). The 3D scaffolds were produced from melt spun 
fibers by a fibre-bonding method into mesh structures with a porosity of ~75%, as 
described previously (5, 6). SPCL fiber mesh scaffolds have shown very promising results 
for bone tissue regeneration in previous studies (8, 11-17). 
 
 
In the present study, SPCL fiber meshes were cut into samples disks of 16mm 
diameter and 3mm of thicknesses with a 6mm interior hole; this inner hole allows the 
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samples/constructs to be positioned within the bioreactor by inserting them into the 
polycarbonate perforated tube, enabling the bidirectional medium flow, from the interior of 
the constructs to the outside (culture chamber) or from outside to the interior of the 
samples (Figure 5.4). 
  
Figure5.4. Schematic representation of the SPCL fiber-mesh scaffolds samples used in 
this study. 
 
5.2.3.2 Cell seeding of scaffolds 
GBMSC’s were isolated and expanded in vitro as previously described (8). The 
sterile SPCL fiber mesh samples were placed in non adherent 12 well -plate (Costar® 
Corning; NY). A total of 56 samples were seeded with a 300µl cell suspension containing 
1x 106 cells in basal medium composed of of α-MEM (Minimal Essential Medium) with 10 
% FCS (foetal calf serum, Gibco), 50 µg/ml gentamycin, 100 µg/ml ampicillin and 0.3 
µg/ml fungizone were added (all sigma) The well plates were then transferred to the 
incubator and three hours after seeding 1.6 ml of basal medium was added to each well 
and incubated overnight. (at 37 ºC environment with 5% CO2) to allow cell attachment. In 
the following day, the cell-scaffolds constructs were either transferred to the bioreactor or 
kept in static conditions. In the later case, 10 mL of osteogenic  medium composed of α-
MEM, supplemented with 10 % FCS (foetal calf serum, Gibco), 50 µg/ml ascorbic acid 
(Sigma, St.Louis, MO, USA), 50 µg/ml gentamin, 100 µg/ml ampicillin, 0.3 µg/ml 
fungizone, 10 mM Na β-glycerophosphate and 10–8 M dexamethasone (all Sigma), was 
added to each well, in order to try to approximate the construct-mediums volume ratio to  
the one in the bioreactor(15 ml per sample). The culture medium was changed each 7 
days. 
 
5.2.3.3 Bioreactor culture 
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The plates containing cell-scaffolds constructs to be cultured in the bioreactor were 
carefully transferred to two BCPB’s, in a laminar flow cabinet, as follows: each sample 
(3mm length and 16 mm diameter, with a inner hole of 6mm) was carefully inserted into 
the polycarbonate perforated tube and stacked until completing a total of 14 samples, 
corresponding to a 42 mm length construct. The perforated tube with the construct was 
then connected to the two end parts of the bioreactor that aims to promote the hermetic 
and aseptic closure of the culture chamber. Afterwards the main chamber of the 
bioreactor was connected to the flow system and slowly filled with the culture medium at a 
rate of 1ml/min, with the flow directed from inside the chamber to the perforated tube, 
enabling the medium to flow from outside to inside the cells-scaffold construct. Finally, the 
whole system was transferred to the incubator (at 37ºC environments with 5% CO2) where 
it was operated for 14 and 21 days. The culture chamber has a capacity for 216 ml of 
culture medium while the bottle reservoir has a capacity of 450 ml of medium; every week 
400 ml of old medium were exchanged with 400 ml of new medium, without stopping 
medium flow in the bioreactor system. Each sample of the static group was cultured in the 
presence of 10 ml of culture medium which was changed every week. 
 
5.2.4. –Characterization of cell-scaffolds constructs 
At the end of time point of culture, cell-scaffolds constructs were collected for DNA 
(n=3 per group and time point), ALP (n=3 per group and time point), and MTS (n=3 per 
group and time point), assays, for SEM (n=2 per group and time point), and for histological 
analysis (n=3 per group and time point). Each sample was carefully and aseptically 
removed from the polycarbonate perforated tube and washed 3 times in PBS. 
 
5.2.4.1 Cell proliferation and viability analysis 
The scaffolds-cells constructs retrieved at the end of each time point,  were rinsed 
3 times with PBS, placed in a vial containing 3 ml of ultrapure water and frozen at -80°C 
overnight; after this were lysed by osmotic and thermal shock and the supernatant used 
for the DNA quantification assay. DNA concentration was measured using the Quant-iTTM 
Picogreen® dsDNA Assay Kit (InvitrogenTM, Molecular ProbesTM, Oregon USA).A 
description of the assay can be found elsewhere (18). Triplicates were made for each 
sample and per culturing time.  
The DNA concentration for each sample was calculated using a standard curve 
(DNA concentration raging from 0.0 to 4.5µg/ml) relating quantity of DNA and 
fluorescence intensity. 
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 The cellular viability was assessed by a colorimetric assay named CellTiter 96® 
AQueos One Solution Cell Proliferation Assay (Promega, USA). The principle of this 
assay is based on the bioreduction of a tetrazolium compound [(3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymetyhoxyphenyl)-2(4-sulphophenyl)-2Htetrazolium, inner salt(MTS)] into a 
brown formazan product that is soluble in culture mediu (19). This conversion is 
accomplished by the production of nicotinamide adenosine dinuccleotide phosphate 
(NADPH) or nicotinamide adenine dinucleotide (NADP) by the dehydrogenase enzymes 
existing in the metabolically active cells. The quantity of formazan product measured by 
the amount of 490nm absorbance in a microplate reader (Bio-Tek, model Synergie HT; 
USA). Three specimens per condition and per time point were characterized. 
 
5.2.4.2 Determination of alkaline phosphatases (ALP) activity of cells 
on scaffolds 
The ALP activity was determined for all time culture periods, using the same 
samples used for DNA quantification. The activity of ALP was assessed using the p-
nitrophenol assay. Nitrophenol phosphate disodium salt (pnPP;Fluka BioChemika, 
Austria), was hydrolysed by the alkaline phosphatase produced by the cells to form free p-
nitrophenol. Standards were prepared with 10 µmol/ml p-nitrophenol(pNP;Sigma, USA) 
solution, to obtain a standard curve ranging from 0 to 0.4 µmolALP/µDNA/h. Triplicates of 
each sample and standard were made, and the ALP concentrations were read directly 
from the standard curve. 
 
5.2.4.3 Cell morphology analysis 
The morphological analysis of cells as well as their growth, attachment, and 
distribution on the surface of the scaffolds was performed with a Scanning Electron 
Microscopy (SEM). For this purpose, the scaffolds-cells constructs were rinsed 3 times 
with PBS and then fixed with 2.5 % Glutaraldehyde (Sigma,USA) in PBS solution during 1 
hour at 4°C; after this, samples were dehydrated through a graded series of ethanol and 
let to dry overnight at room temperature. Finally, samples were gold sputter coated 
(Fisons Instruments, model SC502; England), and analyzed with SEM (Leica Cambridge, 
model S360; England)- 
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5.2.4.4 Histological analysis  
The cell-scaffolds samples were rinsed in PBS, fixed in 4% formalin, and 
embedded in methylmethacrylate (Technovit® 7100 NEW,Kulzer, DE) The procedure was 
based on the protocol provided by the manufacturer and cut into 10 µm sections. In order 
to observe cells and the formed matrix, sections were stained with hematoxylin & eosin. 
Samples were then visualized under a light microscope and images taken with an 
attached camera. 
 
5.2.5 Statistical Analysis 
The PASW Statistics18 software package (IBM, Somers, NY) was used for the 
statistical analysis. Descriptive values are presented as mean ± SD unless stated 
otherwise. Kolmogorov-Smirnov test with Lillefors significance correction was used to test 
the normality of the data. The one way ANOVA test was used to determine statistically 
significant differences among the groups and Tukey test was used to assess the pairwise 
comparisons between groups. The statistical significance level considered was P <0.05. 
 
5.3. Results 
 
5.3.1 Alkaline phosphatises activity  
The osteogenic phenotypic expression of cells was evaluated by a colorimetric 
assay for alkaline phosphatase activity. The Figure (5.5 A) shows the ALP activity results 
corresponding to day 0, day 14 and day 21 of culturing in the bioreactor and static 
condition. The ALP activity registered for samples resulting from flow cultures at day 14 
was statistically significantly higher as compared to all other groups [day 0(P=0.015); day 
14 static (P=0.015); day 21 static (P=0.016) and day 21 flow (P=0.004)]. The maximum 
and minimum ALP activity registered was higher for flow perfusion conditions when 
compared to static culture at all time points (Figure 5.5 B), clearly suggesting that bone 
cell phenotype expression was stimulated under dynamic flow. Under static conditions a 
low level of ALP activity was registered which remained unchanged over the culture 
period studied. 
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Figure5.5. ALP activity in static and flow culture (A), and maximum and minimum ALP 
activity values expressed (B). 
 
5.3.2 Cell proliferation  
DNA quantification results showed higher cellular content in constructs cultured in 
static conditions, as compared to those cultured in the flow perfusion bioreactor (Figure 
5.6 A). It was registered a statistical significant difference between constructs retrieved at 
day 14 after static culture and constructs retrieved at day 14 after flow culture(P=0.010); 
and similarly, between day 21 static and day 21 flow (P=0.027). However, under static 
conditions, statistical increase of DNA concentration over time was not registered a, as 
observed when comparing the results between day 14 static and day 21 static (P=0.645). 
Nevertheless, the Figure 5.6A shows an increase in DNA concentration between day 14 
and day 21 in constructs cultured in the flow perfusion bioreactor, although it was not 
found a significant difference between these two groups (P=0.185). 
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 However, it is possible to observe in figure (5.6 B) that the maximum and 
minimum DNA concentration values, corresponding to the construct cultured for 21 days 
under flow perfusion are higher than the 14 days flow, demonstrating a trend for cellular 
proliferation over time in the bioreactor culture. 
 
Figure5.6. DNA concentration in static and flow culture (A) and maximum and minimum 
DNA concentration values expressed (B). 
 
5.3.3 Cellular viability 
MTS quantification results showed a tendency for higher cellular viability under 
static conditions, which is in good agreement with DNA results (Figure 5.7). In fact, an 
enhanced cell metabolic activity in static cultures was observed as compared to flow 
cultures, at day 14 (P<0.001) and at day 21 (P=0.005)]. Under static conditions there 
seems to be an increase in the metabolic activity between day 14 and day 21, but this 
increase was not significantly different (P=0.176). Similarly, an increase in cells metabolic 
activity between day 14 and day 21 under flow was registered, although it was also not 
found a significant difference between these two groups (P=0.163). 
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Figure5.7. MTS quantification in static and flow culture 
 
5.3.4 Cell Morphology  
The cell adhesion and distribution in the scaffolds was visualized using SEM. 
Analysis from day 0 (control) showed that cells accumulated mainly on the surface of the 
GBMSC’s–SPCL constructs (Figure5.8). However, after 14 and 21 days of culture under 
bioreactor culture, the cells occupied predominantly the interior of GBMC–SPCL 
constructs. The cells are clearly forming layers evenly distributed around the GBMSC’s–
SPCL constructs (Figure 5.9 A and B/ Figure 5.10 A and B). SEM analysis of the static 
groups showed that fewer cells were present within the GBMSC’s–SPCL constructs 
interior where probably the nutrients are insufficient to maintain cell viability (Figure 5.11 A 
and B). 
 
 
Figure5.8. A) Cells in the interior of the scaffolds in day 0, x1000.  
 
 
 
 
 
 
Chapter V: A Novel Bidirectional Continuous Perfusion Bioreactor for the culture of large sized bone tissue 
engineered constructs 
 137 
Leandro S. Gardel, PhD thesis, University of Porto, 2012 
 
Figure5.9. A) Cells in the interior of the scaffolds in day 14 flow, x 200. B) Day 14 flow, 
x1000. 
 
Figure5.10. A) Cells in the interior of the scaffolds in day 21 flow, x200.B) Day 21 flow, 
x1000. 
 
Figure5.11. A) Cells in the interior of the scaffolds in day 14 static, x200.B) Day 21 static, 
x1000. 
 
5.3.5 Histological analysis 
 The observation of sections stained with H&E (Figure 5.12 A and B), shows that 
there was cell proliferation and distribution and ECM formation in the GBMSC’s–SPCL 
constructs cultured under perfusion in 14 and 21 days, which suggests the importance of 
the bioreactor system to stimulate  cell growth and uniform distribution.  
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Under static culture, few cells were found in the samples sections, and these 
showed little ability to synthesizes ECM after 14 and 21 days of culture (Figure 5.13 A and 
B). 
  
Figure5.12. Sections of cell-scaffolds constructs cultured in the bioreactor and stained 
with H&E: (A) 14 days; (B) 21 days of culture. S: Scaffold. 
 
 
Figure5.13. Sections of cell-scaffolds constructs cultured in static conditions and stained 
with H&E: (A) 14 days; (B) 21 days of culture. S: Scaffold. 
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5.4. Discussion 
The viability of tissue engineered constructs grown in vitro is limited by strict 
requirements in terms of oxygen and nutrients supply and metabolic waste elimination 
from the inner regions of the constructs (20, 21). In recent years, many different types of 
bioreactors such as spinner flasks, perfusion bioreactors and rotating wall vessel (RWV) 
bioreactors have been proposed to meet these requirements, but have been beset by 
various limitations. The use of spinner flasks resulted in improved fluid flow through a 
simple design (22-24), although the turbulence generated can be detrimental for seeded 
cells and newly laid down ECM (25, 26). Rotating wall vessel (RWV) bioreactors (27-29), 
which generate low shear forces and 3D high mass transfer capacity, are prone to 
problems of non-homogenous cellular growth and ECM deposition. In addition, during the 
free floating culture, collision between the scaffolds and the bioreactor walls can induce 
cellular damage and disrupt cellular attachment and matrix deposition on the scaffolds 
(25, 30, 31). Several studies have been reported using perfusion bioreactors in the last 
decade (1, 4-6, 30, 32-41). However, in most of these studies, the authors report the use 
of perfusion bioreactors to culture cell-seeded 3D scaffolds that are limited to the use of 
small three-dimensional (3D) scaffolds [volume (Pi x r2 x h)], hence creating a limitation to 
their possible clinical use, indispensable for the future development of this scientific field, 
as we see in the graphic (Figure5.14).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter V: A Novel Bidirectional Continuous Perfusion Bioreactor for the culture of large sized bone tissue 
engineered constructs 
 140 
Leandro S. Gardel, PhD thesis, University of Porto, 2012 
 
 
Figure5.14: Graphical representation of the scaffolds volume cultured in several 
bioreactors reported in literature, as compared to the newly developed BCPB. 
 
  Apart from the bioreactor described by Zhang et al, 2009, all other studies (1, 
4-6, 30, 32, 34, 36, 37, 39-41) describe the use of bioreactors that comprehend individual 
chamber bioreactors, and Zhang’s single chamber bioreactor allows culturing only small 
scaffolds (144 cm3 each). The bioreactor described by Schliephake et al., 2009, uses 9 
scaffolds (59 cm3 each) stacked to form small scaffolds of (531 cm3 total), in a 
singlechamber. In this study we described the design and development of a new bioreactor 
(BCPB), where the samples are cultured in a single chamber that allows using scaffolds of 
variable and large dimensions. Herein we described studies on the preliminary evaluation 
of this bioreactor, in which we have used SPCL fiber meshs scaffolds that were stacked to 
form a scaffold of 42 mm length and 16 mm in diameter (7252 cm3). To the author’s 
knowledge, the BCPB is the first bioreactor described in the literature, enabling the culture 
of 3D’s scaffolds with dimensions meeting the requirements of critical sized defects, and 
thus with potential to use in real clinical situations.  
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 The amounts of DNA registered during the experimental time of culture, 
demonstrated significant lower values for the constructs cultured in the bioreactor, 
indicating that cell proliferation was probably affected by dynamic flow conditions. However 
this decrease can also be explained by the procedure required to stack the GBMSC’s–
SPCL constructs in the coaxial perforated tube before placing them inside the single 
chamber for flow culture, as the use of tweezers to hold the samples is susceptible to 
induce cellular damage and/or disrupt cellular attachment on the scaffolds. This drawback 
of the procedure might be overcome in future studies, performing the seeding directly in 
the system. Furthermore, it is well known that when MSCs differentiate, the proliferation 
rate is expected to decrease because a higher amount of cellular energy is directed to the 
synthesis of ECM matrix proteins rather than for cell replication and proliferation. Thus, the 
decrease in cellular proliferation can also be seen as a direct association of the increase in 
ALP activity in GBMSC’s (8). Although the results show an increase in DNA values 
between day 14 and day 21 for the bioreactor cultures, suggesting that BCPB (perfusion 
culture) promotes cell proliferation, no statistic difference was found between the two 
groups. ALP activity assay revealed increased amounts in all time point of flow cultures, 
and these values were statistically different when compared the control group (day 0), 
showing the osteogenic phenotypic expressions of cells cultured in the BCPB. A significant 
increase in ALP activity was also registered upon 14 days of culture in the bioreactor, 
followed by a decline at 21 days, corresponding to a common behavior in the process of 
osteogenic differentiation of MSCs (32, 42, 43). 
  However, this ALP activity profile was not observed in static conditions, 
indicating that static culturing did not provide the necessary conditions to initiate the 
osteogenic differentiation of the MSCs. These findings are in good agreement with other 
previous studies that have demonstrated the improved osteogenic differentiation in a 
dynamic bioreactor environment over a static culture system, due to the shear stresses 
induced by flow perfusion, which stimulate osteogenic programming in mesenchymal stem 
cells (9, 37, 44-46). SEM micrographs revealed that GBMSC’s seeded onto SPCL fibers, 
appeared to completely and preferentially covered the fibbers on the interior of the 
scaffolds cultured in the bioreactor, and cells showed greater spreading and adhesion in 
the entire depth of the structure, exhibiting abundant cellular connections in the interior of 
the scaffolds. In contrast, SEM showed that in static conditions, cells tend to agglomerate 
and do not spread on the scaffolds structure.  
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 Histological examination of the samples supported SEM findings, showing that 
under the flow perfusion culture cells proliferated, grow and distributed throughout the 
GBMSC’s–SPCL constructs, while under static culture the cells proliferated only in the 
surface of the GBMSC’s–SPCL constructs. 
 
5.5. Conclusions  
One of the challenges in bone tissue engineering is to create a large-scale tissue 
engineered graft in vitro to repair large bone defects. However, one of the main obstacles 
in tissue engineering is to ensure that cells survival in the interior of the large scaffolds, 
which is clearly impossible under static culture conditions. To date, most tissue-
engineering research has been constrained to using scaffolds small dimensions (2mm in 
thickness or less), which are easily sustainable by medium convection or static culture 
methods.  
 In this article, we described and evaluated the design of a novel flow perfusion 
bioreactor system for sustaining “thick” 3D scaffolds that approach sizes of clinical 
relevance. Specifically, as proof of principle, we tested large cylindrical scaffolds (42mm in 
length, 16 mm in diameter and 3 mm thick). Preliminary experiments showed that the 
BCPB enabled cells survival and proliferation in the GBMSC’s–SPCL constructs, 
demonstrating that this new flow perfusion system was superior to static culture conditions 
for large-scale cell-construct culture. Due to their size, without effective fluid flow, these 
GBMSC’s–SPCL constructs would probably suffer central core cells necrosis. The 
continuous cell proliferation under the flow perfusion culture showed that the perfusion 
system ensures the cell proliferation for at least 21 days.  
Additonally, this newly designed BCPB perfusion system is composed of parts that 
can be easily assembled under sterile conditions, avoiding possible contaminations during 
culture. Thus, the BCPB demonstrated to be a simple and efficient system for enabling the 
culture of large-scale scaffolds and for the obtention of highly functional constructs for 
bone regeneration applications. 
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Abstract 
This work aims to evaluate the in vivo performance of a tissue engineered bone 
substitute obtained by culturing cell–scaffold constructs in a flow perfusion bioreactor, 
specifically designed to enable the culture of large constructs, envisioning the 
regeneration of critical sized defects. Therefore, SPCL (a blend of starch with 
polycaprolactone) fibre mesh scaffolds were seeded with goat bone marrow stromal cells 
(GBMSCs) and cultured in the perfusion bioreactor for 14 days using osteogenic medium. 
Static cultures were also performed as controls. After 14 days, the constructs (42 mm 
length and 16 mm in diameter) were implanted in critical size defects performed in the 
tibial bone of six adult goats from which the bone marrow had been collected previously. 
Explants were retrieved after six and twelve weeks of implantation and characterized 
using scanning electron microscopy, energy dispersive spectroscopy, micro-CT and 
radiographic analysis to assess tissue morphology and calcification. Explants were also 
histologically analysed, using hematoxylin & eosin and Masson trichrome staining. The 
results obtained provided relevant information about the performance and functionality of 
SPCL–GBMSCs constructs in a critical sized orthotopic defect performed in a large animal 
model - the goat model - and demonstrated that the culture of the SPCL scaffolds with the 
autologous cells in perfusion culture can provide a good alternative therapy for the healing 
and regenerative process of bone critical sized defects.  
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6.1. Introduction  
In the field of orthopedics there is a significant number of surgical and clinical 
problems such as trauma, infections, and surgical treatment of tumors that lead to critical-
sized defects difficult to solve (1, 2). Currently, these problems are treated using bone 
grafting techniques including autologous, allogeneic and bone transport methods (Ilizarov 
technique). However these techniques present major limitations requiring the pursuit of 
alternatives for the management of critical size bone defects, with the latest approach 
being the use of tissue engineering strategies. Tissue Engineering technology aims at the 
creation of  tissue substitutes by the deliberate and controlled stimulation of selected target 
cells through a systemic combination of molecular and mechanical signals provided by a 
support material and by the culturing environment (3, 4). The general bone tissue 
engineering is based on the use of Mesenchymal Stem Cells (MSCs), most often obtained 
from the bone marrow, associated with 3D scaffolds. The MSCs are multipotent, but are 
present in strikingly low quantities in bone marrow (5) and thus it is usually necessary to 
expand MSCs in vitro before implantation, to obtain a clinically relevant number of cells. 
The scaffold must provide an appropriate environment (interconnected porosity, chemical 
composition, surface topography) to facilitate the ingrowth of cells and vascular tissue and 
must be biodegradable with a rate in par with de novo tissue regeneration (6). Several 
advanced culturing systems, mostly perfusion bioreactors, have been described in the 
literature in recent years to culture bone constructs (7-16) with clear advantages over the 
traditional static culturing methodologies. Unfortunately, the vast majority of these culture 
systems are designed for engineering small cell-scaffolds constructs, measuring only few 
millimeters. Consequently, these perfusion systems are not capable of meeting the real 
clinical needs existing in the field of orthopedic surgery that is to solve the problem of the 
BMSC’s nutrition supply in the center of large 3D scaffolds that can be used in critical-
sized defects regeneration. Thus, in this study we describe the use of a new Bi-directional 
continuous perfusion bioreactor (BCPB) that allows culturing large scaffolds. Constructs 
composed of goat bone marrow stroma cells seeded onto 3D polymeric scaffolds were 
cultured using this bioreactor and then implanted into 42-mm-sized defects in a tibial goat 
model. In general, the histological analysis of the explants (stained with Hematoxylin & 
Eosin and Masson’s trichrome) showed homogeneous distribution and more new bone 
formation in the defects implanted with constructs cultured in the perfusion bioreactor. 
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 Micro-ct 3D image reconstructions also showed new bone formation and 
deposition around the constructs cultured in perfusion conditions, while bone formation 
was not detectable in defects implanted with constructs that were statically cultured.  
Although complete bony union was not radiographically observed in any defect, it 
was possible to visualize bone in the early stages of development in defects filled with 
constructs cultured in perfusion conditions after 12 weeks of implantation. These data 
indicate that BCFB can be used for enhancing the functionality of tissue engineered 
constructs and thus enabling enhanced bone regeneration in real critical-sized bone 
defects. 
 
6.2. Materials and Methods 
 
6.2.1 GBMSC’s harvesting, isolation and culture 
 Six (6) goats were anesthetized, with intramuscular injection medetomidine 
hydrochloride (Domitor®, Pfizer, Portugal) at 0.11mg/kg of body weight, and ketamine 
hydrochloride (Imalgene®, Merial, Portugal) at 10mg/kg of body weight. Thiopentone 
(Tiopental®, BBraum, Portugal) sodium at 5mg/kg of body weight was administered 
intravenously given for general anesthesia. After this, the region of the dorsal iliac crest 
was aseptically prepared and 2 mL of bone marrow (BM) was harvested using a biopsy 
needle (T-Lok TM) and mixed with 100 IU/mL heparin. The goat BM aspirate was mixed 
with 10ml of basal media consisting of α-DMEM with 10% fetal calf serum and the mixture 
was centrifuged (1200rpm/5 min). The pellet was removed and the cells were 
resuspended in the same media and seeded in two 150 cm2 culture flasks and then 
placed inside an incubator. Cells developed a fibroblastic-like morphology in visible 
symmetric colonies at about 4 days after initial plating. Non adherent cells were removed 
with medium changes performed every 2-3 days. Cells were cultured at 37ºC in a 5% CO2 
atmosphere at 95% humidity. On reaching confluence, cells were passed with 0.05% 
trypsin. GBMSC’s cells were enzymatically lifted with 3 ml of trypsin after reaching 80%- 
90% of confluence at passage 4 (p4), were centrifuged (1200rpm/5min) and the pellet was 
removed. A cells suspension containing of 1x106 cells in 300 µl of α-DMEM with 10% fetal 
calf serum was prepared to seed onto each scaffold (SPCL fiber – meshes) used for the 
study. 
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6.2.2 Scaffold design and preparation 
In this study a fiber mesh scaffold based on a biodegrable polymeric blend of 
starch and polycaprolactone (SPCL) that has been extensively investigated for bone 
tissue engineering applications (17-22) was used. The 3D scaffolds were produced by a 
fiber-bonding method into mesh structures with a porosity of ~75%, as described 
previously (15, 16), and cut into disks of 16mm diameters and 3mm of thicknesses with a 
6mm interior hole. The interior hole was performed with two main objectives, the first is to 
allow the samples to be positioned within the bioreactor through insertion of the scaffolds 
into the perforated tube enabling the use of a bidirectional flow from inside to outside or 
outside to inside of the samples; the second goal is to mimic the role of the medullar canal 
in the long bones, allowing the passage of blood vessels and thus support the 
development of a functional bone tissue into the samples upon implantation (Figure 6.1). 
All samples were sterilized using ethylene oxide. 
 
Figure6.1. Schematic representation of the SPCL fiber-meshs stacked into a scaffold of 
critical sized defect dimensions 
 
6.2.3 Flow-perfusion bioreactor design 
The flow perfusion bioreactor used in this study was developed by the 3B’s 
Research Group and named Bi-Directional Continuous Perfusion Bioreactor (BCPB). It 
has an innovative design which consists in the use of a rigid tube, where the scaffold is 
inserted, with perforations in the central part, equivalent to the length of the three-
dimensional scaffold (of large and variable dimensions) that is used. This tube is 
connected to a circular system that is responsible for promoting the medium flow from the 
interior to the exterior of the three-dimensional support (linked to the peristaltic pump) or 
from the exterior to the interior of the three-dimensional medium.  
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This tube is positioned co-axially within a single cell culture chamber with exits 
/entrances hermetically closed, connected to the same circular system, which allows the 
control of the flow and of the pressure gradient inside the chamber and the perforated 
tube. In this experiment two BCPB systems were used, at a continuous flow rate of 1 
ml/min. 
 
6.2.4 GBMSC’s seeding onto SPCL scaffolds and bioreactor culture 
The SPCL scaffolds were placed in 12 well non-adherents plates (Costar; Becton-
Dickinson). A total of 56 samples were seeded with 300 µl of a cell suspension containing 
1x106 cells in basal medium composed of α-MEM (Minimal Essential Medium) with 10 % 
FCS (foetal calf serum, Gibco), 50 µg/ml gentamycin, 100 µg/ml ampicillin and 0.3 µg/ml 
fungizone (all from Sigma), for either static or bioreactor culture during 14 days prior to 
implantation for 6 or 12 weeks. The well plates were then transferred to the incubator and 
three hours after seeding 1.6 ml of basal medium was added to each well and the plates 
were left to incubate overnight. The 12 well plates containing cell-scaffolds for static 
culture were kept in the same incubator for 14 days, in osteogenic medium, with weekly 
medium change. The osteogenic medium was composed of α-MEM, supplemented with 
10 % FCS (foetal calf serum, Gibco), 50 µg/ml ascorbic acid (Sigma, St.Louis, MO, USA), 
50 µg/ml gentamin, 100 µg/ml ampicillin, 0.3 µg/ml fungizone, 10 mM Na β-
glycerophosphate and 10–8 M dexamethasone (all Sigma). The plates containing cell-
scaffolds constructs to be cultured in the bioreactor were carefully transferred to two 
BCPB’s, in a laminar flow cabinet, as follows: each sample (3mm length and 16 mm 
diameter), with a inner hole of 6mm was carefully inserted into the polycarbonate 
perforated tube and stacked until completing a total of 14 samples, corresponding to a 42 
mm length construct. The perforated tube with the inserted construct, was then connected 
to the two end parts of the bioreactor that assure the hermetic and aseptic closure of the 
culture chamber; subsequently these were connected to the system flow and the culture 
chamber was slowly filled with the culture medium at a rate of 1ml/min, with a direction 
from inside the chamber to the perforated tube, which will cause a flow direction from 
outside to inside the scaffold. Finally, the system was transferred to an incubator (at 37 ºC 
environment with 5% CO2).  
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A 14 days of the culture period inside of bioreactor was selected to surpass the 
‘cusp of viability in static culture’ (determined in previous studies to be 4 days), such that 
experimental duration would be sufficient to detect any measureable difference among 
static and flow cultures viability (23). This culture period is also comparable to that of 
previous in vitro investigations (10, 24) and other ex vivo studies found in the literature 
(25). The culture chamber has a capacity for 216 ml of culture medium while the bottle 
reservoir was filled up to 450 ml of medium; every week 400 ml of medium were 
exchanged with 400 ml of fresh medium, without stopping the medium flow in the 
bioreactor system. Each sample of the static group was cultured in the presence of 10 ml 
of culture medium which was changed every week. 
 
6.2.4.1 Characterization of cell viability in seeded scaffolds 
To ensure the reliability of seeding, 3 samples (day 0), of each group were 
collected for studies of cell viability, for this DNA, MTS and SEM assay were performed 
using previously reported methods (15, 26, 27). 
 
6.2.5 Animal surgical procedures 
Care and management of animals was conducted as per the guidelines of the 
Institutional Animal Ethics Committee and the Committee for the Purpose of Control and 
Supervision of Experiments on Animals. Six goats, 2-year-old female (n=2 in each group), 
with an average weight of 25 kg (ranged, 23–27.5 kg) and fed in separate cages with free 
access to food and water, were used in this study. The animals were premedicated with 
intramuscular injection of medetomidine hydrochloride (Domitor®, Pfizer, Portugal) at 
0.11mg/kg of body weight, and ketamine hydrochloride (Imalgene®, Merial, Portugal) at 
10mg/kg of body weight. Thiopentone (Tiopental®, BBraum, Portugal) sodium at 5mg/kg of 
body weight was given intravenously for induction of anesthesia. Cephazolin (Cefazolin® 
500mg, Sagent), 10 mg/kg was administered subcutaneously as prophylactic antibiotics. 
The animals were intubated immediately with size nº 9 Magill endotracheal tube. 
Anesthesia was maintained with increments of medetomidine hydrochloride and ketamine 
hydrochloride dose-effect every 20–30 min. The animals were in right recumbency on the 
operating table.  
 
 
 
Chapter VI: Assessing the repair of critical size bone defects performed in a goat tibia model using tissue 
engineered constructs cultured in a bi-directional flow perfusion bioreactor 
 156 
Leandro S. Gardel, PhD thesis, University of Porto, 2012 
 
Asepsis of the skin after shaving was achieved with a chlorhexidine (LifoScrub®, 
BBraum, Portugal) solution and wrapped using a sterile technique. A skin incision of 15 
cm length was made along the right tibia and the tibia was exposed using a standard 
medial approach. 
 A 42 mm bone segment (with periosteum included) was excised from the mid 
diaphyseal region using an oscillating saw under abundant irrigation (Figure.6.2A). A 
stainless steel biological healing plate of 7 holes with 3.5 cortical screws and cerclage 
(Servive Portugal®, Valencia), were used for immobilization of the bone (Figure 6..2B). 
The 3D cell - scaffolds (42 mm length and 16 mm in diameter) constructs were placed into 
the right tibia defects divided into bioreactor group (6 and 12 weeks), static group, (6 and 
12 weeks) (Figure 6..2C) and control group (empty defect, 6 and 12 weeks) (Figure 6..2D) 
by the same procedure. The surrounding soft tissue and skin incision was closed with 
uninterrupted sutures using absorbable synthetic monofilament suture (MonoPlus®, 
BBraum, Portugal). During the first week after surgery, cephazolin (Kefzolan®) (10 mg/kg) 
and 0.2mg/kg butorphanol (Torbugesic®) were routinely administered intramuscularly once 
a day and the physical states of all the animals were also closely monitored. All animals 
recovered successfully from surgery, remained in good health, and the implants remained 
stably fixed and in correct positioning (Figure 6.3 A,B,C). The animals were sacrificed at 6 
and 12 weeks with injection of high doses of thiopentone (Tiopental®, BBraum, Portugal). 
 
 
Figure6.2. (A) Bone fragment removed together with the periosteum; (B) Osteosynthesis 
material applied to the tibia; (C) Implantation of the biomaterial in tibia bone and fixation 
with osteosynthesis material; (D) Empty defect (control group). 
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Figure6.3. X-ray obtained immediately after surgery, showing the correct positioning of the 
bone fixation device. (A) Control group (empty defect); (B) Static group; (C) Bioreactor 
group. In B and C images it is possible to visualize radiographically the cells-scaffolds 
constructs implanted within the defect. 
 
6.2.6 Characterization of explants from in vivo studies 
 
6.2.6.1 Radiographic analysis 
In vivo digital X-rays of all the groups were obtained in the immediate 
postoperative, and at 6 and 12 weeks post operation using an X-ray equipment (PHILIPS 
Corp). Exposure was at 50 kVp for 2.5 mAs, using diagnostic imaging software 
(CrystalView®). The differences in radiopacity in and around the 3D scaffolds at the defect 
and bone union at the cut-ends of the original tibias were analyzed. Radiographs of the 
tibia removed from the goats were obtained by routine procedures. 
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 6.2.6.2 Scanning Electron Microscopy (SEM) and Energy-
Dispersive X-ray Spectroscopy (EDS) analysis 
 The morphological analysis of cells growth, attachment, and distribution on the 
surface of the scaffolds was performed by SEM (Leica Cambridge, model S360; England) 
and measurements of the amount of calcium and phosphorous in samples were 
performed by Energy Dispersive Spectroscopy (EDS) in a link-el-II equipment. For this 
purpose, the constructs (scaffolds-cells) were fixed with 2.5 % Glutaraldehyde 
(Sigma,USA) in PBS solution, dehydrated through a graded series of ethanol, let to dry 
overnight at room temperature and finally gold sputter coated (Fisons Instruments, model 
SC502; England). 
 
 6.2.6.3 Micro-CT analysis 
The formation of mineralized tissue in the explants was evaluated using a high-
resolution µ-CT Skyscan 1072 scanner (Skyscan, Konitich, Belgium). Each sample was 
scanned in a high-resolution mode with a pixel size of 17.58µm and exposure time of 
1.6ms. The x-ray source was set at 52 keV of energy and 163µA of intensity. 
Approximately 400 projections were acquired over a rotation of 180º with a rotation step of 
0.45º. Each one of these projections were segmented into binary images with dynamic 
threshold of 55-225 (grey values) to assess new bone formation. These data sets were 
used for morphometric analysis (CT analyser, v1.51.5 SkyScan); for this purpose a 
cylinder (6 mm in diameter) between the outer and inner edge of each scaffold analyzed 
was designated as region of interest (ROI); the new bone formation was measured and 
calculated by percentage of object volume values (total volume values/object volume 
values). The distribution and quantification of the new bone formation in the scaffolds was 
assessed by 3D virtual models that were created, visualized and registered using both 
image processing software´s (CT analyser and ANT 3D creator). 
 
 
 
 
 
Chapter VI: Assessing the repair of critical size bone defects performed in a goat tibia model using tissue 
engineered constructs cultured in a bi-directional flow perfusion bioreactor 
 159 
Leandro S. Gardel, PhD thesis, University of Porto, 2012 
 
6.2.6.4 Histological analysis 
Following euthanasia, the implants and their surrounding tissue were retrieved and 
prepared for histological evaluation. The explants were rinsed in PBS, fixed in 4% formalin 
solution, dehydrated in a graded series of ethanol and embedded in paraffin. Then 5 µm 
sections were obtained with a microtome and stained with hematoxylin & Eosin (HE) and 
Masson Trichrome (MT) which is frequently used as a bone-specific staining. Samples 
were then visualized under a light microscope and images taken with an attached camera. 
 
6.2.7 Statistical analysis 
The PASW Statistics18 software package (IBM, Somers, NY) was used for the 
statistical analysis. Descriptive values are presented as mean ± SD unless stated 
otherwise. Kolmogorov-Smirnov test with Lillefors significance correction was used to test 
the normality of the data. The one way ANOVA test was used to determine statistically 
significant differences among the groups and the Tukey test was used to assess the 
pairwise comparisons between groups. The statistical significance level considered was P 
<0.05. 
 
6.3. Results 
6.3.1 Cell adhesion and viability of scaffolds 
MTS (Figure 6.4 A) and DNA (Figure 6.4 B) quantification results of samples from 
day 0 (control), showed that there was no apparent difference between the results for 
each group. In fact, the ANOVA test for DNA and MTS results did not detect statistically 
significant differences among all samples for the selected statistical level (P <0.05), 
suggesting that the seeding technique used was effective to all groups. SEM picture 
(Figure 6.4 C), shows adhesion and cellular distribution along the SPCL fiber after the 
seeding.  
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Figure6.4. (A) Boxplot of MTS quantification from all groups, day 0;(B) Boxplot of DNA 
quantification from all groups, day 0;(C) SEM photomicrographs obtained from cell seeded 
SPCL samples at day 0. 
 
6.3.2 Radiographic analysis 
 After 6 weeks of implantation it was possible to visualize that the bone fixation 
device remained in the same position (figure 6.5) as immediately after surgery (Figure 
6.3). No bony union was visualized between proximal/distal bone fragments in any 
groups, and it was also not possible to radiographically detect any early bone healing 
(Figure 6.5 A,B,C). 
 
Figure6.5. Radiographs obtained after 6 weeks of implantation: (A) Control- empty defect 
(B) Static group (C) Bioreactor group. 
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After 12 weeks of implantation, it was possible to visualize that the bone fixation 
device remained in the same position as of immediately after surgery (figure 6.6). 
However, in the control group, it is apparent that the device bone fixation was subjected to 
strong mechanical forces (angulation, rotation and shears forces bone) active in the empty 
bone defect. The entire weight of the limb (bone) was supported by the device, which 
resulted in a strong bone resorption at the bone screws-plate and bone interface, in both 
the proximal/distal bone fragments. In distal fragment it is possible to see that this reaction 
was more intense (Figure 6.6 A). Probably if the time of study was broader the collapse of 
this device would occur. In the static group, unlike what happened with the empty defect 
(control), it was not visualized bone resorption between the screw-plate and bone. 
Probably this reaction did not occur because of the division of bone forces between the 
device and the 3D scaffold, and no early bone healing was detected radiographically 
(Figure 6.6 B). In the bioreactor group it is possible to radiographically visualize bone 
deposition in the vicinity of the cut edges of the proximal fragment (inside the biomaterial) 
and distal fragment (medially under the bone plate), but bone resorption was also not 
visualized (Figure 6.6 C). In any of the study groups was possible to radiographically 
visualized complete bony union between proximal/distal bone fragments. 
 
 
Figure6.6. Radiographs obtained after 12 weeks of implantation: (A) Control-empty 
defects weeks; (B) Static; (C) Bioreactor. 
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6.3.3 SEM analysis 
  SEM photomicrographs were obtained from samples retrieved from the region 
indicated by the white arrows in the X-ray images depicted in the Figure 6.7, which were 
obtained at the moment of euthanasia for the static and bioreactor groups, after 6 and 12 
weeks of implantation. 
 
 
Figure6.7. Radiographs obtained after implantation: (A) Static 6/ weeks group;(b) Static/12 
weeks group; (C) Bioreactor/6 weeks group; (D) Bioreactor/12 weeks group.  
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Figure6.8. SEM photomicrographs of the cell-scaffolds constructs retrieved upon 
implantation: (A) Static 6 weeks [A1 (x200),A2 (x500),A3 (x1000)]; (B) Static 12 weeks [B1 
(x200),B2 (x500),B3 (x1000)]; (C) Bioreactor 6 weeks [C1(x200),C2(x500),C3(x1000)] and 
(D) Bioreactor 12 weeks (D1 (x200),D2 (x500),D3 (x1000)]. 
 
SEM (Figure 6.8), showed the formation of dense sheets of tissue crossing 
adjacent fibers of SPCL meshes, mostly for the longer periods of implantation in both 
static and bioreactor groups (12 weeks) (Figure 6.8 B1-B3 and D1-D3). Cells embedded 
in a matrix were observed covering the fibers surface, but also colonizing the inner 
pores/regions of the scaffold. Nevertheless, in the constructs cultured in the bioreactor 
groups, it was also possible to observe the formation of a layer of calcified globular 
accretions associated with collagen bundles, deposited on and into of the scaffolds 
(Figure 6.8 C1-C3 and D1-D3), that is more evident after 12 weeks of implantation (Figure 
6.8 D1-D3). 
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Analysis of the EDS spectra obtained from samples corresponding to bioreactor 6 
weeks group (Figure 6.9 A), bioreactor 12 weeks group (Figure 6.9 B), static 6 weeks 
(Figure 6.9 C) and static 12 weeks group (Figure 6.9 D) allowed  to detect an increment of 
the calcium (Ca) and phosphorus (P) elements that corresponding to the deposition of a 
mineralized matrix. By observation of the figure (6.9 B) it is possible to detect that the 
graphic corresponding to the bioreactor 12 week surgical group shows a higher increase 
of Ca and P in the SPCL-cell construct when compared to other groups. 
 
 
Figure6.9. EDS spectra for Bioreactor 6 weeks  group (A), Bioreactors 12 weeks  group 
(B), Static 6 weeks  group (C) and Static 12 weeks  group (D). 
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6.3.4. Micro-CT analysis 
In figure 6.10, it is possible to visualize four representative images of SPCL-cells 
constructs retrieved from the in vivo experiments and analyzed by micro-ct. These images 
were obtained precisely in the region of the interface among the proximal/distal bone and 
the scaffolds. In both bioreactor study groups (6 and 12 weeks) it was possible to detect 
development and deposition of lamellar bone tissue in this bone defect borders, but only 
in the 12 weeks group bioreactor it was possible to visualize a high degree of bone 
calcification. This calcification not only occurred on the surface of the scaffold but also 
inside, suggesting the important role of the homogenous distribution of the cells in the 
scaffolds and their active metabolism and osteogenic differentiation, when cultured in the 
flow perfusion bioreactor. The results of the morphometric measurements in the 3D 
analysis of the new bone formation in all samples were analyzed using a threshold 
ranging from 120 (lower grey) to 225 (upper grey). However, with this threshold value it 
was not possible to obtain data from the static group. The data obtained from the 
bioreactor group (6 and 12 weeks), showed that the bioreactor 12 weeks group was filled 
for 10 ± 3% of their volume with bone. In contrast, the bioreactor 6 weeks group showed 
0.9 ±1.4 % of the bone. Statistical evaluation revealed that significantly more bone was 
present in bioreactor 12 weeks group compared with bioreactor 6 weeks group (P=0.009). 
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Figure 6.10: µ-CT 3D virtual models images of the region corresponding to the bone 
interfaces with SPCL-Cells constructs. A) Interface between proximal fragment and 
scaffolds bioreactor 6 weeks group; B) Interface between distal fragment and scaffolds 
bioreactor 6 weeks group; C) Interface between proximal fragment and scaffolds 
bioreactor 12 weeks group and D) Interface among distal fragment and scaffolds 
bioreactor 12 weeks group. 
 
6.3.5 Histological analysis 
Upon harvesting of the explants, a thin fibrous capsule surrounding all scaffolds 
groups was observed. No inflammatory reaction was observed inside or around the 
implants. No bone formation could be observed macroscopically. Histologically (Figures 
6.11 and 6.12), after 6 weeks of implantation in static and bioreactor group, matrix 
deposition, revascularization and neovascularization (small vessels with thick 
endothelium) were observed inside the scaffolds in both experimental groups. The matrix 
was red stained (similar to bone tissue), but lacked osteocyte-like cells and was not 
surrounded by osteoid with active osteoblasts.  
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Mineralized-like matrix deposition was mainly found at the scaffolds edges that 
were in direct contact with the bone, in the bioreactor group 6 weeks. In the same 
samples, it was possible to observe revascularization and neovascularization (Figure 6.11 
A and B). Furthermore, for static surgical group 6 weeks, no connection or union of bone 
with scaffolds was observed (Figure 6.11 C and D). 
 
 
Figure6.11. Light microscopy images of cell-scaffolds sections corresponding to the  
bioreactor groups after 6 weeks implantation (HE (A) and MT (B) and static groups after 6 
weeks implantation ( H&E(C) and MT(D). Bone (B); Matrix Deposition (MD); Fibrous 
Tissue (FT); Revascularization (R); Neovacularization (NV); SPCL fiber-meshs (S). 
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 After 12 weeks of implantation, revascularization and neovascularization of blood 
vessels into scaffolds porosity was found in both experimental groups, but bone formation 
and bone marrow was only observed in the bioreactor groups (Figure 6.12 E and F). In 
static groups, fibrous tissue and mineralized-like matrix deposition could be observed 
(Figure 6.12 G and H), but new bone formation was not observed. 
 
Figure6.12. Light microscopy images of cell-scaffolds constructs sections corresponding 
to bioreactor groups after 12 weeks implantation (HE (E) and MT (F), and static groups 
after 12 weeks of implantation. Bone (B); Bone Marrow (BM); Matrix Deposition (MD); 
Revascularization(R); Neovacularization(NV); SPCL fiber-meshs (S). 
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6.4. Discussion 
In the present work, aimed to observe the effect of using SPCL fibre mesh 
scaffolds seeded with GBMSC’s cultured in a flow perfusion bioreactor, specifically 
designed to enable the culture of large sized constructs, in the regeneration of critical size 
defects (42mm in length) performed in goat tibial diaphysis. Goat has a metabolic rate and 
bone remodeling rate similar to that of human’s presenting a suitable animal model for 
testing human implants and materials. The constructs were cultured in the bioreactor with 
osteogenic medium for a period of 14 days, determined based on earlier studies, which 
revealed that this period of time enabled the initiation of  osteogenic differentiation of cells 
in SPCL fiber meshes (24). All animals survived and no signs of infection or inflammation 
were found nearby the implantation areas 12 weeks after implantation. X-ray images 
obtained after the surgery and on the day of euthanasia, demonstrated that the choice of 
primary bone fixation device was correct. The critical defects implanted with GBMSC’s–
SPCL constructs can be compared to a complicated comminuted fracture in which the 
fracture site is unlikely to contribute substantially to the transfer of load during weight-
bearing, and thus the plate must essentially support all of the forces transmitted through 
the limb. This requires a very rigid, strong plate-bone construction. These transmissions of 
forces were easily visible in the control animals (with defects left empty) after 12 weeks of 
implantation, where it’s visible the stress caused by the plate-screws in the proximal/distal 
bone fragments. In higher strain environments, cellular differentiation favors osteoclasis 
and chondrogenesis or fibrogenisis. This was not visualized in other study group animals 
(control 6 weeks and static 6 weeks), which can probably be explained by the short time 
of the weight-bearing of the limb, since during the first two weeks a limb immobilization by 
a modified Robert-Jones bandage was applied in the operated limb (of the all animals). 
However, this was not observed in the groups that were implanted for longer periods of 
time (static 12 weeks and bioreactor 12 weeks), due to the biomechanical sustenance 
provided by the SPCL constructs(20), that supported the load together with the bone 
fixation device, since it was loaded with the purpose of compressing the stacked 
GBMSC’s–SPCL constructs. The X-ray results confirm that during the time of the study 
there was no bone union among the proximal/distal bone fragments in all the study 
animals, and it was only possible to visualize radiographically bone formation in both 
proximal/distal bone fragments, in the defects treated with constructs cultured in the 
bioreactor, upon 12 weeks of implantation.  
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However, the results obtained from µ-CT 3D virtual models images showed a 
representative volumetric bone formation among the proximal/distal bone fragments and 
GBMSC’s–SPCL constructs cultured in the bioreactor, after 6 weeks of implantation.  
This might be explained by the fact that µ-CT is a much more sensitive method for 
detection of bone formation and mineralization than x-ray. In the defects filled with 
constructs cultured in the bioreactor after 12 weeks of implantation, where bone formation 
is radiographically visible and mineralization in both proximal and distal bone fragments, 
the µ-CT 3D virtual models images of this same region show a much more intense and 
compact bone formation and mineralization. In fact, these 3D images corroborate with the 
SEM observations and EDS analysis spectra, which showed matrix mineralization in the 
GBMSC’s–SPCL constructs cultured under perfusion, even after the shortest implantation 
time (6 weeks); in this group, a layer of calcified globular accretions associated with 
collagen bundles was deposited on and into the scaffolds, but this was even more evident 
in the defects filled with constructs cultured in the bioreactor, 12 weeks after implantation. 
Additionally, connection and integration of newly formed bone directly with the original 
proximal/distal bone fragments of the tibia (as shown in micro-CT 3D images) will result in 
rapid stabilization of the implant. As consequence, it can support further growth of bone 
through the scaffolds. These findings are clinically very relevant, because this will ensure 
the mechanical integrity of the constructs, protect and assist the distribution of forces 
among the bone fixation device and the large dimensions implanted construct. 
Histological analysis also illustrated that bone marrow and bone formation 
(osteoid) inside the SPCL fiber meshes only occurred in the defects treated with 
bioreactor cultured constructs, after 12 weeks of implantation. Furthermore, occlusion of 
pores of the GBMSC’s–SPCL constructs was not observed, possibly allowing the 
continuous exchange of oxygen, nutrients, and removal of metabolites that is expected to 
facilitate neovascularization. Morphometrical measurements demonstrated a higher new 
bone formation in the scaffolds cultured under perfusion, suggesting that GBMSC’s–SPCL 
constructs cultured under a flow perfusion bioreactor exhibit a higher osteogenic potential 
in vitro and in vivo. Several other studies show that perfusion culturing of cell/scaffold 
constructs has a positive effect on cell proliferation and osteogenic differentiation (16, 28), 
but few studies have analyzed the effect of constructs cultured under these conditions 
upon implantation onto an orthotopic defect. Furthermore, studies focusing on orthotopic 
models are typically conducted using non critical size defects.  
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This methodology is very important to obtain information on the biocompatibility of 
the biomaterial used (immunologic and inflammatory reactions), to define optimal in vitro 
culture conditions before implantation and to analyze the importance of the number of 
cells and their differentiation stage at the moment of the cell-construct implantation. 
However, the results provided by non-critical size defect models, do not provide a 
complete answer regarding the feasibility (biomechanical behavior) of the cell-scaffold 
construct, when it is selected to be implanted in a critical size defect. In this study we have 
analyzed the role of cell-scaffolds constructs cultured in a perfusion bioreactor upon 
implantation in a critical size defect. The results obtained showed that bone development 
was enhanced with the perfusion culture of the constructs, demonstrating the importance 
of the culturing conditions in the in vivo functionality of the constructs composed of 
GBMSC’s and SPCL scaffolds. Furthermore, it was demonstrated that SPCL fibre mesh 
scaffolds showed an appropriate biomechanical behavior, providing an adequate tissue 
3D support for the regeneration of bone in critical size defects. The results of this study 
also confirm previous findings (18) on the biocompatibility of SPCL fiber meshes and their 
suitability for bone regeneration. 
To the author’s knowledge, no reference can be found to other studies that have 
used a single culture chamber perfusion bioreactor for culturing scaffolds of large 
dimensions and subsequently implanted it in a critical size defect performed on large 
animal models. With this study, we also show that bone formation was enhanced in the 
presence of GBMSC’s–SPCL constructs cultured under a flow perfusion bioreactor in 
comparison to static groups in an orthopedic critical sized defect. 
Consequently, we conclude that inoculating SPCL fiber meshes and osteogenic 
cells cultured in a perfusion system can improve the bone healing capacity of this tissue 
engineered construct and demonstrates that the use of this perfusion culture system is a 
valuable and convenient tool for applications in bone regeneration. Most perfusion 
bioreactors described in the literature do not enable the culture of large constructs and 
few studies have reported on the in vivo functionality of such constructs using critical size 
defects on large animal models. The BCPB demonstrated its potential as an important tool 
that fulfills the expectations for the successful culture of large bone tissue engineered 
substitutes. 
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CHAPTER VII 
Autologous stem cell therapy for the treatment of a tibial fracture gap in a 
cat. 
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ABSTRACT 
Autologous stem cell therapy is a new field of veterinary medicine regenerative 
that involve harvesting, proliferation and differentiation of stem cells, most often from the 
bone marrow our adipose tissue, for posterior application in the same patient. This work 
describes a successful clinical treatment of a tibial fracture gap in a cat using an 
autologous stem cell therapy (ASCT). Bone marrow (BM) was harvested from the femoral 
medullar cavity. Cat Bone Marrow Stromal Cells (CBMSC’s) were cultured in osteogenic 
medium for a pre--differentiation into osteoblasts, before applying the cells suspension 
percutaneously in the fracture site. Alkaline phosphatase (ALP) assay and alizarin red 
staining were used to assess osteogenic differentiation/mineralization of in vitro cultured 
cells and X-rays were performed to follow up bone repair. The postoperative of an 
orthopaedic patient requires a degree of reduction of movement of the member affected 
until the clinic union occurs, which is very difficult to achieve for most patients In this study 
it was shown that two weeks after the application of the autologous stem cell therapy 
(ASCT) in the gap fracture, the animal developed a callus with high opacity and also 
developed a clinical bone union that allowed the animal to fully utilize the affected limb. 
Thus ASCT should be considered as a successful adjuvant therapy for rapid repair in 
large gap sites. 
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7.1 INTRODUCTION 
 Autologous Stem Cell Therapy (ASCT) is a field of regenerative veterinary 
medicine that involves harvesting tissue, such as bone marrow, from the patient, isolating 
the stem cells, and administering the cells back to the patient, with or without in vitro 
expansions and/or differentiation. It has been described in humans (1-3) dogs (4-7), and 
horses (8-10) to treat orthopaedics conditions. Cat bone marrow stem cells (CBMSCs) are 
multipotent adult stem cells and have become an important cell source for cell therapy 
and engineered tissue repair. Their osteogenic differentiation potential has been well 
characterized in vitro (11). With an increasing feline pet population that currently exceeds 
the canine pet population, veterinary practitioners and specialists are expected to treat a 
growing variety and number of fractures involving the humerus, radius/ulna, femur, and 
tibia/fibula (12). Fractures of the tibia are common in cats (about 20 % of all fractures) 
(13). Diaphyseal fractures of the tibia are encountered frequently (14). They are most often 
caused by trauma, but occasionally spontaneous fractures occur, being frequently 
accompanied by diaphyseal fractures of the fibula. These are not addressed during tibial 
fracture repair. Posttraumatic synostoses between the tibia and fibula have no negative 
effect on the clinical outcome (15). External fixators are widely used for the treatment of 
tibial injuries since there is little soft-tissue coverage of the crus (16). In one study, closed 
reduction and external skeletal fixation of comminuted tibial fractures resulted in a 27% 
shorter fracture healing period compared with an open approach and plate osteosynthesis 
(17).  
This case report describes the successful clinical treatment of a cat with a large 
fracture gap after percutaneous application of the CBMCs pre-differentiated into 
osteoblasts, clearly demonstrates that the use of ASCT can help shorten fracture healing 
time.  
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7.2 CASE REPORT 
A 3 years-old female sterilized European cat weighing 7.200kg, presented a high-
impact fracture of the medial shaft of the right tibia due to a fall from a height of 15 meters, 
which was stabilized using External Skeletal Fixation type II (ESF), applied through a 
closed approach performed by the referring veterinarian, was referred to the Veterinary 
Medical Teaching Clinical (UPVET) at the ICBAS-University of Porto, Porto (UP), two 
days after the surgery because of a small collapse in the ESF utilized, for application of 
ASCT. Thoracic radiographs, hematologic, biochemical and urinalysis profiles were within 
normal parameters. After craneo-caudal radiography projections (Figure 7.1) of the 
affected limb, a lateral displacement in the axial focus of fracture was observed and a 
large bone gap was visualized (Latero-lateral projections were made but due to 
overlapping of the bone fixation device, not was possible to visualize displacement). This 
usually indicates a long time for repair or it can lead to a non union. In this clinical 
situation, it is very important to assure a significant reduction in the mobility of the 
patients. However this is very difficult to achieve in most cases. This small collapse was 
probably caused by the method selected (smooth pins rather than positive threaded pins), 
associated with the inability of owners to keep the patient in cage rest. With this in mind, it 
was decided to apply a cellular therapy with the goal of enhancing fracture healing in a 
shorten time. 
 
Figure7.1. Craneo-caudal radiography projections of the affected limb, where it is 
observed a lateral displacement in the axial focus of fracture. 
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Under general anaesthesia (ketamine HCl, Merial, Sintra, PT) at 5 mg/kg IM and 
medetomidine(Virbac, Sintra, PT) at 80µ/kg IM), maintained on isoflurane(Abbott 
laboratories, Amadora, PT) (2%) in oxygen(1500ml/min), 2ml of bone marrow (BM) was 
harvested from the femoral medullar cavity through the use of a biopsy needle (T-Lok TM 
Angiotech,Vancouver, British Columbia, CA, USA). The cat bone marrow aspirate was 
mixed with 10ml of osteogenic media consisting of alfa-DMEM (Sigma-Aldrich, St. Louís, 
USA) supplemented with osteogenic supplements namely, 108 M dexamethasone 
(Sigma-Aldrich, St. Louís, USA), 1% Antibiotics (Sigma, St. Louís, USA); 10% Fetal 
bovine serum (Invitrogen, Burlington, ON, CA) 50µgml-1 ascorbic acid (Sigma, St. Louís, 
USA) and 10mM β-glycerophosphate (Sigma, St. Louís, USA), and heparin (BBraun 
medical, Barcarena, PT) (1/1000units) and the mixture was centrifuged (1200rpm/5 min). 
The pellet was removed and the cells were resuspended in the same media and seeded 
in two 75 cm2 culture flasks and then placed inside an incubator. Cells developed a 
fibroblastic- like morphology in visible symmetric colonies at about 4 days after initial 
plating. Nonadherent cells were removed with medium changes performed every 2-3 
days. The osteoblastic differentiation was induced by culturing cells for 2 weeks. 
CBMSC’s cells were enzymatically lifted with 3 ml of trypsin after reaching 80%- 
90% of confluence at passage 3 (p3), centrifuged (1200rpm/5min) and the pellet was 
removed. A cells suspension containing 9x106 cells in 0, 6 ml of phosphate-buffered saline 
(PBS) (Sigma, St. Louís USA) solution was prepared to be injected in the gap site using a 
1mL sterile syringe(Figure 7.2).  
 
 
Figure7.2. Syringe containing the cells suspension, used for the application of the cells in 
fracture gap.  
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To characterize the osteogenic differentiation in vitro, cells were cultured in 6 well 
plates at a density of 3x105 cells/well. Plates with osteogenic medium for days 0, 7(first 
week) and 21(third week), changing the medium every 2-3 days. ALP activity of the 
CBMSC’s was measured to evaluate osteoblastic-like differentiation; for this purpose, the 
samples were collected on days 0, 7(first week) and 21(third week), washed twice with a 
sterile PBS solution and transferred into 1.5 ml microtubes containing 1ml of ultra pure 
water; the tubes containing the cells samples were then incubated for 1h at 37 0C in a 
water –bath and then stored in a -80 0C freezer until testing. For the ALP assay, 20µl of 
each sample plus 60µl of substrate solution 0.2% (w/v) p-nytrophenyl (pNP) phosphate 
(Sigma, St. Louís USA) in a substrate buffer: 1 M diethanolamine HCL (Merck, Darmstadt, 
DE), at pH 9.8 was placed in each well of a 96-well plate. The plate was then incubated in 
the dark for 45 min at 37 0C. After the incubation period, 80 µl of a stop solution (2M 
NaOH) (Panreac, Barcelona, ES) containing 0.2 mM ethylenediaminetetraacetic acid 
(EDTA) (Sigma, St. Louís, USA), was added to each well. Standards were prepared with 
10µmol ml-1 pNP and the stop solutions in order to achieve final concentrations ranging 
between 0 and 0.3µmol-1. Triplicates were made for each sample and standard. 
Absorbance was read at 405 nm Microplate ELISA Reader (Synergie HT, Bio-Tek 
Instruments, Inc, Winooski, USA) and sample concentrations were read off from standard 
graph. To asses mineralization, cells cultured in 6-well plates with osteogenic medium for 
different time points were stained with Alizarin Red (Fluca, GE). 
Assessment of ALP In vivo was carried out by harvest of 2 ml of peripheral blood 
serum for assay in IDEXX VetTest® chemistry analyzer(Barcelona, ES) in days 0 ( day of 
the application of the cells), 7(first week) and 21(third week). To visualize the development 
of the mineralization in the gap site, X-rays (Philips Medical Systems, Carlsbad, CA) were 
carried out at days 0, 7(first week) and 21(third week) upon cells implantation. 
 
7.3 RESULTS 
 The CBMSCs presented a high in vitro osteoblastic-like differentiation potential, 
similarly to others studies carried out in mouse (18), rabbits (19), dogs (20), goats (21) 
sheep (22) and human (23).  
The high ALP activity registered after two weeks of in vitro culture in osteogenic 
media - day 0 (day of application) – demonstrated that these cells are undergoing 
osteoblastic differentiation. The synthesis of ALP has the main function of stimulating the 
extracellular matrix formation, carried out by osteoblasts through mineral deposition 
(mineralization).  
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This phenomenon can be evidenced by the gradual decrease of ALP activity 
registered at day 7(first week of implantantion) and day 21(third week of implantantion) in 
cells cultured in vitro (Figure 7.3).  
The Alizarin red staining was performed after day 21(three week) of culture, 
showing the mineralization of the cells at this stage (Figure 7.4). 
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Figure7.3. ALP activity in cells cultured in vitro, in osteogenic medium, at the day of 
implantation (after expansion for 2 weeks in osteogenic medium) and at 7 and 21 days of 
subsequent culturing. 
 
 
 
Figure7.4. Alizarin red staining of the cat bone marrow cells after 3 weeks of in vitro 
culture in osteogenic medium  
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 Values of the ALP activity measured in blood serum cat immediately before the 
application of the cells were within normal values reported for feline species. Abnormal 
values of the ALP (2 times or more) are indicative of pathological changes in bone, 
muscle, liver and reproductive tissues. The effect of the CBMSCs implanted was 
evidenced by the increase of ALP activity in cat serum registered at day 7(first week) and 
day 21 (three week) after cell application (Figure 7.5). 
 In fact, stem cells have great tropism for the injured site and participate in tissue 
regeneration by differentiating into specific cell types that are necessary in the damaged 
tissue, producing anabolic effects, stimulating neovascularization, recruiting additional 
stem cells and promoting anti-inflammatory effects (by secreting great levels of 
immunomodulatory and trophic agents) (24, 25). Thus, this increase in serum ALP is 
probably associated with an enhanced regeneration and bone healing at the fracture site. 
These findings are supported by the results displayed in the X-rays images, which showed 
an excellent outcome of the applied autogenic therapy. 
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Figure7.5. ALP activity in blood serum of the cat, measured at the day of the application of 
the cells (day 0) and 7 and 21 days after application. 
 
Specifically, in the X-ray images (Figure 7.6 A,B and C), the formation of new bone 
is easily identified as demonstrated by the rounded tops of fracture distal and proximal as 
well as the gradual increase in opacity within the focus of fracture, caused by the 
formation and deposition of calcium, characteristic of bone formation. After 3 weeks of the 
cells application, the radiographs showed satisfactory healing of the tibia, bone 
consolidation was observed (lamellar bone), and the animal had full use of the affected 
limb, was then given directions to the referring veterinarian to remove the ESF.  
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The owners reported that were not any signs of pain or lameness of the limb six 
months after application, and no side effects (inflammation) were visualized at the 
application site. Eighteen months after application, radiographs showed a medial deviation 
and recurvatum deformity of the tibial bone (Figure 7.7), caused initially after the surgery 
by the difficulty of the owners to keep the patient in cage rest, but the cat walked normally 
and without lameness. The joint mobilization was pain free and the range-of-motion in 
flexion and extension was similar to the contralateral limb.  
 
 
 
Figure7.6.Craneo-caudal radiographic projections obtained at: (A) day 0 (day of cells 
application); (B) after 1 weeks of cells application in the fracture site; (C) after 3 weeks of 
cells application in the fracture site. 
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Figure7.7. Craneo-caudal and latero-medial radiographic projections showing a medial 
deviation and recurvatum deformity of the tibial bone after eighteen months of follow-up. 
 
7.4 CONCLUSION 
 
 A major challenge for the owners of an orthopaedic veterinary patient is to keep 
the pet on the recommended laid down by the veterinary surgeon preventing it from doing 
high impact exercises, climbing up/down stairs, preventing slips on smooth floor, etc., 
during the first weeks of postoperative. Therefore these recommendations are very 
difficult to be strictly followed in most cases, which can lead to collapse of the bone 
fixation method selected according to the different classification of the long bone fractures 
types. This highlights the importance of a good planning of the fixation method type to 
select before surgery. Stem cell therapy is currently being used as an alternative 
treatment in various pathologies related to bone. This case report demonstrates that 
CBMCs differentiated into osteoblasts applied at the fracture site allows a rapid bone 
healing and functional return bone tissue, and thus ASCT should be considered as a new 
successful adjuvant therapy for a quick treatment of long-bone fracture in the orthopaedic 
surgery of small animals. 
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CONCLUSIONS 
The work developed under the scope of this thesis enabled to achieve results that 
led to several conclusions concerning the main objectives of this thesis, which are 
summarized below: 
1) Importance of bone marrow MSCs and scaffold material in the regeneration of 
critical sized defects 
The in vivo study performed in a rat model was designed to assess the influence of 
the 3D scaffolds loaded/non loaded with rat bone marrow stromal cells and cultured in 
static conditions with osteogenic medium in the regeneration of a rat calvarial critical size 
defect. For this purpose, the scaffold materials that was select to use in this thesis - 
starch/polycaprolactone (SPCL) fiber meshes - pre-loaded with RBMSCs or alone, were 
implanted in a the rat critical-sized cranial defects, for two different periods of implantation, 
namely four and eight weeks. Results obtained by Micro-CT reconstructions and 
histological analysis showed that bone formation increased over the implantation time and 
was enhanced in the defects filled with the scaffolds pre-loaded with RBMSCs as 
compared to SPCL scaffolds alone.  
These results showed that the pre-loaded RBMSCs contributed to the bone 
regeneration process in a critical-sized bone defect, possibly by the release of factors that 
induce the recruitment of osteprogenitor cells rather that participating directly in the new 
bone formed. SPCL fiber mesh scaffolds have also proved to be a suitable scaffold for 
bone engineering. In summary, this study clearly demonstrated that the regeneration of 
critical size bone defects requires the presence of both osteoprogenitor cells and a 
suitable scaffold. 
 
2) Development a flow perfusion bioreactor BCPB: 
A major challenge in the translation of tissue engineered bone grafts to viable clinical 
treatments of osseous defects has been the need to grow large, fully viable grafts that are 
several centimetres in size. This was the main motivation for the development of the flow 
perfusion Bioreactor (BCPB) under this thesis. The BCPB presents an innovative design 
that has proven to create mechanical cellular stimulus (described in chapter V,VI) through 
the generation of shear forces due to medium flow perfusion using different pressure 
gradients, controlled by peristaltic pumps. Furthermore, the flow-perfusion bioreactor is a 
scalable technology that should support the culture of porous scaffolds with large 
dimensions, up to 120 mm in length and 60 mm in diameter, which constitutes the main 
innovation of this system.  
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The culture of large sized constructs is enabled by the control of flow perfusion and 
pressure gradient from inside to outside of the scaffold and vice-versa, providing the 
adequate access to nutrients and removal of metabolic wastes of the cells located in the 
inner regions of thick 3D constructs, thereby maintaining cell viability and activity.  
Most tissue-engineering research has been constrained to using scaffolds of small 
dimensions (2mm in thickness or less), which are easily sustainable by medium convection 
or static culture methods. The experiments performed in this thesis showed that the BCPB 
enabled cells survival and proliferation in constructs of the 42mm in length, 16 mm in 
diameter and 3 mm thick, demonstrating that this new system flow perfusion is superior to 
the static culture for large-scale cell-construct culture. 
 
3) Functionality of the developed bioreactor: Effect of culture conditions provided 
by the newly developed flow perfusion bioreactor versus static condition, on the 
proliferation, distribution and differentiation of GBMSC’s seeded onto SPCL fiber mesh 
scaffolds. 
This in vitro study described under chapter V was planned to evaluate the 
feasibility of the newly developed flow perfusion bioreactor system for sustaining “thick” 
3D scaffolds that approach sizes of clinical relevance in the orthopaedic field. Specifically, 
as proof of principle, it were cultured in the bioreactor large cylindrical scaffolds (42mm in 
length, 16 mm in diameter and 3 mm thick), seeded with goat bone marrow stromal cells 
(GBMSCs), and compared to scaffolds cultured under static conditions. Results showed 
that the BCPB enabled GBMSC’s survival and proliferation in the GBMSC’s–SPCL 
constructs, and enabled superior outcomes as compared to the static culture conditions, 
particularly regarding GBMSCs osteogenic differentiation. Thus, the BCPB demonstrate 
be a simple and efficient system for enabling to culture large-scale scaffolds and obtain 
highly functional constructs for bone regeneration applications. 
 
4) Assessment of the in vivo functionality of constructs cultured in the newly 
developed bioreactor, using a critical size defect performed in a large animal 
The in vivo study described under chapter VI, performed in a goat model, 
demonstrated that 14 days of flow perfusion culturing of SPCL scaffolds-GBMSCs 
constructs induces differences in the functionality of the resulting constructs upon 
implantation in a critical size defect.  
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The results obtained showed that bone development was enhanced with the 
perfusion culture of the constructs of large dimension, demonstrating the importance of 
the culturing conditions in the in vivo functionality of the constructs composed of GBMSC’s 
and SPCL scaffolds. Furthermore, it was demonstrated that SPCL fibre mesh scaffolds 
enabled an appropriate biomechanical environment, providing an adequate tissue 3D 
support for the regeneration of bone in critical size defects. Thus, in summary, it was 
conclude that inoculating SPCL fiber meshes and osteogenic cells cultured in a perfusion 
system can improve the bone healing capacity of this tissue engineered constructs and 
demonstrates that the use of this perfusion culture system is a valuable and convenient 
tool for applications in bone regeneration. 
 
5) Studying autologous stem cell therapy of CBMSCs when applied in the 
treatment of a tibial fracture gap in a cat. Case report  
A major challenge in orthopedic veterinary surgery is to keep the pet on the 
recommended laid down by the veterinary surgeon preventing it from doing high impact 
exercises, during the first weeks of postoperative. 
 With know-how obtained along of this thesis, it was possible to assess, in a 
clinical case-study the application of an autologous stem cell therapy to enhance bone 
healing in a cat feline patient who presented a large gap fracture after fixing bone with 
external skeletal fixation type II. For this purpose, cat bone marrow stromal cells were 
harvested from the femoral medullar cavity through the use of a biopsy needle and pre-
differentiated in osteoblasts-like cells. A cells suspension containing 9x106 cells was 
injected in the gap site. The animal developed a callus with high opacity identified 
radiographically and also developed a clinical bone union that allowed the animal to fully 
utilize the affected limb two weeks after the application of the autologous stem cell 
therapy. 
Final concluding remarks: 
Accordingly to all the above mentioned findings it was possible to conclude that the 
work carried out in the scope of this thesis resulted in the development of a novel flow 
perfusion bioreactor that enables to culture large sized constructs allowing to obtain 
functional bone tissue-like substitutes for the regeneration of critical size defects. To the 
author’s knowledge, no reference can be found to other studies that have used a single 
culture chamber perfusion bioreactor for culturing scaffolds of large dimensions and 
subsequently implanted it in a critical size defect performed on large animal model.  
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The results obtained have also clearly demonstrated the important capabilities of 
the bone marrow stromal cells and SPCL as a 3D scaffold with high osteogenic potential 
within the area of bone tissue engineering. Finally is was shown that the application of 
autologous pre-differentiated stem cells presents itself as an alternative and adjuvant 
therapy for the repair of bone tissue. 
 
